0001410578-22-003348.txt : 20221114 0001410578-22-003348.hdr.sgml : 20221114 20221114160226 ACCESSION NUMBER: 0001410578-22-003348 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 48 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kubient, Inc. CENTRAL INDEX KEY: 0001729750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 821808844 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39441 FILM NUMBER: 221384909 BUSINESS ADDRESS: STREET 1: 500 7TH AVE., SUITE 14A131 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (800) 409-9456 MAIL ADDRESS: STREET 1: 500 7TH AVE., SUITE 14A131 CITY: NEW YORK STATE: NY ZIP: 10018 10-Q 1 kbnt-20220930x10q.htm 10-Q
0001729750--12-312022Q30014337412142528861430002213627435Kubient, Inc.14402500142539480.120.160.780.43P4Yhttp://www.kubient.com/20220930#ChangeInFairValueOfContingentConsiderationfalse0001729750kbnt:TwoThousandTwentyOneEquityIncentivePlanMember2022-01-012022-03-310001729750us-gaap:CommonStockMember2022-07-012022-09-300001729750us-gaap:RetainedEarningsMember2022-09-300001729750us-gaap:AdditionalPaidInCapitalMember2022-09-300001729750us-gaap:RetainedEarningsMember2022-06-300001729750us-gaap:AdditionalPaidInCapitalMember2022-06-3000017297502022-06-300001729750us-gaap:RetainedEarningsMember2022-03-310001729750us-gaap:AdditionalPaidInCapitalMember2022-03-3100017297502022-03-310001729750us-gaap:RetainedEarningsMember2021-12-310001729750us-gaap:AdditionalPaidInCapitalMember2021-12-310001729750us-gaap:RetainedEarningsMember2021-09-300001729750us-gaap:AdditionalPaidInCapitalMember2021-09-300001729750us-gaap:RetainedEarningsMember2021-06-300001729750us-gaap:AdditionalPaidInCapitalMember2021-06-3000017297502021-06-300001729750us-gaap:RetainedEarningsMember2021-03-310001729750us-gaap:AdditionalPaidInCapitalMember2021-03-3100017297502021-03-310001729750us-gaap:RetainedEarningsMember2020-12-310001729750us-gaap:AdditionalPaidInCapitalMember2020-12-310001729750us-gaap:CommonStockMember2022-09-300001729750us-gaap:CommonStockMember2022-06-300001729750us-gaap:CommonStockMember2022-03-310001729750us-gaap:CommonStockMember2021-12-310001729750us-gaap:CommonStockMember2021-09-300001729750us-gaap:CommonStockMember2021-06-300001729750us-gaap:CommonStockMember2021-03-310001729750us-gaap:CommonStockMember2020-12-310001729750us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberkbnt:TwoThousandTwentyOneEquityIncentivePlanMember2022-01-012022-03-310001729750us-gaap:RestrictedStockUnitsRSUMemberkbnt:TwoThousandTwentyOneEquityIncentivePlanMember2022-01-012022-03-310001729750us-gaap:RestrictedStockMemberkbnt:TwoThousandTwentyOneEquityIncentivePlanMember2022-01-012022-03-310001729750us-gaap:PerformanceSharesMemberkbnt:TwoThousandTwentyOneEquityIncentivePlanMember2022-01-012022-03-310001729750us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001729750us-gaap:RestrictedStockMember2022-01-012022-09-300001729750us-gaap:RetainedEarningsMember2022-07-012022-09-300001729750us-gaap:RetainedEarningsMember2022-04-012022-06-300001729750us-gaap:RetainedEarningsMember2022-01-012022-03-310001729750us-gaap:RetainedEarningsMember2021-07-012021-09-300001729750us-gaap:RetainedEarningsMember2021-04-012021-06-300001729750us-gaap:RetainedEarningsMember2021-01-012021-03-310001729750us-gaap:FairValueInputsLevel3Member2021-12-310001729750us-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:TopSevenSuppliersMember2022-07-012022-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierBMember2022-07-012022-09-300001729750kbnt:TopFiveCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001729750kbnt:CustomerEMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001729750kbnt:CustomerDMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001729750kbnt:CustomerBMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:TopSevenSuppliersMember2022-01-012022-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierMember2022-01-012022-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierCMember2022-01-012022-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierBMember2022-01-012022-09-300001729750kbnt:TopFourCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001729750kbnt:TopFiveCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001729750kbnt:CustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001729750kbnt:CustomerEMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001729750kbnt:CustomerDMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001729750kbnt:CustomerDMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001729750kbnt:CustomerBMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001729750kbnt:CustomerBMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:TopSevenSuppliersMember2021-07-012021-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierGMember2021-07-012021-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierFMember2021-07-012021-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierEMember2021-07-012021-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierDMember2021-07-012021-09-300001729750kbnt:TopFiveCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012021-09-300001729750kbnt:CustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012021-09-300001729750kbnt:CustomerCMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012021-09-300001729750kbnt:TopFourCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750kbnt:CustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750kbnt:CustomerCMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:TopSevenSuppliersMember2021-01-012021-09-300001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierEMember2021-01-012021-09-300001729750kbnt:TopFiveCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-09-300001729750kbnt:CustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-09-300001729750kbnt:CustomerCMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-09-3000017297502021-09-3000017297502020-12-310001729750kbnt:MediacrossingIncMember2021-11-300001729750us-gaap:WarrantMember2022-01-012022-09-300001729750us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001729750us-gaap:RestrictedStockMember2022-01-012022-09-300001729750us-gaap:EmployeeStockMember2022-01-012022-09-300001729750us-gaap:WarrantMember2021-01-012021-09-300001729750us-gaap:EmployeeStockMember2021-01-012021-09-300001729750us-gaap:TechnologyServiceMember2022-07-012022-09-300001729750us-gaap:SellingAndMarketingExpenseMember2022-07-012022-09-300001729750us-gaap:GeneralAndAdministrativeExpenseMember2022-07-012022-09-300001729750us-gaap:TechnologyServiceMember2022-01-012022-09-300001729750us-gaap:SellingAndMarketingExpenseMember2022-01-012022-09-300001729750us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-300001729750us-gaap:TechnologyServiceMember2021-07-012021-09-300001729750us-gaap:SellingAndMarketingExpenseMember2021-07-012021-09-300001729750us-gaap:GeneralAndAdministrativeExpenseMember2021-07-012021-09-300001729750us-gaap:TechnologyServiceMember2021-01-012021-09-300001729750us-gaap:SellingAndMarketingExpenseMember2021-01-012021-09-300001729750us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-09-300001729750us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001729750us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-3000017297502021-07-012021-09-300001729750us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001729750us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001729750us-gaap:CommonStockMember2021-04-012021-06-300001729750us-gaap:CommonStockMember2021-01-012021-03-310001729750us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001729750us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100017297502022-01-012022-03-310001729750us-gaap:CommonStockMember2022-04-012022-06-300001729750us-gaap:CommonStockMember2022-01-012022-03-310001729750us-gaap:RestrictedStockMember2022-07-012022-09-3000017297502022-04-012022-06-300001729750srt:MinimumMemberkbnt:TwoThousandTwentyOneEquityIncentivePlanMember2022-01-012022-03-310001729750srt:MaximumMemberkbnt:TwoThousandTwentyOneEquityIncentivePlanMember2022-01-012022-03-3100017297502022-07-012022-09-300001729750srt:MinimumMember2022-01-012022-09-300001729750srt:MaximumMember2022-01-012022-09-3000017297502021-04-012021-06-3000017297502021-01-012021-03-310001729750kbnt:MediacrossingIncMember2021-11-302021-11-300001729750srt:ExecutiveOfficerMember2022-01-012022-03-310001729750us-gaap:WarrantMember2022-09-300001729750kbnt:MediacrossingIncMember2022-07-012022-09-300001729750kbnt:MediacrossingIncMember2022-01-012022-09-3000017297502021-01-012021-09-3000017297502022-09-3000017297502021-12-310001729750us-gaap:WarrantMember2022-01-012022-09-300001729750us-gaap:CommonStockMember2022-01-012022-09-3000017297502022-11-1000017297502022-01-012022-09-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number: 001-39441

Graphic

KUBIENT, INC.

(Exact name of registrant as specified in its charter)

Delaware

   

82-1808844

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

500 7th Avenue, 8th Floor

New York, New York 10018

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (800) 409-9456

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

   

Trading Symbol

    

Name of each exchange on which registered

Common Stock, par value $0.00001 per share

KBNT

 

The Nasdaq Stock Market LLC

Common Stock Purchase Warrants

KBNTW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes    No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes      No  

As of November 10, 2022, the registrant had 14,402,500 shares of common stock outstanding.

KUBIENT, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED September 30, 2022

INDEX

 

 

Page

Part I.

FINANCIAL INFORMATION

Item 1.

Financial Statements

1

Condensed Consolidated Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021

1

Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2022 and 2021

2

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three and Nine Months Ended September 30, 2022 and 2021

3

Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021

5

Notes to Unaudited Condensed Consolidated Financial Statements

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

14

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

22

Item 4.

Controls and Procedures

23

 

Part II.

OTHER INFORMATION

24

Item 1.

Legal Proceedings

24

Item 1A.

Risk Factors

24

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

24

Item 3.

Defaults Upon Senior Securities

24

Item 4.

Mine Safety Disclosure

24

Item 5.

Other Information

24

Item 6.

Exhibits

25

Signatures

26

Glossary

A-1

Item 1. Financial Statements

Kubient, Inc.

Condensed Consolidated Balance Sheets

    

September 30, 

    

December 31, 

2022

2021

(unaudited)

Assets

 

  

 

  

Current Assets:

 

  

 

  

Cash and cash equivalents

$

16,897,563

$

24,907,963

Accounts receivable, net

 

448,815

 

2,291,533

Other receivables

526,070

Prepaid expenses and other current assets

 

502,912

 

495,178

Total Current Assets

 

17,849,290

 

28,220,744

Intangible assets, net

 

 

2,946,610

Goodwill

463,000

Property and equipment, net

 

 

44,756

Deferred offering costs

 

10,000

 

10,000

Total Assets

$

17,859,290

$

31,685,110

 

  

 

  

Liabilities and Stockholders’ Equity

 

  

 

  

Current Liabilities:

 

  

 

  

Accounts payable - suppliers

$

727,432

$

1,844,544

Accounts payable - trade

 

369,040

 

659,362

Accrued expenses and other current liabilities

 

716,484

 

2,493,287

Deferred revenue

767,833

395,914

Notes payable

 

1,539

 

151,336

Total Current Liabilities

 

2,582,328

 

5,544,443

Contingent consideration

613,000

Notes payable, non-current portion

 

77,361

 

77,407

Total Liabilities

 

2,659,689

 

6,234,850

 

  

 

  

Commitments and contingencies

 

  

 

  

Stockholders’ Equity:

 

  

 

  

Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of September 30, 2022 and December 31, 2021

 

 

Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,402,500 and 14,253,948 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively

 

144

 

143

Additional paid-in capital

 

52,891,794

 

52,030,907

Accumulated deficit

 

(37,692,337)

 

(26,580,790)

Total Stockholders’ Equity

 

15,199,601

 

25,450,260

Total Liabilities and Stockholders’ Equity

$

17,859,290

$

31,685,110

The accompanying notes are an integral part of these condensed consolidated financial statements.

1

Kubient, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

    

For the Three Months Ended

    

For the Nine Months Ended

September 30, 

September 30, 

    

2022

    

2021

    

2022

    

2021

Net Revenues

$

481,812

$

676,986

$

2,127,467

$

1,882,311

Costs and Expenses:

 

 

 

 

Sales and marketing

735,296

715,820

3,118,729

1,977,150

Technology

 

525,383

 

776,573

 

2,640,239

 

1,916,020

General and administrative

 

1,132,649

 

1,514,913

 

4,824,406

 

3,878,765

Impairment loss on intangible assets

2,626,974

Impairment loss on property and equipment

49,948

Impairment loss on goodwill

463,000

Loss accrual on customer contract

(232,964)

142,723

Total Costs and Expenses

 

2,160,364

 

3,007,306

 

13,866,019

 

7,771,935

Loss From Operations

 

(1,678,552)

 

(2,330,320)

 

(11,738,552)

 

(5,889,624)

Other (Expense) Income:

 

  

 

  

 

  

 

  

Interest expense

 

(2,508)

 

(2,098)

 

(8,916)

 

(5,308)

Interest income

6,896

21,805

11,921

84,469

Change in fair value of contingent consideration

613,000

Other income

 

 

 

11,000

 

233

Total Other Income

 

4,388

 

19,707

 

627,005

79,394

Net Loss

$

(1,674,164)

$

(2,310,613)

$

(11,111,547)

$

(5,810,230)

Net Loss Per Share - Basic and Diluted

$

(0.12)

$

(0.16)

$

(0.78)

$

(0.43)

Weighted Average Common Shares Outstanding - Basic and Diluted

 

14,337,412

 

14,252,886

 

14,300,022

 

13,627,435

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

Kubient, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(unaudited)

    

For the Nine Months Ended September 30, 2022

Additional

Common Stock

Paid-In

Accumulated

    

Shares

    

Amount

    

Capital

    

Deficit

    

Total

Balance - January 1, 2022

 

14,253,948

$

143

$

52,030,907

$

(26,580,790)

$

25,450,260

Surrender and cancellation of common stock

(3,397)

(18,683)

(18,683)

Stock-based compensation:

Common stock

 

53,192

 

 

430,361

 

 

430,361

Options

2,295

2,295

Net loss

 

 

 

 

(3,627,492)

 

(3,627,492)

Balance - March 31, 2022

 

14,303,743

 

143

 

52,444,880

 

(30,208,282)

 

22,236,741

Surrender and cancellation of common stock

 

(8,323)

(36,188)

(36,188)

Stock-based compensation:

 

 

  

 

  

 

  

 

  

Common stock

 

105,832

 

1

 

308,950

 

 

308,951

Options

 

 

 

2,067

 

 

2,067

Net loss

 

 

 

 

(5,809,891)

 

(5,809,891)

Balance - June 30, 2022

14,401,252

144

52,719,709

(36,018,173)

16,701,680

Stock-based compensation:

Common stock

 

1,248

 

 

169,849

 

 

169,849

Options

2,236

2,236

Net loss

 

 

 

 

(1,674,164)

 

(1,674,164)

Balance - September 30, 2022

 

14,402,500

$

144

$

52,891,794

$

(37,692,337)

$

15,199,601

3

    

For the Nine Months Ended September 30, 2021

Additional

Common Stock

Paid-In

Accumulated

    

Shares

    

Amount

    

Capital

    

Deficit

    

Total

Balance - January 1, 2021

 

11,756,109

$

118

$

40,770,504

$

(16,289,077)

$

24,481,545

Shares issued upon exercise of warrants, net of issuance costs [1]

2,047,361

20

9,274,891

9,274,911

Stock-based compensation:

 

  

 

  

 

  

 

  

 

  

Common stock

70,040

1

513,102

513,103

Options

 

 

 

2,576

 

 

2,576

Net loss

 

 

 

 

(1,796,612)

 

(1,796,612)

Balance - March 31, 2021

 

13,873,510

139

50,561,073

(18,085,689)

32,475,523

Shares issued upon exercise of warrants, net of issuance costs [2]

 

108,961

 

1

 

428,718

 

 

428,719

Common stock issued upon exercise of options

2,815

8,361

8,361

Shares issued as partial consideration for intangible asset

100,000

1

531,999

532,000

Stock-based compensation:

 

  

 

  

 

  

 

  

 

  

Common stock

167,600

2

27,568

27,570

Options

 

 

 

2,509

 

 

2,509

Net loss

 

 

 

 

(1,703,005)

 

(1,703,005)

Balance - June 30, 2021

 

14,252,886

143

51,560,228

(19,788,694)

31,771,677

Stock-based compensation:

 

 

  

 

  

 

  

 

  

Common stock

264,502

264,502

Options

2,533

2,533

Net loss

 

 

 

 

(2,310,613)

 

(2,310,613)

Balance - September 30, 2021

 

14,252,886

$

143

$

51,827,263

$

(22,099,307)

$

29,728,099

[1]

Includes gross proceeds of $9,708,038, less issuance costs of $433,127.

[2]

Includes gross proceeds of $460,989, less issuance costs of $32,270.

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Kubient, Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited)

    

For the Nine Months Ended

September 30, 

    

2022

    

2021

Cash Flows From Operating Activities:

 

  

 

  

Net loss

$

(11,111,547)

$

(5,810,230)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

  

Bad debt expense

7,000

Impairment loss on intangible assets

2,626,974

Impairment loss on property and equipment

49,948

Impairment loss on goodwill

463,000

Depreciation and amortization

 

330,993

 

304,068

Change in fair value of contingent consideration

(613,000)

Stock-based compensation:

 

  

 

  

Common stock

 

872,123

 

516,381

Options

6,598

7,618

Changes in operating assets and liabilities:

 

  

 

Accounts receivable

 

1,835,718

 

1,000,783

Other receivable

507,387

Prepaid expenses and other current assets

 

350,132

 

(155,367)

Accounts payable - suppliers

 

(1,117,112)

 

115,681

Accounts payable - trade

 

(290,321)

 

(289,215)

Accrued expenses and other current liabilities

(1,817,278)

(274,667)

Accrued interest

 

 

7,025

Deferred revenue

371,919

Net Cash Used In Operating Activities

 

(7,527,466)

 

(4,577,923)

 

  

 

  

Cash Flows From Investing Activities:

 

  

 

  

Purchase of intangible assets

 

 

(1,133,072)

Purchase of property and equipment

 

(16,549)

 

(24,331)

Net Cash Used In Investing Activities

 

(16,549)

 

(1,157,403)

Cash Flows From Financing Activities:

 

  

 

  

Proceeds from exercise of warrants [1]

9,787,149

Proceeds from exercise of options

8,361

Repayment of PPP loan

(149,843)

(68,346)

Repayment of financed director and officer insurance premiums

(316,542)

Payment of deferred offering costs

(27,510)

Net Cash (Used In) Provided By Financing Activities

 

(466,385)

 

9,699,654

Net (Decrease) Increase In Cash and Cash Equivalents

 

(8,010,400)

 

3,964,328

Cash and Cash Equivalents - Beginning of the Period

 

24,907,963

 

24,782,128

Cash and Cash Equivalents - End of the Period

$

16,897,563

$

28,746,456

[1]

Includes gross proceeds of $10,169,027, less issuance costs of $381,878.

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Kubient, Inc.

Condensed Consolidated Statements of Cash Flows (Continued)

For the Nine Months Ended

September 30, 

2022

    

2021

Supplemental Disclosures of Cash Flow Information:

Cash paid during the period for:

 

  

 

  

Interest

$

4,847

$

4,588

Income taxes

$

$

 

  

 

  

Non-cash investing and financing activities:

 

  

 

  

Surrender and cancellation of common stock

$

(18,683)

$

Shares of common stock issued in satisfaction of accrued issuable equity

$

$

507,044

Accrual of warrant exercise issuance costs

$

$

83,519

Shares issued as partial consideration for intangible asset

$

$

532,000

Financing of insurance premiums

$

357,866

362,625

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

Organization and Operations

Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Risks and Uncertainties

The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company’s operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted.

Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.

There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.

7

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair statement of the unaudited condensed consolidated financial statements of the Company as of September 30, 2022 and for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the operating results for the full year ending December 31, 2022 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures as of December 31, 2021 and 2020 and for the years then ended which are included the Annual Report filed on Form 10-K on March 31, 2022.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

There have been no material changes to the significant accounting policies included in the audited consolidated financial statements as of December 31, 2021 and 2020 and for the years then ended, which were included the Annual Report filed on Form 10-K on March 31, 2022, except as disclosed in this note.

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

8

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized an estimated loss accrual (reversal) on a customer contract of $(232,964) and $142,723, respectively, related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

As of September 30, 2022 and December 31, 2021, the Company did not have any contract assets from contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized $0 and $395,914 of revenue that was deferred as of December 31, 2021. As of September 30, 2022 and December 31, 2021, the Company had $767,833 and $395,914, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three and nine months ended September 30, 2022, there was $107,538 and $282,244 of net revenue, respectively, recognized from performance obligations satisfied during the three months ended March 31, 2022. During the three and nine months ended September 30, 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Three and Nine Months Ended

September 30, 

    

2022

    

2021

Warrants [1]

5,122,074

5,122,074

Restricted stock units

538,104

Restricted stock awards

64,585

Stock options

 

36,667

 

94,447

 

5,761,430

 

5,216,521

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.

NOTE 3 – LONG-LIVED ASSETS AND GOODWILL

During the three months ended June 30, 2022, the Company identified triggering events that indicated its long-lived assets including its definite-lived intangible assets were at risk of impairment and, as such, performed a quantitative impairment assessment to evaluate recoverability and, ultimately, whether carrying value exceeded fair value. The primary triggers for the impairment review were a loss of customers as well as a reduction in the value of Kubient's market capitalization. As a result of the quantitative assessments, the Company determined the fair value of the asset group was less than the carrying value and, accordingly, determined the Company's long-lived assets were fully impaired. As a result, during the nine months ended September 30, 2022, the Company recognized an impairment loss on intangible assets and property and equipment of $2,626,974 and $49,948, respectively, on its condensed consolidated statements of operations.

9

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

During the three months ended June 30, 2022, the Company identified triggering events that indicated its goodwill associated with its acquisition of MediaCrossing was at risk of impairment and, as such, performed a quantitative impairment assessment to determine whether the fair value of the reporting unit (determined to be the Company) exceeded its fair value. The primary triggers for the impairment review were a loss of customers as well as a reduction in the value of Kubient's market capitalization. As a result of the quantitative assessments, the Company determined the fair value of the reporting unit was less than the carrying value and, accordingly, determined the Company's goodwill was fully impaired. As a result, during the nine months ended September 30, 2022, the Company recognized an impairment loss on goodwill of $463,000 on its condensed consolidated statements of operations.

NOTE 4 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

    

September 30, 

    

December 31, 

2022

2021

Accrued bonuses

$

79,842

$

554,997

Accrued payroll

13,750

Financed director and officer insurance premiums

252,720

217,575

Accrued supplier expenses

 

57,902

 

67,971

Accrued legal settlement

975,000

Accrued legal and professional fees

 

12,000

 

20,323

Accrued commissions

 

2,272

 

36,109

Accrued media commissions

138,028

Credit card payable

 

198,212

 

328,075

Accrued programming expenses

 

 

1,750

Accrued issuable equity

 

409

 

1,258

Accrued interest

13,388

9,017

Accrued warrant exercise costs

83,519

83,519

Other

 

16,220

 

45,915

Total accrued expenses and other current liabilities

$

716,484

$

2,493,287

NOTE 5 – STOCKHOLDERS’ EQUITY

Stock-Based Compensation

For the three and nine months ended September 30, 2022 and 2021, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows:

    

For the Three Months Ended

    

For the Nine Months Ended

September 30, 

 

September 30, 

2022

    

2021

 

2022

    

2021

Sales and marketing

$

67,864

$

35,309

$

95,288

$

274,274

Technology

 

36,129

 

34,703

171,720

36,063

General and administrative

 

53,101

 

193,235

611,713

213,662

Total

$

157,094

$

263,247

$

878,721

$

523,999

10

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

As of September 30, 2022, there was approximately $1,392,000 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 3.4 years.

During the three months ended March 31, 2022, the Company granted 53,192 shares of immediately vested restricted stock awards (“RSAs”) to non-employee directors under the Kubient, Inc. 2021 Equity Incentive Plan (the “2021 Plan”) with an aggregate grant date fair value of $100,000 that was recognized immediately.

During the three months ended March 31, 2022, the Company granted 100,000 RSAs, 489,990 restricted stock units (“RSUs”) and a target number of 234,376 performance stock units (“PSUs”), all issued under the 2021 Plan. The RSAs and RSUs generally vest over four years and the PSUs are earned based upon actual net revenue generated by the Company during 2022 as compared to the targeted revenue specified in each award. Depending on actual net revenues generated as compared to the targeted amounts, the grantees may earn between 0% and 150% of their target award. The awards had an aggregate issuance date fair value of approximately $1,900,000. During the three months ended September 30, 2022, the Company issued 1,248 shares of common stock related to the aforementioned RSUs.

During the three months ended September 30, 2022, the Company granted 22,917 shares of immediately vested RSAs to a former employee under the 2021 Plan with an aggregate grant date fair value of approximately $28,000 that was recognized immediately.

During the three months ended September 30, 2022, the Company granted 25,000 shares of  RSAs to an employee under the 2021 Plan with an aggregate grant date fair value of approximately $29,000 which is being recognized over the 4 year vesting term of the award.

Common Stock

During the three months ended March 31, 2022, the Company’s chief financial officer surrendered to the Company 3,397 shares of common stock, which were subsequently cancelled by the Company, in order to satisfy a tax withholding obligation of approximately $18,000 in connection with a previous grant.

During the three months ended June 30, 2022, the Company cancelled 8,323 shares of common stock related to the forfeiture of RSAs from a terminated employee.

NOTE 6 – FAIR VALUE MEASUREMENT

On November 30, 2021, Kubient entered into and consummated an Asset Purchase Agreement (the “Purchase Agreement”) between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”), pursuant to which the Company acquired certain assets and liabilities that were critical to continue to operate the business of MediaCrossing for (i) $500,000 in cash and (ii) if the acquired business achieves certain milestones in 2022, up to 822,369 shares of the Company’s common stock, par value $0.00001 per share (the “Earnout Shares”) (the “Transaction”). The Earnout Shares had a fair value of $2.55 as of the acquisition date. The Earnout Shares were measured using a Monte Carlo simulation. Key assumptions used in the fair value assessment consisted of revenue projections (which were used to estimate the number of Earnout Shares issuable), discount rate and standard deviation. The fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect Kubient’s own assumptions in measuring fair value.

On September 30, 2022, the Company recomputed the fair value of its Earnout Shares as $0 using the Monte Carlo simulation. The Company recorded a gain on the change in fair value of the contingent consideration of $0 and $613,000 during the three and nine months ended September 30, 2022, respectively. The loss is primarily due to the decline in the Companys stock price as well as changes in the likelihood that forecasted milestones would be met for the remainder of 2022.

11

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis:

Contingent Consideration

    

  

Beginning balance as of January 1, 2022

$

613,000

Change in fair value of contingent consideration

 

(613,000)

Ending balance as of September 30, 2022

$

NOTE 7 – CONCENTRATIONS

Customer Concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Three Months Ended

    

For the Nine Months Ended

 

September 30, 

September 30, 

 

Customer

    

2022

    

2021

    

2022

    

2021

 

Customer A

 

N/A

81.82

%

24.59

%

94.20

%

Customer B

10.67

%  

N/A

29.08

%

N/A

Customer C

N/A

32.82

%

N/A

12.66

%

Customer D

53.58

%  

N/A

15.76

%  

N/A

Customer E

22.32

%

N/A

15.55

%  

N/A

Total

 

86.58

%  

114.64

%

84.98

%  

106.86

%

From time to time, certain customers generate negative net revenues that resulted from Supplier Costs that exceeded the Gross Billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:

    

September 30, 

    

December 31, 

 

Customer

2022

2021

 

Customer A

 

N/A

 

22.08

%

Customer B

 

41.35

%  

*

Customer C

 

*

52.18

%

Customer D

 

30.58

%  

N/A

Total

 

71.93

%  

74.26

%

* Less than 10%.

A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.

12

Table of Contents

Kubient, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Supplier Concentrations

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:

    

For the Three Months Ended

    

For the Nine Months Ended

 

September 30, 

September 30, 

 

Supplier

    

2022

    

2021

    

2022

    

2021

 

Supplier A

 

N/A

N/A

13.34

%

N/A

Supplier B

 

24.31

%

N/A

26.79

%

N/A

Supplier C

 

N/A

N/A

11.74

%

N/A

Supplier D

 

*

13.85

%  

*

*

Supplier E

N/A

24.18

%  

*

16.60

%

Supplier F

N/A

10.97

%  

*

*

Supplier G

N/A

10.43

%  

N/A

*

Total

 

24.31

%  

59.43

%  

51.87

%  

16.60

%

* Less than 10%.

13

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future financial or operating performance and may include statements concerning, among other things, our business strategy (including anticipated trends and developments in, and management plans for, our business and the markets in which we operate), financial results, the impact of COVID-19 on our business, operations, and the markets and communities in which we, our clients, and partners operate, results of operations, revenues, operating expenses, and capital expenditures, sales and marketing initiatives and competition. In some cases, you can identify forward-looking statements because they contain words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “suggests,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. These statements are not guarantees of future performance; they reflect our current views with respect to future events and are based on assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from expectations or results projected or implied by forward-looking statements.

We discuss many of these risks in other filings we make from time to time with the Securities and Exchange Commission (the “SEC”). Also, these forward-looking statements represent our estimates and assumptions only as of the date of this Quarterly Report on Form 10-Q, which are inherently subject to change and involve risks and uncertainties. Unless required by federal securities laws, we assume no obligation to update any of these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated, to reflect circumstances or events that occur after the statements are made. Given these uncertainties, investors should not place undue reliance on these forward-looking statements.

Investors should read this Quarterly Report on Form 10-Q and the documents that we reference in this report and have filed with the SEC, including our Annual Report on Form 10-K, filed with the SEC on March 31, 2022, with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Unless the context requires otherwise, references to the “Company,” “Kubient,” “we,” “us” and “our” refer to Kubient, Inc., a Delaware corporation and its wholly-owned subsidiary, Fidelity Media, LLC, a Delaware limited liability company. For explanations of certain terms used in this Quarterly Report on Form 10-Q, please read “Glossary” beginning on page A-1.

Overview

Kubient, Inc. (“Kubient,” “we,” “our,” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection & prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. Most importantly, it’s self-learning, getting smarter and more accurate over time. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

14

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Russian Sanctions

The current invasion of Ukraine by Russia has escalated tensions among the United States, the North Atlantic Treaty Organization (“NATO”) and Russia. The United States and other NATO member states, as well as non-member states, have announced new sanctions against Russia and certain Russian banks, enterprises and individuals. Violation of such sanctions could result in civil and criminal, monetary and non-monetary penalties, disruptions to our business, limitations on our ability to import and export products and services, and damage to our reputation. As a result, the Company had terminated 10 contractors performing software engineering services as of March 25, 2022. As a result, the Company does not currently employ or contract with any engineers located in Russia. The current political climate has reduced the available number of engineers for hire in such regions. Furthermore, on-going conflict in Ukraine and the spread of political tensions in surrounding areas could increase the threat of cyberwarfare as well as wide-spread internet service interruptions, which would likely disrupt or delay the operations of many digitally-focused companies such as our own.

COVID-19

The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company’s operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted.

Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.

There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.

15

Results of Operations

Three Months Ended September 30, 2022 Compared With Three Months Ended September 30, 2021

The following table presents the results of operations for the three months ended September 30, 2022 and 2021:

For the Three Months Ended

September 30, 

    

2022

    

2021

Net Revenues

$

481,812

$

676,986

Costs and Expenses:

 

 

Sales and marketing

 

735,296

 

715,820

Technology

 

525,383

 

776,573

General and administrative

 

1,132,649

 

1,514,913

Loss accrual on customer contract

(232,964)

Total Costs and Expenses

 

2,160,364

 

3,007,306

Loss From Operations

 

(1,678,552)

 

2,330,320

Other (Expense) Income:

 

  

 

  

Interest expense

 

(2,508)

 

(2,098)

Interest income

 

6,896

 

21,805

Total Other Income

 

4,388

 

19,707

Net Loss

$

(1,674,164)

$

(2,310,613)

Net Revenues

For the three months ended September 30, 2022, net revenues decreased by $195,174, or 29%, to $481,812 from $676,986 for the three months ended September 30, 2021. The decrease was primarily attributable to a decrease of $495,000 of net revenues associated with a major customer as compared to the 2021 period, partially offset by revenues generated in the 2022 period related to customer contracts acquired in connection with our acquisition of MediaCrossing in November 2021.

See Loss Accrual on Customer Contract for a discussion of a reversal of an estimated loss accrual recorded during the three months ended September 30, 2022 associated with a contract with a customer.

Sales and Marketing

For the three months ended September 30, 2022, sales and marketing expenses increased by $19,476, or 3%, to $735,296 from $715,820 for the three months ended September 30, 2021. The increase is primarily due to an increase in headcount costs of approximately $119,000, partially offset by a decrease in selling expenses of approximately $110,000.

Technology

For the three months ended September 30, 2022, technology expenses decreased by $251,190, or 32%, to $525,383 from $776,573 for the three months ended September 30, 2021. The decrease is primarily due to a decrease in headcount costs of approximately $74,000, hosting fees of approximately $13,000, software-technology subscription expense of approximately $10,000, amortization of approximately $141,000 and consulting expenses of approximately $14,000.

16

General and Administrative

For the three months ended September 30, 2022, general and administrative expenses decreased by $382,264, or 25%, to $1,132,649 from $1,514,913 for the three months ended September 30, 2021. The decrease is primarily due to decreases in non-cash stock-based compensation of approximately $141,000, professional services expense of approximately $118,000 and consulting expense of approximately $108,000.

Loss Accrual on Customer Contract

During the three months ended September 30, 2022, we reversed $232,964 of the loss accrual on customer contract related to media costs incurred associated with a contract with a customer. The reversal was a result of our recognition of revenue during the three months ended September 30, 2022 for cash payments received related to the loss accrual we recognized the quarter ended March 31, 2022. We will continue to monitor this loss accrual going forward.

Other Income

For the three months ended September 30, 2022, other income decreased by $15,319, or 78%, to $4,388 from other income of $19,707 for the three months ended September 30, 2021, primarily as a result of decreased interest income.

Nine Months Ended September 30, 2022 Compared With Nine Months Ended September 30, 2021

The following table presents the results of operations for the nine months ended September 30, 2022 and 2021:

    

For the Nine Months Ended

September 30,

    

2022

    

2021

Net Revenues

$

2,127,467

$

1,882,311

Costs and Expenses:

 

  

 

  

Sales and marketing

 

3,118,729

 

1,977,150

Technology

 

2,640,239

 

1,916,020

General and administrative

 

4,824,406

 

3,878,765

Impairment loss on intangible assets

 

2,626,974

 

Impairment loss on property and equipment

49,948

Impairment loss on goodwill

 

463,000

 

Loss accrual on customer contract

 

142,723

 

Total Costs and Expenses

 

13,866,019

 

7,771,935

Loss From Operations

 

(11,738,552)

 

(5,889,624)

Other (Expense) Income:

 

  

 

  

Interest expense

 

(8,916)

 

(5,308)

Interest income

 

11,921

 

84,469

Change in fair value of contingent consideration

 

613,000

 

Other income

 

11,000

 

233

Total Other Income

 

627,005

 

79,394

Net Loss

$

(11,111,547)

$

(5,810,230)

Net Revenues

For the nine months ended September 30, 2022, net revenues increased by $245,156, or 13%, to $2,127,467 from $1,882,311 for the nine months ended September 30, 2021. The increase in net revenues is primarily attributable to net revenues generated related to customer contracts acquired in connection with our acquisition of MediaCrossing in November 2021, partially offset by a decrease of $696,000 of net revenues associated with a major customer as compared to the 2021 period.

17

See Loss Accrual on Customer Contract for a discussion of an estimated loss accrual recorded during the nine months ended September 30, 2022 associated with a contract with a customer.

Sales and Marketing

For the nine months ended September 30, 2022, sales and marketing expenses increased by $1,141,579, or 58%, to $3,118,729 from $1,977,150 for the nine months ended September 30, 2021. The increase is primarily due to an increase in headcount costs of approximately $1,610,000 and software tools of approximately $87,000, partially offset by a decrease in non-cash stock-based compensation of approximately $179,000, selling expense of approximately $250,000, sales commissions expense of approximately $56,000 and consulting expense of approximately $78,000.

Technology

For the nine months ended September 30, 2022, technology expenses increased by $724,219, or 38%, to $2,640,239 from $1,916,020 for the nine months ended September 30, 2021. The increase is primarily due to an increase in headcount costs of approximately $310,000, hosting fees of approximately $286,000, non-cash stock-based compensation of approximately $137,000, amortization of approximately $27,000, software tools expense of approximately $23,000, partially offset by a decrease in consulting expense of approximately $39,000.

General and Administrative

For the nine months ended September 30, 2022, general and administrative expenses increased by $945,641, or 24%, to $4,824,406 from $3,878,765 for the nine months ended September 30, 2021. The increase is primarily due to increases in professional fees of approximately $542,000, non-cash stock-based compensation of approximately $397,000, office expenses of approximately $130,000, director fees of approximately $89,000, headcount costs of approximately $49,000, state taxes of approximately $22,000, dues and software subscriptions of approximately $53,000, partially offset by a decrease in consulting services expense of approximately $234,000, recruiting expense of approximately $98,000, and insurance expense of approximately $5,000.

Impairment Loss on Intangible Assets, Property and Equipment and Goodwill

During the nine months ended September 30, 2022, we recognized an impairment loss on intangible assets of $2,626,974, an impairment loss on property and equipment of $49,948 and an impairment loss on goodwill of $463,000.

During the nine months ended September 30, 2022, we identified triggering events that indicated its finite-lived intangible assets and goodwill were at risk of impairment and, as such, performed the required quantitative impairment assessment to ultimately evaluate whether carrying value exceeded fair value. The primary triggers for the impairment review were a loss of customers as well as a reduction in the value of Kubient’s market capitalization. As a result of the quantitative assessments, we determined the intangible assets and goodwill were fully impaired.

Loss Accrual on Customer Contract

During the nine months ended September 30, 2022, we recognized an estimated loss accrual on a customer contract of $142,723 related to media costs incurred associated with a contract with a customer. We will continue to monitor this loss accrual going forward.

Other Income

For the nine months ended September 30, 2022, other income increased by $547,611, or 690%, to $627,005 from $79,394 for the nine months ended September 30, 2021. The increase is primarily due to a gain recognized related to a decrease in the fair value of the earnout shares issuable to MediaCrossing.

18

Non-GAAP Measures

Adjusted EBITDA

The Company defines EBITDA as net income (loss) before interest, taxes and depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, further adjusted to eliminate the impact of certain non-recurring items and other items that we do not consider in our evaluation of our ongoing operating performance from period to period. These items will include stock-based compensation, restructuring and severance costs, transaction costs, acquisition costs, certain other non-recurring charges and gains that the Company does not believe reflects the underlying business performance.

For the three and nine months ended September 30, 2022 and 2021, EBITDA and Adjusted EBITDA consisted of the following:

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

    

2022

    

2021

    

2022

    

2021

Net Loss

$

(1,674,164)

$

(2,310,613)

$

(11,111,547)

$

(5,810,230)

Interest expense

 

2,508

 

2,098

8,916

5,308

Interest income

 

(6,896)

 

(21,805)

(11,921)

(84,469)

Depreciation and amortization

 

 

144,775

330,993

304,068

EBITDA

 

1,678,552

 

(2,185,545)

(10,783,559)

(5,585,323)

 

 

Adjustments:

 

 

Stock-based compensation expense

$

157,094

$

263,247

878,721

523,999

Impairment loss on intangible assets

2,626,974

Impairment loss on property and equipment

49,948

Impairment loss on goodwill

463,000

Change in fair value of contingent consideration

(613,000)

Adjusted EBITDA

$

(1,521,458)

$

(1,922,298)

$

(7,377,916)

$

(5,061,324)

Adjusted Loss Per Share

$

(0.11)

$

(0.13)

$

(0.51)

$

(0.37)

Weighted Average Common Shares Outstanding -

Basic and Diluted

14,337,412

14,252,886

14,300,022

13,627,435

EBITDA and Adjusted EBITDA is a financial measure that is not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes that because Adjusted EBITDA excludes (a) certain non-cash expenses (such as depreciation, amortization and stock-based compensation) and (b) expenses that are not reflective of the Company’s core operating results over time (such as stock-based compensation expense), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period. The Company’s management uses EBITDA and Adjusted EBITDA (a) as a measure of operating performance, (b) for planning and forecasting in future periods, and (c) in communications with the Company’s board of directors concerning the Company’s financial performance. The Company’s presentation of EBITDA and Adjusted EBITDA are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation and should not be used by investors as a substitute or alternative to net income or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes EBITDA and Adjusted EBITDA should be used to supplement the Company’s financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.

Although Adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, Adjusted EBITDA has limitations as an analytical tool, and investors should not consider it in isolation or as a substitute for, or more meaningful than, amounts determined in accordance with U.S. GAAP. Some of the limitations to using non-GAAP measures as an analytical tool are (a) they do not reflect the Company’s interest income and expense, or the requirements necessary to service interest or principal payments on the Company’s debt, (b) they do not reflect future requirements for capital expenditures or contractual commitments, and (c) although depreciation and amortization charges are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and non-GAAP measures do not reflect any cash requirements for such replacements.

19

Liquidity and Capital Resources

We measure our liquidity in a number of ways, including the following:

    

September 30, 

    

December 31, 

2022

2021

 

(unaudited)

Cash and cash equivalents

$

16,897,563

$

24,907,963

Working capital

$

15,266,962

$

22,676,301

Availability of Additional Funds

As a result of its public offerings and the related note conversions, the Company believes its current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. Our operating needs include the planned costs to operate our business, including amounts required to fund working capital and capital expenditures. Our future capital requirements and the adequacy of our available funds will depend on many factors, including our ability to successfully commercialize our products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement our product and service offerings.

Cash Flows

Nine Months Ended September 30, 2022 Compared With Nine Months Ended September 30, 2021

Our sources and uses of cash were as follows:

Cash Flows From Operating Activities

We experienced negative cash flows from operating activities for the nine months ended September 30, 2022 and 2021 in the amounts of $7,527,466 and $4,577,923, respectively. The net cash used in operating activities for the nine months ended September 30, 2022 was primarily a result of cash used to fund a net loss of $11,111,547, adjusted for net non-cash expenses of $3,743,636, partially offset by $159,555 of net cash used in changes in the levels of operating assets and liabilities. The net cash used in operating activities for the nine months ended September 30, 2021 was primarily a result of cash used to fund a net loss of $5,810,230, adjusted for net non-cash expenses of $828,067, partially offset by $404,240 of net cash provided by changes in the levels of operating assets and liabilities.

Cash Flows From Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2022 was $16,549, which was attributable to purchases of property and equipment. Net cash used in investing activities for the nine months ended September 30, 2021 was $1,157,403, which was attributable to purchases of intangible assets and property and equipment.

Cash Flows From Financing Activities

Net cash used in financing activities for the nine months ended September 30, 2022 was $466,385, which was attributable to repayments of our PPP loan of $149,843 as well as repayments of financed director and officer insurance premiums of $316,542. Net cash provided by financing activities for the nine months ended September 30, 2021 was $9,699,654, which was attributable by the exercises of options and warrants of $9,795,510, partially offset by $27,510 of cash used to pay deferred offering costs and $68,346 of cash was used to partially repay our PPP loan.

20

Critical Accounting Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, contingent assets and liabilities, each as of the date of the financial statements, and revenues and expenses during the periods presented. On an ongoing basis, management evaluates their estimates and assumptions, and the effects of any such revisions are reflected in the financial statements in the period in which they are determined to be necessary. Management bases their estimates on historical experience and on various other factors that they believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual outcomes could differ materially from those estimates in a manner that could have a material effect on our consolidated financial statements. While our significant accounting policies are more fully described in the notes to our consolidated financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies and estimates are critical to the process of making significant judgments and estimates in the preparation of our financial statements and understanding and evaluating our reported financial results.

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized an estimated loss accrual (reversal) on a customer contract of $(232,964) and $142,723, respectively, related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

21

Business Combinations

Business combinations are accounted for using the acquisition method and, accordingly, the assets acquired (including identified intangible assets), the liabilities assumed and any contingent consideration are recorded at their acquisition date fair values. The Company’s fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect the Company’s own assumptions in measuring fair value.

Intangible Assets

Intangible assets are comprised of costs to acquire and develop computer software, including the costs to acquire third-party data which is used to improve the Company’s artificial intelligence platform for client use, as well as costs to acquire customer lists, customer contracts and related customer relationship and restrictive covenant agreements. The intangible assets have estimated useful lives of two years for the computer software, five years for the capitalized data, seven years for the customer lists and three years for the restrictive covenant agreements. Once placed into service, the Company amortizes the cost of the intangible assets over their estimated useful lives on a straight-line basis.

Impairment of Long-lived Assets

The Company reviews for the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. An impairment would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount.

Stock-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.

Item 3. Quantitative and Qualitative Disclosure About Market Risk

Not applicable to smaller reporting companies.

22

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of June 30, 2022. Our disclosure controls and procedures are designed to provide reasonable assurance that information we are required to disclose in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosures, and is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Based on this evaluation, our CEO and CFO have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of September 30, 2022.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Management recognizes that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

23

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, we may be subject to various other legal proceedings and claims that are routine and incidental to our business. Although some of the legal proceedings set forth herein may result in adverse decisions or settlements, Management believes that the final disposition of such matters will not have a material adverse effect on our business, financial position, results of operations or cash flows.

In August, we received subpoenas from both the SEC and the United States Attorney’s Office for the Southern District of New York requesting certain information from us relating to revenue in connection with two of our customers. Kubient is fully cooperating with both of these agencies.

Item 1A. Risk Factors.

Not applicable to smaller reporting companies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosure.

Not applicable.

Item 5. Other Information.

There is no other information required to be disclosed under this item which was not previously disclosed.

24

Item 6. Exhibits

Exhibit
Number

    

Exhibit Description

 

Incorporated by Reference

 

Filed
Herewith

 

 

    

Form

    

Filing Date

    

Exhibit
 Number

    

 

31.1

Certification of Principal Executive Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

 

 

X

31.2

Certification of Principal Financial Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

 

 

X

32.1 *

Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)

 

 

 

 

 

 

 

X

101.ins

XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

 

 

 

 

 

X

101.sch

Inline XBRL Taxonomy Schema Document

 

 

 

 

 

 

 

X

101.cal

Inline XBRL Taxonomy Calculation Linkbase Document

 

 

 

 

 

 

 

X

101.def

Inline XBRL Taxonomy Definition Linkbase Document

 

 

 

 

 

 

 

X

101.lab

Inline XBRL Taxonomy Label Linkbase Document

 

 

 

 

 

 

 

X

101.pre

Inline XBRL Taxonomy Presentation Linkbase Document

 

 

 

 

 

 

 

X

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

X

*This certification is being furnished solely to accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, and it is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

KUBIENT, INC.

 

 

Dated: November 14, 2022

/s/ Paul Roberts 

 

Paul Roberts

 

Chief Executive Officer

 

(principal executive officer)

Dated: November 14, 2022

/s/ Joshua Weiss 

 

Joshua Weiss

 

Chief Financial Officer

 

(principal financial and accounting officer)

26

GLOSSARY

“Ad network” means an intermediary network or company that acts as a broker between advertisers who want to purchase ad placements and content publishers who want to host the advertiser’s ads. Examples of advertisers are consumer good companies, multimedia companies and automobile manufacturers. Publishers in the context are website operators or app developers.

“Audience Marketplace” means the modular, highly scalable, transparent, cloud-based software platform created by the Company for real-time trading of digital, Programmatic Advertising.

“Bot” or “internet bot” means an autonomous program (or robot) running on a network (usually, the internet) that can interact with computer systems or users. Typically, Bots perform tasks that are both simple and structurally repetitive, at a much higher rate than would be possible for a human alone. According to Imperva, more than half of all web traffic is fraudulent, as it is made up of Bots rather than actual human beings.

“Brand” means a particular name used to identify a type of product or products manufactured by a particular company.

“Latency” means the lag time between a customer click on an internet link and the conversion of that customer to a sale. The term can also refer to the lag time between ad inventory’s purchase and its display on publisher’s media.

“Programmatic advertising” means the purchase of advertising space meant to target audiences using software and tools that help agencies and brands target, deliver, and analyze their digital advertising efforts., rather than the traditional method of purchasing time slots in mass media, such as television programming.

“Pre-bid” means the bid placed by an advertiser for placement of its ad, verified prior to such ad being run or displayed.

“Post-bid” means the verification of the running or display of an ad, after such running or display has occurred.

“Publisher” means a source of ad inventory, such as website owners, website operators or app developers. Publishers are generally either managed or owned and operated. An owned and operated publisher receives 100% of the profit for impressions sold. This is opposed to a managed publisher: a publisher that does not own its inventory but has a financial relationship with those who do.

A-1

EX-31.1 2 kbnt-20220930xex31d1.htm EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

pursuant to

Exchange Act Rules 13a-14(a) and 15d-14(a),

as adopted pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Paul Roberts, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Kubient, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:        November 14, 2022

/s/ Paul Roberts

Paul Roberts

Chief Executive Officer

(principal executive officer)


EX-31.2 3 kbnt-20220930xex31d2.htm EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

pursuant to

Exchange Act Rules 13a-14(a) and 15d-14(a),

as adopted pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Joshua Weiss, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Kubient, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:        November 14, 2022

/s/ Joshua Weiss

Joshua Weiss

Chief Financial Officer

(principal financial and accounting officer)


EX-32.1 4 kbnt-20220930xex32d1.htm EX-32.1

Exhibit 32.1

Certifications of Principal Executive Officer and Principal Financial Officer

pursuant to

18 U.S.C. Section 1350,

as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Paul Roberts, Chief Executive Officer (principal executive officer) of Kubient, Inc. (the “Company”), and Joshua Weiss, Chief Financial Officer (principal financial and accounting officer) of the Company, each hereby certifies that, to the best of his knowledge:

1)

The Company’s Annual Report on Form 10-Q for the quarter ended September 30, 2022, to which this certification is attached as Exhibit 32.1 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 14, 2022

/s/ Paul Roberts

 

Paul Roberts

Chief Executive Officer

(principal executive officer)

/s/ Joshua Weiss

 

Joshua Weiss

Chief Financial Officer

(principal financial and accounting officer)

The foregoing certifications are being furnished pursuant to 18 U.S.C. Section 1350. They are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the Company, regardless of any general incorporation language in such filing.


GRAPHIC 5 kbnt-20220930x10q001.jpg GRAPHIC begin 644 kbnt-20220930x10q001.jpg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end EX-101.SCH 6 kbnt-20220930.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - FAIR VALUE MEASUREMENT (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - FAIR VALUE MEASUREMENT - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - LONG-LIVED ASSETS AND GOODWILL link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - FAIR VALUE MEASUREMENT link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - FAIR VALUE MEASUREMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - CONCENTRATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - LONG-LIVED ASSETS AND GOODWILL (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 kbnt-20220930_cal.xml EX-101.CAL EX-101.DEF 8 kbnt-20220930_def.xml EX-101.DEF EX-101.LAB 9 kbnt-20220930_lab.xml EX-101.LAB EX-101.PRE 10 kbnt-20220930_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2022
Nov. 10, 2022
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2022  
Entity File Number 001-39441  
Entity Registrant Name Kubient, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 82-1808844  
Entity Address, Address Line One 500 7th Avenue,  
Entity Address, Adress Line Two 8th Floor  
Entity Address, City or Town New York  
Entity Address State Or Province NY  
Entity Address, Postal Zip Code 10018  
City Area Code 800  
Local Phone Number 409-9456  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   14,402,500
Entity Central Index Key 0001729750  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Stock, par value $0.00001 per share    
Document and Entity Information    
Title of 12(b) Security Common Stock, par value $0.00001 per share  
Trading Symbol KBNT  
Security Exchange Name NASDAQ  
Common Stock Purchase Warrants    
Document and Entity Information    
Title of 12(b) Security Common Stock Purchase Warrants  
Trading Symbol KBNTW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 16,897,563 $ 24,907,963
Accounts receivable, net 448,815 2,291,533
Other receivables   526,070
Prepaid expenses and other current assets 502,912 495,178
Total Current Assets 17,849,290 28,220,744
Intangible assets, net   2,946,610
Goodwill   463,000
Property and equipment, net   44,756
Deferred offering costs 10,000 10,000
Total Assets 17,859,290 31,685,110
Current Liabilities:    
Accounts payable - suppliers 727,432 1,844,544
Accounts payable - trade 369,040 659,362
Accrued expenses and other current liabilities 716,484 2,493,287
Deferred revenue 767,833 395,914
Notes payable 1,539 151,336
Total Current Liabilities 2,582,328 5,544,443
Contingent consideration   613,000
Notes payable, non-current portion 77,361 77,407
Total Liabilities 2,659,689 6,234,850
Commitments and contingencies
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of September 30, 2022 and December 31, 2021
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,402,500 and 14,253,948 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 144 143
Additional paid-in capital 52,891,794 52,030,907
Accumulated deficit (37,692,337) (26,580,790)
Total Stockholders' Equity 15,199,601 25,450,260
Total Liabilities and Stockholders' Equity $ 17,859,290 $ 31,685,110
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2022
Dec. 31, 2021
Condensed Consolidated Balance Sheets    
Preferred stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 95,000,000 95,000,000
Common stock, shares issued 14,402,500 14,253,948
Common stock, shares outstanding 14,402,500 14,253,948
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Condensed Consolidated Statements of Operations        
Net Revenues $ 481,812 $ 676,986 $ 2,127,467 $ 1,882,311
Costs and Expenses:        
Sales and marketing 735,296 715,820 3,118,729 1,977,150
Technology 525,383 776,573 2,640,239 1,916,020
General and administrative 1,132,649 1,514,913 4,824,406 3,878,765
Impairment loss on intangible assets     2,626,974  
Impairment loss on property and equipment     49,948  
Impairment loss on goodwill     463,000  
Loss accrual on customer contract (232,964)   142,723  
Total Costs and Expenses 2,160,364 3,007,306 13,866,019 7,771,935
Loss From Operations (1,678,552) (2,330,320) (11,738,552) (5,889,624)
Other (Expense) Income:        
Interest expense (2,508) (2,098) (8,916) (5,308)
Interest income 6,896 21,805 11,921 84,469
Change in fair value of contingent consideration     613,000  
Other income     11,000 233
Total Other Income 4,388 19,707 627,005 79,394
Net Loss $ (1,674,164) $ (2,310,613) $ (11,111,547) $ (5,810,230)
Net Loss Per Share - Basic $ (0.12) $ (0.16) $ (0.78) $ (0.43)
Net Loss Per Share - Diluted $ (0.12) $ (0.16) $ (0.78) $ (0.43)
Weighted Average Common Shares Outstanding - Basic 14,337,412 14,252,886 14,300,022 13,627,435
Weighted Average Common Shares Outstanding - Diluted 14,337,412 14,252,886 14,300,022 13,627,435
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 118 $ 40,770,504 $ (16,289,077) $ 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (decrease) in stockholders' equity        
Shares issued upon exercise of warrants, net of issuance costs [1] $ 20 9,274,891   9,274,911
Shares issued upon exercise of warrants, net of issuance costs (in shares) [1] 2,047,361      
Stock-based compensation: Common stock $ 1 513,102   513,103
Stock-based compensation: Common stock (in shares) 70,040      
Stock-based compensation: Options   2,576   2,576
Net loss     (1,796,612) (1,796,612)
Balance at the end at Mar. 31, 2021 $ 139 50,561,073 (18,085,689) 32,475,523
Balance at the end (in shares) at Mar. 31, 2021 13,873,510      
Balance at the beginning at Dec. 31, 2020 $ 118 40,770,504 (16,289,077) 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (decrease) in stockholders' equity        
Net loss       (5,810,230)
Balance at the end at Sep. 30, 2021 $ 143 51,827,263 (22,099,307) 29,728,099
Balance at the end (in shares) at Sep. 30, 2021 14,252,886      
Balance at the beginning at Mar. 31, 2021 $ 139 50,561,073 (18,085,689) 32,475,523
Balance at the beginning (in shares) at Mar. 31, 2021 13,873,510      
Increase (decrease) in stockholders' equity        
Shares issued upon exercise of warrants, net of issuance costs [2] $ 1 428,718   428,719
Shares issued upon exercise of warrants, net of issuance costs (in shares) [2] 108,961      
Stock-based compensation: Common stock $ 2 27,568   27,570
Stock-based compensation: Common stock (in shares) 167,600      
Stock-based compensation: Options   2,509   2,509
Common stock issued upon exercise of options   8,361   8,361
Common stock issued upon exercise of options (in shares) 2,815      
Shares issued as partial consideration for intangible asset $ 1 531,999   532,000
Shares issued as partial consideration for intangible asset (in shares) 100,000      
Net loss     (1,703,005) (1,703,005)
Balance at the end at Jun. 30, 2021 $ 143 51,560,228 (19,788,694) 31,771,677
Balance at the end (in shares) at Jun. 30, 2021 14,252,886      
Increase (decrease) in stockholders' equity        
Stock-based compensation: Options   2,533   2,533
Common stock issued upon exercise of options   264,502   264,502
Net loss     (2,310,613) (2,310,613)
Balance at the end at Sep. 30, 2021 $ 143 51,827,263 (22,099,307) 29,728,099
Balance at the end (in shares) at Sep. 30, 2021 14,252,886      
Balance at the beginning at Dec. 31, 2021 $ 143 52,030,907 (26,580,790) 25,450,260
Balance at the beginning (in shares) at Dec. 31, 2021 14,253,948      
Increase (decrease) in stockholders' equity        
Surrender and cancellation of common stock   (18,683)   (18,683)
Surrender and cancellation of common stock (in shares) (3,397)      
Stock-based compensation: Options   2,295   2,295
Common stock issued upon exercise of options   430,361   430,361
Common stock issued upon exercise of options (in shares) 53,192      
Net loss     (3,627,492) (3,627,492)
Balance at the end at Mar. 31, 2022 $ 143 52,444,880 (30,208,282) 22,236,741
Balance at the end (in shares) at Mar. 31, 2022 14,303,743      
Balance at the beginning at Dec. 31, 2021 $ 143 52,030,907 (26,580,790) 25,450,260
Balance at the beginning (in shares) at Dec. 31, 2021 14,253,948      
Increase (decrease) in stockholders' equity        
Net loss       (11,111,547)
Balance at the end at Sep. 30, 2022 $ 144 52,891,794 (37,692,337) 15,199,601
Balance at the end (in shares) at Sep. 30, 2022 14,402,500      
Balance at the beginning at Mar. 31, 2022 $ 143 52,444,880 (30,208,282) 22,236,741
Balance at the beginning (in shares) at Mar. 31, 2022 14,303,743      
Increase (decrease) in stockholders' equity        
Surrender and cancellation of common stock   (36,188)   (36,188)
Surrender and cancellation of common stock (in shares) (8,323)      
Stock-based compensation: Options   2,067   2,067
Common stock issued upon exercise of options $ 1 308,950   308,951
Common stock issued upon exercise of options (in shares) 105,832      
Net loss     (5,809,891) (5,809,891)
Balance at the end at Jun. 30, 2022 $ 144 52,719,709 (36,018,173) 16,701,680
Balance at the end (in shares) at Jun. 30, 2022 14,401,252      
Increase (decrease) in stockholders' equity        
Stock-based compensation: Options   2,236   2,236
Common stock issued upon exercise of options   169,849   169,849
Common stock issued upon exercise of options (in shares) 1,248      
Net loss     (1,674,164) (1,674,164)
Balance at the end at Sep. 30, 2022 $ 144 $ 52,891,794 $ (37,692,337) $ 15,199,601
Balance at the end (in shares) at Sep. 30, 2022 14,402,500      
[1] Includes gross proceeds of $9,708,038, less issuance costs of $433,127.
[2] Includes gross proceeds of $460,989, less issuance costs of $32,270.
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - USD ($)
3 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Condensed Consolidated Statements of Changes in Stockholders' Equity    
Gross proceeds from initial public offering $ 460,989 $ 9,708,038
Issuance costs on initial public offering $ 32,270 $ 433,127
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows From Operating Activities:    
Net loss $ (11,111,547) $ (5,810,230)
Adjustments to reconcile net loss to net cash used in operating activities:    
Bad debt expense 7,000  
Impairment loss on intangible assets 2,626,974  
Impairment loss on property and equipment 49,948  
Impairment loss on goodwill 463,000  
Depreciation and amortization 330,993 304,068
Change in fair value of contingent consideration (613,000)  
Common stock 872,123 516,381
Options 6,598 7,618
Changes in operating assets and liabilities:    
Accounts receivable 1,835,718 1,000,783
Other receivable 507,387  
Prepaid expenses and other current assets 350,132 (155,367)
Accounts payable - suppliers (1,117,112) 115,681
Accounts payable - trade (290,321) (289,215)
Accrued expenses and other current liabilities (1,817,278) (274,667)
Accrued interest   7,025
Deferred revenue 371,919  
Net Cash Used In Operating Activities (7,527,466) (4,577,923)
Cash Flows From Investing Activities:    
Purchase of intangible assets   (1,133,072)
Purchase of property and equipment (16,549) (24,331)
Net Cash Used In Investing Activities (16,549) (1,157,403)
Cash Flows From Financing Activities:    
Proceeds from exercise of warrants [1]   9,787,149
Proceeds from exercise of options   8,361
Repayment of PPP loan (149,843) (68,346)
Repayment of financed director and officer insurance premiums (316,542)  
Payment of deferred offering costs   (27,510)
Net Cash (Used In) Provided By Financing Activities (466,385) 9,699,654
Net (Decrease) Increase In Cash and Cash Equivalents (8,010,400) 3,964,328
Cash and Cash Equivalents - Beginning of the Period 24,907,963 24,782,128
Cash and Cash Equivalents - End of the Period 16,897,563 28,746,456
Cash paid during the period for:    
Interest 4,847 4,588
Non-cash investing and financing activities:    
Surrender and cancellation of common stock (18,683)  
Shares of common stock issued in satisfaction of accrued issuable equity   507,044
Accrual of warrant exercise issuance costs   83,519
Shares issued as partial consideration for intangible asset   532,000
Financing of insurance premiums $ 357,866 $ 362,625
[1] Includes gross proceeds of $10,169,027, less issuance costs of $381,878.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Parenthetical)
9 Months Ended
Sep. 30, 2022
USD ($)
Condensed Consolidated Statements of Cash Flows  
Gross proceeds from initial public offering $ 10,169,027
Issuance costs $ 381,878
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION
9 Months Ended
Sep. 30, 2022
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION  
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION

Organization and Operations

Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Risks and Uncertainties

The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company’s operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted.

Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.

There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair statement of the unaudited condensed consolidated financial statements of the Company as of September 30, 2022 and for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the operating results for the full year ending December 31, 2022 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures as of December 31, 2021 and 2020 and for the years then ended which are included the Annual Report filed on Form 10-K on March 31, 2022.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2022
SIGNIFICANT ACCOUNTING POLICIES  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

There have been no material changes to the significant accounting policies included in the audited consolidated financial statements as of December 31, 2021 and 2020 and for the years then ended, which were included the Annual Report filed on Form 10-K on March 31, 2022, except as disclosed in this note.

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized an estimated loss accrual (reversal) on a customer contract of $(232,964) and $142,723, respectively, related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

As of September 30, 2022 and December 31, 2021, the Company did not have any contract assets from contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized $0 and $395,914 of revenue that was deferred as of December 31, 2021. As of September 30, 2022 and December 31, 2021, the Company had $767,833 and $395,914, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three and nine months ended September 30, 2022, there was $107,538 and $282,244 of net revenue, respectively, recognized from performance obligations satisfied during the three months ended March 31, 2022. During the three and nine months ended September 30, 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Three and Nine Months Ended

September 30, 

    

2022

    

2021

Warrants [1]

5,122,074

5,122,074

Restricted stock units

538,104

Restricted stock awards

64,585

Stock options

 

36,667

 

94,447

 

5,761,430

 

5,216,521

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
LONG-LIVED ASSETS AND GOODWILL
9 Months Ended
Sep. 30, 2022
LONG-LIVED ASSETS AND GOODWILL  
LONG-LIVED ASSETS AND GOODWILL

NOTE 3 – LONG-LIVED ASSETS AND GOODWILL

During the three months ended June 30, 2022, the Company identified triggering events that indicated its long-lived assets including its definite-lived intangible assets were at risk of impairment and, as such, performed a quantitative impairment assessment to evaluate recoverability and, ultimately, whether carrying value exceeded fair value. The primary triggers for the impairment review were a loss of customers as well as a reduction in the value of Kubient's market capitalization. As a result of the quantitative assessments, the Company determined the fair value of the asset group was less than the carrying value and, accordingly, determined the Company's long-lived assets were fully impaired. As a result, during the nine months ended September 30, 2022, the Company recognized an impairment loss on intangible assets and property and equipment of $2,626,974 and $49,948, respectively, on its condensed consolidated statements of operations.

During the three months ended June 30, 2022, the Company identified triggering events that indicated its goodwill associated with its acquisition of MediaCrossing was at risk of impairment and, as such, performed a quantitative impairment assessment to determine whether the fair value of the reporting unit (determined to be the Company) exceeded its fair value. The primary triggers for the impairment review were a loss of customers as well as a reduction in the value of Kubient's market capitalization. As a result of the quantitative assessments, the Company determined the fair value of the reporting unit was less than the carrying value and, accordingly, determined the Company's goodwill was fully impaired. As a result, during the nine months ended September 30, 2022, the Company recognized an impairment loss on goodwill of $463,000 on its condensed consolidated statements of operations.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
9 Months Ended
Sep. 30, 2022
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES  
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

NOTE 4 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

    

September 30, 

    

December 31, 

2022

2021

Accrued bonuses

$

79,842

$

554,997

Accrued payroll

13,750

Financed director and officer insurance premiums

252,720

217,575

Accrued supplier expenses

 

57,902

 

67,971

Accrued legal settlement

975,000

Accrued legal and professional fees

 

12,000

 

20,323

Accrued commissions

 

2,272

 

36,109

Accrued media commissions

138,028

Credit card payable

 

198,212

 

328,075

Accrued programming expenses

 

 

1,750

Accrued issuable equity

 

409

 

1,258

Accrued interest

13,388

9,017

Accrued warrant exercise costs

83,519

83,519

Other

 

16,220

 

45,915

Total accrued expenses and other current liabilities

$

716,484

$

2,493,287

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY
9 Months Ended
Sep. 30, 2022
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY

NOTE 5 – STOCKHOLDERS’ EQUITY

Stock-Based Compensation

For the three and nine months ended September 30, 2022 and 2021, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows:

    

For the Three Months Ended

    

For the Nine Months Ended

September 30, 

 

September 30, 

2022

    

2021

 

2022

    

2021

Sales and marketing

$

67,864

$

35,309

$

95,288

$

274,274

Technology

 

36,129

 

34,703

171,720

36,063

General and administrative

 

53,101

 

193,235

611,713

213,662

Total

$

157,094

$

263,247

$

878,721

$

523,999

As of September 30, 2022, there was approximately $1,392,000 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 3.4 years.

During the three months ended March 31, 2022, the Company granted 53,192 shares of immediately vested restricted stock awards (“RSAs”) to non-employee directors under the Kubient, Inc. 2021 Equity Incentive Plan (the “2021 Plan”) with an aggregate grant date fair value of $100,000 that was recognized immediately.

During the three months ended March 31, 2022, the Company granted 100,000 RSAs, 489,990 restricted stock units (“RSUs”) and a target number of 234,376 performance stock units (“PSUs”), all issued under the 2021 Plan. The RSAs and RSUs generally vest over four years and the PSUs are earned based upon actual net revenue generated by the Company during 2022 as compared to the targeted revenue specified in each award. Depending on actual net revenues generated as compared to the targeted amounts, the grantees may earn between 0% and 150% of their target award. The awards had an aggregate issuance date fair value of approximately $1,900,000. During the three months ended September 30, 2022, the Company issued 1,248 shares of common stock related to the aforementioned RSUs.

During the three months ended September 30, 2022, the Company granted 22,917 shares of immediately vested RSAs to a former employee under the 2021 Plan with an aggregate grant date fair value of approximately $28,000 that was recognized immediately.

During the three months ended September 30, 2022, the Company granted 25,000 shares of  RSAs to an employee under the 2021 Plan with an aggregate grant date fair value of approximately $29,000 which is being recognized over the 4 year vesting term of the award.

Common Stock

During the three months ended March 31, 2022, the Company’s chief financial officer surrendered to the Company 3,397 shares of common stock, which were subsequently cancelled by the Company, in order to satisfy a tax withholding obligation of approximately $18,000 in connection with a previous grant.

During the three months ended June 30, 2022, the Company cancelled 8,323 shares of common stock related to the forfeiture of RSAs from a terminated employee.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENT
9 Months Ended
Sep. 30, 2022
FAIR VALUE MEASUREMENT  
FAIR VALUE MEASUREMENT

NOTE 6 – FAIR VALUE MEASUREMENT

On November 30, 2021, Kubient entered into and consummated an Asset Purchase Agreement (the “Purchase Agreement”) between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”), pursuant to which the Company acquired certain assets and liabilities that were critical to continue to operate the business of MediaCrossing for (i) $500,000 in cash and (ii) if the acquired business achieves certain milestones in 2022, up to 822,369 shares of the Company’s common stock, par value $0.00001 per share (the “Earnout Shares”) (the “Transaction”). The Earnout Shares had a fair value of $2.55 as of the acquisition date. The Earnout Shares were measured using a Monte Carlo simulation. Key assumptions used in the fair value assessment consisted of revenue projections (which were used to estimate the number of Earnout Shares issuable), discount rate and standard deviation. The fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect Kubient’s own assumptions in measuring fair value.

On September 30, 2022, the Company recomputed the fair value of its Earnout Shares as $0 using the Monte Carlo simulation. The Company recorded a gain on the change in fair value of the contingent consideration of $0 and $613,000 during the three and nine months ended September 30, 2022, respectively. The loss is primarily due to the decline in the Companys stock price as well as changes in the likelihood that forecasted milestones would be met for the remainder of 2022.

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis:

Contingent Consideration

    

  

Beginning balance as of January 1, 2022

$

613,000

Change in fair value of contingent consideration

 

(613,000)

Ending balance as of September 30, 2022

$

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONCENTRATIONS
9 Months Ended
Sep. 30, 2022
CONCENTRATIONS  
CONCENTRATIONS

NOTE 7 – CONCENTRATIONS

Customer Concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Three Months Ended

    

For the Nine Months Ended

 

September 30, 

September 30, 

 

Customer

    

2022

    

2021

    

2022

    

2021

 

Customer A

 

N/A

81.82

%

24.59

%

94.20

%

Customer B

10.67

%  

N/A

29.08

%

N/A

Customer C

N/A

32.82

%

N/A

12.66

%

Customer D

53.58

%  

N/A

15.76

%  

N/A

Customer E

22.32

%

N/A

15.55

%  

N/A

Total

 

86.58

%  

114.64

%

84.98

%  

106.86

%

From time to time, certain customers generate negative net revenues that resulted from Supplier Costs that exceeded the Gross Billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:

    

September 30, 

    

December 31, 

 

Customer

2022

2021

 

Customer A

 

N/A

 

22.08

%

Customer B

 

41.35

%  

*

Customer C

 

*

52.18

%

Customer D

 

30.58

%  

N/A

Total

 

71.93

%  

74.26

%

* Less than 10%.

A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.

Supplier Concentrations

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:

    

For the Three Months Ended

    

For the Nine Months Ended

 

September 30, 

September 30, 

 

Supplier

    

2022

    

2021

    

2022

    

2021

 

Supplier A

 

N/A

N/A

13.34

%

N/A

Supplier B

 

24.31

%

N/A

26.79

%

N/A

Supplier C

 

N/A

N/A

11.74

%

N/A

Supplier D

 

*

13.85

%  

*

*

Supplier E

N/A

24.18

%  

*

16.60

%

Supplier F

N/A

10.97

%  

*

*

Supplier G

N/A

10.43

%  

N/A

*

Total

 

24.31

%  

59.43

%  

51.87

%  

16.60

%

* Less than 10%.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2022
SIGNIFICANT ACCOUNTING POLICIES  
Revenue Recognition

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized an estimated loss accrual (reversal) on a customer contract of $(232,964) and $142,723, respectively, related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.

As of September 30, 2022 and December 31, 2021, the Company did not have any contract assets from contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized $0 and $395,914 of revenue that was deferred as of December 31, 2021. As of September 30, 2022 and December 31, 2021, the Company had $767,833 and $395,914, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three and nine months ended September 30, 2022, there was $107,538 and $282,244 of net revenue, respectively, recognized from performance obligations satisfied during the three months ended March 31, 2022. During the three and nine months ended September 30, 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Net Loss Per Common Share

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Three and Nine Months Ended

September 30, 

    

2022

    

2021

Warrants [1]

5,122,074

5,122,074

Restricted stock units

538,104

Restricted stock awards

64,585

Stock options

 

36,667

 

94,447

 

5,761,430

 

5,216,521

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2022
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of calculation of weighted average dilutive common shares

    

For the Three and Nine Months Ended

September 30, 

    

2022

    

2021

Warrants [1]

5,122,074

5,122,074

Restricted stock units

538,104

Restricted stock awards

64,585

Stock options

 

36,667

 

94,447

 

5,761,430

 

5,216,521

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)
9 Months Ended
Sep. 30, 2022
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES  
Schedule of accrued expenses and other current liabilities

    

September 30, 

    

December 31, 

2022

2021

Accrued bonuses

$

79,842

$

554,997

Accrued payroll

13,750

Financed director and officer insurance premiums

252,720

217,575

Accrued supplier expenses

 

57,902

 

67,971

Accrued legal settlement

975,000

Accrued legal and professional fees

 

12,000

 

20,323

Accrued commissions

 

2,272

 

36,109

Accrued media commissions

138,028

Credit card payable

 

198,212

 

328,075

Accrued programming expenses

 

 

1,750

Accrued issuable equity

 

409

 

1,258

Accrued interest

13,388

9,017

Accrued warrant exercise costs

83,519

83,519

Other

 

16,220

 

45,915

Total accrued expenses and other current liabilities

$

716,484

$

2,493,287

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2022
STOCKHOLDERS' EQUITY  
Schedule of stock-based compensation expense related to stock options, restricted stock awards and restricted stock units

    

For the Three Months Ended

    

For the Nine Months Ended

September 30, 

 

September 30, 

2022

    

2021

 

2022

    

2021

Sales and marketing

$

67,864

$

35,309

$

95,288

$

274,274

Technology

 

36,129

 

34,703

171,720

36,063

General and administrative

 

53,101

 

193,235

611,713

213,662

Total

$

157,094

$

263,247

$

878,721

$

523,999

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENT (Tables)
9 Months Ended
Sep. 30, 2022
FAIR VALUE MEASUREMENT  
Summary of changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis

Contingent Consideration

    

  

Beginning balance as of January 1, 2022

$

613,000

Change in fair value of contingent consideration

 

(613,000)

Ending balance as of September 30, 2022

$

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONCENTRATIONS (Tables)
9 Months Ended
Sep. 30, 2022
CONCENTRATIONS  
Summary of customer and supplier concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Three Months Ended

    

For the Nine Months Ended

 

September 30, 

September 30, 

 

Customer

    

2022

    

2021

    

2022

    

2021

 

Customer A

 

N/A

81.82

%

24.59

%

94.20

%

Customer B

10.67

%  

N/A

29.08

%

N/A

Customer C

N/A

32.82

%

N/A

12.66

%

Customer D

53.58

%  

N/A

15.76

%  

N/A

Customer E

22.32

%

N/A

15.55

%  

N/A

Total

 

86.58

%  

114.64

%

84.98

%  

106.86

%

    

September 30, 

    

December 31, 

 

Customer

2022

2021

 

Customer A

 

N/A

 

22.08

%

Customer B

 

41.35

%  

*

Customer C

 

*

52.18

%

Customer D

 

30.58

%  

N/A

Total

 

71.93

%  

74.26

%

* Less than 10%.

    

For the Three Months Ended

    

For the Nine Months Ended

 

September 30, 

September 30, 

 

Supplier

    

2022

    

2021

    

2022

    

2021

 

Supplier A

 

N/A

N/A

13.34

%

N/A

Supplier B

 

24.31

%

N/A

26.79

%

N/A

Supplier C

 

N/A

N/A

11.74

%

N/A

Supplier D

 

*

13.85

%  

*

*

Supplier E

N/A

24.18

%  

*

16.60

%

Supplier F

N/A

10.97

%  

*

*

Supplier G

N/A

10.43

%  

N/A

*

Total

 

24.31

%  

59.43

%  

51.87

%  

16.60

%

* Less than 10%.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
SIGNIFICANT ACCOUNTING POLICIES        
Loss accrual (reversal) on a customer contract $ (232,964) $ 142,723    
Contracts with customers, revenue recognized 0 395,914    
Contract liabilities 767,833 767,833 $ 395,914  
Net revenue $ 107,538 $ 282,244    
Revenue recognized from performance obligations satisfied       $ 0
Minimum        
SIGNIFICANT ACCOUNTING POLICIES        
Invoice payment terms   45 days    
Maximum        
SIGNIFICANT ACCOUNTING POLICIES        
Invoice payment terms   90 days    
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) - $ / shares
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Net Loss Per Common Share    
Shares excluded from the calculation of weighted average dilutive common shares 5,761,430 5,216,521
Number of warrants exercisable (in shares) 368,711  
Warrants    
Net Loss Per Common Share    
Shares excluded from the calculation of weighted average dilutive common shares 5,122,074 5,122,074
Warrants term (in years) 5 years  
Warrants to purchase shares of common stock 368,711  
Exercise price of warrants (in dollars per share) $ 5.50  
Restricted stock units    
Net Loss Per Common Share    
Shares excluded from the calculation of weighted average dilutive common shares 538,104  
Restricted stock awards    
Net Loss Per Common Share    
Shares excluded from the calculation of weighted average dilutive common shares 64,585  
Stock options    
Net Loss Per Common Share    
Shares excluded from the calculation of weighted average dilutive common shares 36,667 94,447
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
LONG-LIVED ASSETS AND GOODWILL (Details)
9 Months Ended
Sep. 30, 2022
USD ($)
LONG-LIVED ASSETS AND GOODWILL.  
Impairment loss on intangible assets $ 2,626,974
Impairment loss on property and equipment 49,948
Impairment loss on goodwill $ 463,000
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES    
Accrued bonuses $ 79,842 $ 554,997
Accrued payroll   13,750
Financed director and officer insurance premiums 252,720 217,575
Accrued supplier expenses 57,902 67,971
Accrued legal settlement   975,000
Accrued legal and professional fees 12,000 20,323
Accrued commissions 2,272 36,109
Accrued media commissions   138,028
Credit card payable 198,212 328,075
Accrued programming expenses   1,750
Accrued issuable equity 409 1,258
Accrued interest 13,388 9,017
Accrued warrant exercise costs 83,519 83,519
Other 16,220 45,915
Total accrued expenses and other current liabilities $ 716,484 $ 2,493,287
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
STOCKHOLDERS' EQUITY            
Unrecognized stock-based compensation expense $ 1,392,000         $ 1,392,000
Unrecognized stock-based compensation expense, period of recognition           3 years 4 months 24 days
Shares of common stock granted 22,917          
Common stock aggregate issuance date fair value       $ 27,570 $ 513,103  
Vesting period 4 years          
Number of common stock issued 1,248          
Aggregate grant date fair value $ 28,000          
Shares of common stock related to the forfeiture   8,323        
Restricted stock units            
STOCKHOLDERS' EQUITY            
Vesting period           4 years
Restricted stock awards            
STOCKHOLDERS' EQUITY            
Shares of common stock granted 25,000          
Vesting period           4 years
Aggregate grant date fair value $ 29,000          
Executive Officer            
STOCKHOLDERS' EQUITY            
Common stock surrendered     3,397      
Stock-based compensation tax withholding obligation     $ 18,000      
2021 Equity Incentive Plan            
STOCKHOLDERS' EQUITY            
Common stock aggregate issuance date fair value     $ 1,900,000      
2021 Equity Incentive Plan | Restricted stock units            
STOCKHOLDERS' EQUITY            
Shares of common stock granted     489,990      
2021 Equity Incentive Plan | PSUs            
STOCKHOLDERS' EQUITY            
Shares of common stock granted     234,376      
2021 Equity Incentive Plan | Restricted stock awards            
STOCKHOLDERS' EQUITY            
Shares of common stock granted     100,000      
Common stock aggregate issuance date fair value     $ 100,000      
2021 Equity Incentive Plan | Restricted stock awards | Employees            
STOCKHOLDERS' EQUITY            
Shares of common stock granted     53,192      
Minimum | 2021 Equity Incentive Plan            
STOCKHOLDERS' EQUITY            
Percentage of grantees earnings     0.00%      
Maximum | 2021 Equity Incentive Plan            
STOCKHOLDERS' EQUITY            
Percentage of grantees earnings     150.00%      
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Stock-Based Compensation        
Total $ 157,094 $ 263,247 $ 878,721 $ 523,999
Unrecognized stock-based compensation expense 1,392,000   $ 1,392,000  
Unrecognized stock-based compensation expense, period of recognition     3 years 4 months 24 days  
Sales and marketing        
Stock-Based Compensation        
Total 67,864 35,309 $ 95,288 274,274
Technology        
Stock-Based Compensation        
Total 36,129 34,703 171,720 36,063
General and administrative        
Stock-Based Compensation        
Total $ 53,101 $ 193,235 $ 611,713 $ 213,662
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENT (Details)
9 Months Ended
Sep. 30, 2022
USD ($)
FAIR VALUE MEASUREMENT  
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Change In Fair Value Of Contingent Consideration
Fair value of Level 3  
FAIR VALUE MEASUREMENT  
Beginning balance as of January 1, 2022 $ 613,000
Change in fair value of contingent consideration $ (613,000)
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENT - Additional information (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2021
Sep. 30, 2022
Sep. 30, 2022
FAIR VALUE MEASUREMENT      
Change in fair value of contingent consideration     $ 613,000
MediaCrossing Inc      
FAIR VALUE MEASUREMENT      
Cash $ 500,000    
Earnout shares acquired by the company 822,369    
Earnout shares par value $ 0.00001    
Earnout shares fair value $ 2.55    
Recomputed fair value of earnout shares     0
Change in fair value of contingent consideration   $ 0 $ 613,000
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONCENTRATIONS - Customer Concentrations (Details) - Customer Concentrations
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Revenue | Customer A          
CONCENTRATIONS          
Concentration risk (as a percent)   81.82% 24.59% 94.20%  
Revenue | Customer B          
CONCENTRATIONS          
Concentration risk (as a percent) 10.67%   29.08%    
Revenue | Customer C          
CONCENTRATIONS          
Concentration risk (as a percent)   32.82%   12.66%  
Revenue | Customer D          
CONCENTRATIONS          
Concentration risk (as a percent) 53.58%   15.76%    
Revenue | Customer E          
CONCENTRATIONS          
Concentration risk (as a percent) 22.32%   15.55%    
Revenue | Top Five Customers          
CONCENTRATIONS          
Concentration risk (as a percent) 86.58% 114.64% 84.98% 106.86%  
Accounts Receivable | Customer A          
CONCENTRATIONS          
Concentration risk (as a percent)         22.08%
Accounts Receivable | Customer B          
CONCENTRATIONS          
Concentration risk (as a percent)     41.35%    
Accounts Receivable | Customer C          
CONCENTRATIONS          
Concentration risk (as a percent)         52.18%
Accounts Receivable | Customer D          
CONCENTRATIONS          
Concentration risk (as a percent)     30.58%    
Accounts Receivable | Top Four Customers          
CONCENTRATIONS          
Concentration risk (as a percent)     71.93%   74.26%
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONCENTRATIONS - Supplier Concentrations (Details) - Cost of goods sold - Supplier Concentrations
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Supplier A        
CONCENTRATIONS        
Concentration risk (as a percent)     13.34%  
Supplier B        
CONCENTRATIONS        
Concentration risk (as a percent) 24.31%   26.79%  
Supplier C        
CONCENTRATIONS        
Concentration risk (as a percent)     11.74%  
Supplier D        
CONCENTRATIONS        
Concentration risk (as a percent)   13.85%    
Supplier E        
CONCENTRATIONS        
Concentration risk (as a percent)   24.18%   16.60%
Supplier F        
CONCENTRATIONS        
Concentration risk (as a percent)   10.97%    
Supplier G        
CONCENTRATIONS        
Concentration risk (as a percent)   10.43%    
Top Seven Suppliers        
CONCENTRATIONS        
Concentration risk (as a percent) 24.31% 59.43% 51.87% 16.60%
XML 42 kbnt-20220930x10q_htm.xml IDEA: XBRL DOCUMENT 0001729750 kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001729750 us-gaap:RetainedEarningsMember 2022-09-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001729750 us-gaap:RetainedEarningsMember 2022-06-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001729750 2022-06-30 0001729750 us-gaap:RetainedEarningsMember 2022-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001729750 2022-03-31 0001729750 us-gaap:RetainedEarningsMember 2021-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001729750 us-gaap:RetainedEarningsMember 2021-09-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001729750 us-gaap:RetainedEarningsMember 2021-06-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001729750 2021-06-30 0001729750 us-gaap:RetainedEarningsMember 2021-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001729750 2021-03-31 0001729750 us-gaap:RetainedEarningsMember 2020-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001729750 us-gaap:CommonStockMember 2022-09-30 0001729750 us-gaap:CommonStockMember 2022-06-30 0001729750 us-gaap:CommonStockMember 2022-03-31 0001729750 us-gaap:CommonStockMember 2021-12-31 0001729750 us-gaap:CommonStockMember 2021-09-30 0001729750 us-gaap:CommonStockMember 2021-06-30 0001729750 us-gaap:CommonStockMember 2021-03-31 0001729750 us-gaap:CommonStockMember 2020-12-31 0001729750 us-gaap:RestrictedStockMember us-gaap:ShareBasedPaymentArrangementEmployeeMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockUnitsRSUMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 us-gaap:PerformanceSharesMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001729750 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001729750 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001729750 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001729750 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001729750 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001729750 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001729750 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001729750 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001729750 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopSevenSuppliersMember 2022-07-01 2022-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierBMember 2022-07-01 2022-09-30 0001729750 kbnt:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001729750 kbnt:CustomerEMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001729750 kbnt:CustomerDMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001729750 kbnt:CustomerBMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopSevenSuppliersMember 2022-01-01 2022-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierMember 2022-01-01 2022-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierCMember 2022-01-01 2022-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierBMember 2022-01-01 2022-09-30 0001729750 kbnt:TopFourCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001729750 kbnt:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001729750 kbnt:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001729750 kbnt:CustomerEMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001729750 kbnt:CustomerDMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001729750 kbnt:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001729750 kbnt:CustomerBMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001729750 kbnt:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopSevenSuppliersMember 2021-07-01 2021-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierGMember 2021-07-01 2021-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierFMember 2021-07-01 2021-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierEMember 2021-07-01 2021-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierDMember 2021-07-01 2021-09-30 0001729750 kbnt:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001729750 kbnt:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001729750 kbnt:CustomerCMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001729750 kbnt:TopFourCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopSevenSuppliersMember 2021-01-01 2021-09-30 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierEMember 2021-01-01 2021-09-30 0001729750 kbnt:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001729750 kbnt:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001729750 kbnt:CustomerCMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001729750 2021-09-30 0001729750 2020-12-31 0001729750 kbnt:MediacrossingIncMember 2021-11-30 0001729750 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001729750 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001729750 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001729750 us-gaap:EmployeeStockMember 2022-01-01 2022-09-30 0001729750 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001729750 us-gaap:EmployeeStockMember 2021-01-01 2021-09-30 0001729750 us-gaap:TechnologyServiceMember 2022-07-01 2022-09-30 0001729750 us-gaap:SellingAndMarketingExpenseMember 2022-07-01 2022-09-30 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001729750 us-gaap:TechnologyServiceMember 2022-01-01 2022-09-30 0001729750 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-09-30 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0001729750 us-gaap:TechnologyServiceMember 2021-07-01 2021-09-30 0001729750 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2021-09-30 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001729750 us-gaap:TechnologyServiceMember 2021-01-01 2021-09-30 0001729750 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-09-30 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001729750 2021-07-01 2021-09-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001729750 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001729750 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001729750 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001729750 2022-01-01 2022-03-31 0001729750 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001729750 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001729750 us-gaap:RestrictedStockMember 2022-07-01 2022-09-30 0001729750 2022-04-01 2022-06-30 0001729750 srt:MinimumMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 srt:MaximumMember kbnt:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001729750 2022-07-01 2022-09-30 0001729750 srt:MinimumMember 2022-01-01 2022-09-30 0001729750 srt:MaximumMember 2022-01-01 2022-09-30 0001729750 2021-04-01 2021-06-30 0001729750 2021-01-01 2021-03-31 0001729750 kbnt:MediacrossingIncMember 2021-11-30 2021-11-30 0001729750 srt:ExecutiveOfficerMember 2022-01-01 2022-03-31 0001729750 us-gaap:WarrantMember 2022-09-30 0001729750 kbnt:MediacrossingIncMember 2022-07-01 2022-09-30 0001729750 kbnt:MediacrossingIncMember 2022-01-01 2022-09-30 0001729750 2021-01-01 2021-09-30 0001729750 2022-09-30 0001729750 2021-12-31 0001729750 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001729750 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001729750 2022-11-10 0001729750 2022-01-01 2022-09-30 shares iso4217:USD iso4217:USD shares pure 0001729750 --12-31 2022 Q3 0 0 14337412 14252886 14300022 13627435 Kubient, Inc. 14402500 14253948 -0.12 -0.16 -0.78 -0.43 P4Y http://www.kubient.com/20220930#ChangeInFairValueOfContingentConsideration false 10-Q true 2022-09-30 false 001-39441 DE 82-1808844 500 7th Avenue, 8th Floor New York NY 10018 800 409-9456 Common Stock, par value $0.00001 per share KBNT NASDAQ Common Stock Purchase Warrants KBNTW NASDAQ Yes Yes Non-accelerated Filer true true false false 14402500 16897563 24907963 448815 2291533 526070 502912 495178 17849290 28220744 2946610 463000 44756 10000 10000 17859290 31685110 727432 1844544 369040 659362 716484 2493287 767833 395914 1539 151336 2582328 5544443 613000 77361 77407 2659689 6234850 0.00001 0.00001 5000000 5000000 0 0 0.00001 0.00001 95000000 95000000 14402500 14253948 144 143 52891794 52030907 -37692337 -26580790 15199601 25450260 17859290 31685110 481812 676986 2127467 1882311 735296 715820 3118729 1977150 525383 776573 2640239 1916020 1132649 1514913 4824406 3878765 2626974 49948 463000 -232964 142723 2160364 3007306 13866019 7771935 -1678552 -2330320 -11738552 -5889624 2508 2098 8916 5308 6896 21805 11921 84469 613000 11000 233 4388 19707 627005 79394 -1674164 -2310613 -11111547 -5810230 -0.12 -0.16 -0.78 -0.43 14337412 14252886 14300022 13627435 14253948 143 52030907 -26580790 25450260 -3397 -18683 -18683 53192 430361 430361 2295 2295 -3627492 -3627492 14303743 143 52444880 -30208282 22236741 -8323 -36188 -36188 105832 1 308950 308951 2067 2067 -5809891 -5809891 14401252 144 52719709 -36018173 16701680 1248 169849 169849 2236 2236 -1674164 -1674164 14402500 144 52891794 -37692337 15199601 11756109 118 40770504 -16289077 24481545 2047361 20 9274891 9274911 70040 1 513102 513103 2576 2576 -1796612 -1796612 13873510 139 50561073 -18085689 32475523 108961 1 428718 428719 2815 8361 8361 100000 1 531999 532000 167600 2 27568 27570 2509 2509 -1703005 -1703005 14252886 143 51560228 -19788694 31771677 264502 264502 2533 2533 -2310613 -2310613 14252886 143 51827263 -22099307 29728099 9708038 433127 460989 32270 -11111547 -5810230 7000 2626974 49948 463000 330993 304068 613000 872123 516381 6598 7618 -1835718 -1000783 -507387 -350132 155367 -1117112 115681 -290321 -289215 -1817278 -274667 7025 371919 -7527466 -4577923 1133072 16549 24331 -16549 -1157403 9787149 8361 149843 68346 316542 27510 -466385 9699654 -8010400 3964328 24907963 24782128 16897563 28746456 10169027 381878 4847 4588 -18683 507044 83519 532000 357866 362625 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Organization and Operations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Risks and Uncertainties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company’s operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Basis of Presentation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair statement of the unaudited condensed consolidated financial statements of the Company as of September 30, 2022 and for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the operating results for the full year ending December 31, 2022 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures as of December 31, 2021 and 2020 and for the years then ended which are included the Annual Report filed on Form 10-K on March 31, 2022.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">There have been no material changes to the significant accounting policies included in the audited consolidated financial statements as of December 31, 2021 and 2020 and for the years then ended, which were included the Annual Report filed on Form 10-K on March 31, 2022, except as disclosed in this note.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Revenue Recognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized an estimated loss accrual (reversal) on a customer contract of $(232,964) and $142,723, respectively, related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of September 30, 2022 and December 31, 2021, the Company did not have any contract assets from contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized $0 and $395,914 of revenue that was deferred as of December 31, 2021. As of September 30, 2022 and December 31, 2021, the Company had $767,833 and $395,914, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three and nine months ended September 30, 2022, there was $107,538 and $282,244 of net revenue, respectively, recognized from performance obligations satisfied during the three months ended March 31, 2022. During the three and nine months ended September 30, 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Net Loss Per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:30.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Three and Nine Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:30.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 538,104</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64,585</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 36,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,447</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,761,430</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,216,521</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock and (ii) </span><span style="text-decoration-line:none;">five-year</span><span style="text-decoration-line:none;"> warrants to purchase </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock at an exercise price of </span><span style="text-decoration-line:none;">$5.50</span><span style="text-decoration-line:none;"> per share.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Revenue Recognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains a contract with each customer and supplier, which specifies the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The transaction price is determined based on the consideration to which the Company expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, the Company records loss accruals for estimated costs that exceed estimated revenue related to its contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized an estimated loss accrual (reversal) on a customer contract of $(232,964) and $142,723, respectively, related to media costs incurred associated with a contract with a customer, which was included in costs and expenses on the condensed consolidated statement of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of September 30, 2022 and December 31, 2021, the Company did not have any contract assets from contracts with customers. During the three and nine months ended September 30, 2022, the Company recognized $0 and $395,914 of revenue that was deferred as of December 31, 2021. As of September 30, 2022 and December 31, 2021, the Company had $767,833 and $395,914, respectively, of contract liabilities where performance obligations have not yet been satisfied. During the three and nine months ended September 30, 2022, there was $107,538 and $282,244 of net revenue, respectively, recognized from performance obligations satisfied during the three months ended March 31, 2022. During the three and nine months ended September 30, 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods.</p> P45D P90D -232964 142723 0 395914 767833 395914 107538 282244 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Net Loss Per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:30.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Three and Nine Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:30.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 538,104</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64,585</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 36,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,447</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,761,430</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,216,521</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock and (ii) </span><span style="text-decoration-line:none;">five-year</span><span style="text-decoration-line:none;"> warrants to purchase </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock at an exercise price of </span><span style="text-decoration-line:none;">$5.50</span><span style="text-decoration-line:none;"> per share.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:30.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the Three and Nine Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:30.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,122,074</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 538,104</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 64,585</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 36,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 94,447</p></td></tr><tr><td style="vertical-align:bottom;width:67.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,761,430</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.91%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5,216,521</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock and (ii) </span><span style="text-decoration-line:none;">five-year</span><span style="text-decoration-line:none;"> warrants to purchase </span><span style="text-decoration-line:none;">368,711</span><span style="text-decoration-line:none;"> shares of common stock at an exercise price of </span><span style="text-decoration-line:none;">$5.50</span><span style="text-decoration-line:none;"> per share.</span></p> 5122074 5122074 538104 64585 36667 94447 5761430 5216521 368711 P5Y 368711 5.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">NOTE 3 – LONG-LIVED ASSETS AND GOODWILL</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the three months ended June 30, 2022, the Company identified triggering events that indicated its long-lived assets including its definite-lived intangible assets were at risk of impairment and, as such, performed a quantitative impairment assessment to evaluate recoverability and, ultimately, whether carrying value exceeded fair value. The primary triggers for the impairment review were a loss of customers as well as a reduction in the value of Kubient's market capitalization. As a result of the quantitative assessments, the Company determined the fair value of the asset group was less than the carrying value and, accordingly, determined the Company's long-lived assets were fully impaired. As a result, during the nine months ended September 30, 2022, the Company recognized an impairment loss on intangible assets and property and equipment of $2,626,974 and $49,948, respectively, on its condensed consolidated statements of operations. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the three months ended June 30, 2022, the Company identified triggering events that indicated its goodwill associated with its acquisition of MediaCrossing was at risk of impairment and, as such, performed a quantitative impairment assessment to determine whether the fair value of the reporting unit (determined to be the Company) exceeded its fair value. The primary triggers for the impairment review were a loss of customers as well as a reduction in the value of Kubient's market capitalization. As a result of the quantitative assessments, the Company determined the fair value of the reporting unit was less than the carrying value and, accordingly, determined the Company's goodwill was fully impaired. As a result, during the nine months ended September 30, 2022, the Company recognized an impairment loss on goodwill of $463,000 on its condensed consolidated statements of operations.</p> 2626974 49948 463000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Accrued expenses and other current liabilities consisted of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued bonuses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 554,997</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,750</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financed director and officer insurance premiums</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 252,720</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 217,575</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued supplier expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,902</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 67,971</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 975,000</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal and professional fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,323</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,109</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued media commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 138,028</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit card payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 198,212</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 328,075</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued programming expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,750</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued issuable equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,258</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,017</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued warrant exercise costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,220</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 45,915</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total accrued expenses and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 716,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,493,287</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="font-size:1pt;font-weight:normal;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued bonuses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 79,842</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 554,997</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,750</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financed director and officer insurance premiums</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 252,720</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 217,575</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued supplier expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 57,902</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 67,971</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 975,000</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal and professional fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,323</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,109</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued media commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 138,028</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit card payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 198,212</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 328,075</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued programming expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,750</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued issuable equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 409</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,258</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,388</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,017</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued warrant exercise costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,220</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 45,915</p></td></tr><tr><td style="vertical-align:bottom;width:72.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total accrued expenses and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 716,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,493,287</p></td></tr></table> 79842 554997 13750 252720 217575 57902 67971 975000 12000 20323 2272 36109 138028 198212 328075 1750 409 1258 13388 9017 83519 83519 16220 45915 716484 2493287 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5 – STOCKHOLDERS’ EQUITY</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Stock-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the three and nine months ended September 30, 2022 and 2021, the Company recognized stock-based compensation expense related to stock options, restricted stock awards and restricted stock units as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Nine Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 67,864</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 95,288</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 274,274</p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 34,703</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 171,720</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,063</p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 53,101</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 193,235</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 611,713</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 213,662</p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 157,094</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 263,247</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 878,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 523,999</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of September 30, 2022, there was approximately $1,392,000 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 3.4 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended March 31, 2022, the Company granted 53,192 shares of immediately vested restricted stock awards (“RSAs”) to non-employee directors under the Kubient, Inc. 2021 Equity Incentive Plan (the “2021 Plan”) with an aggregate grant date fair value of $100,000 that was recognized immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended March 31, 2022, the Company granted 100,000 RSAs, 489,990 restricted stock units (“RSUs”) and a target number of 234,376 performance stock units (“PSUs”), all issued under the 2021 Plan. The RSAs and RSUs generally <span style="-sec-ix-hidden:Hidden_7a9-R2bFlUOHexksL40kGA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">vest</span></span> over four years and the PSUs are earned based upon actual net revenue generated by the Company during 2022 as compared to the targeted revenue specified in each award. Depending on actual net revenues generated as compared to the targeted amounts, the grantees may earn between 0% and 150% of their target award. The awards had an aggregate issuance date fair value of approximately $1,900,000. During the three months ended September 30, 2022, the Company issued 1,248 shares of common stock related to the aforementioned RSUs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended September 30, 2022, the Company granted 22,917 shares of immediately vested RSAs to a former employee under the 2021 Plan with an aggregate grant date fair value of approximately $28,000 that was recognized immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended September 30, 2022, the Company granted 25,000 shares of  RSAs to an employee under the 2021 Plan with an aggregate grant date fair value of approximately $29,000 which is being recognized over the 4 year vesting term of the award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Common Stock </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended March 31, 2022, the Company’s chief financial officer surrendered to the Company 3,397 shares of common stock, which were subsequently cancelled by the Company, in order to satisfy a tax withholding obligation of approximately $18,000 in connection with a previous grant. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">During the three months ended June 30, 2022, the Company cancelled 8,323 shares of common stock related to the forfeiture of RSAs from a terminated employee.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Three Months Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Nine Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 67,864</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 35,309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 95,288</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 274,274</p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 34,703</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 171,720</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,063</p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 53,101</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 193,235</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 611,713</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 213,662</p></td></tr><tr><td style="vertical-align:bottom;width:49.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 157,094</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 263,247</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 878,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 523,999</p></td></tr></table> 67864 35309 95288 274274 36129 34703 171720 36063 53101 193235 611713 213662 157094 263247 878721 523999 1392000 P3Y4M24D 53192 100000 100000 489990 234376 P4Y 0 1.50 1900000 1248 22917 28000 25000 29000 P4Y 3397 18000 8323 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 6 – FAIR VALUE MEASUREMENT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">On November 30, 2021, Kubient entered into and consummated an Asset Purchase Agreement (the “Purchase Agreement”) between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”), pursuant to which the Company acquired certain assets and liabilities that were critical to continue to operate the business of MediaCrossing for (i) </span><span style="font-weight:normal;">$500,000</span><span style="font-weight:normal;"> in cash and (ii) if the acquired business achieves certain milestones in 2022, up to </span><span style="font-weight:normal;">822,369</span><span style="font-weight:normal;"> shares of the Company’s common stock, par value </span><span style="font-weight:normal;">$0.00001</span><span style="font-weight:normal;"> per share (the “Earnout Shares”) (the “Transaction”). The Earnout Shares had a fair value of </span><span style="font-weight:normal;">$2.55</span><span style="font-weight:normal;"> as of the acquisition date. The Earnout Shares were measured using a Monte Carlo simulation. Key assumptions used in the fair value assessment consisted of revenue projections (which were used to estimate the number of Earnout Shares issuable), discount rate and standard deviation. The fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect Kubient’s own assumptions in measuring fair value.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">On September 30, 2022, the Company recomputed the fair value of its Earnout Shares as </span><span style="font-weight:normal;">$0</span><span style="font-weight:normal;"> using the Monte Carlo simulation. The Company recorded a gain on the change in fair value of the contingent consideration of </span><span style="font-weight:normal;">$0</span><span style="font-weight:normal;"> and </span><span style="font-weight:normal;">$613,000</span><span style="font-weight:normal;"> during the three and nine months ended September 30, 2022, respectively. The loss is primarily due to the decline in the Company</span><span style="font-weight:normal;">’</span><span style="font-weight:normal;">s stock price as well as changes in the likelihood that forecasted milestones would be met for the remainder of 2022.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Contingent Consideration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Beginning balance as of January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 613,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_ZYevpge7VkS_iJAOvAjqvQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in fair value of contingent consideration</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (613,000)</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ending balance as of September 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 500000 822369 0.00001 2.55 0 0 613000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Contingent Consideration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Beginning balance as of January 1, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 613,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="-sec-ix-hidden:Hidden_ZYevpge7VkS_iJAOvAjqvQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Change in fair value of contingent consideration</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (613,000)</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ending balance as of September 30, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table> 613000 -613000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 7 – CONCENTRATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Customer Concentrations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Nine Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 81.82</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32.82</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 53.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15.55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 86.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 114.64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84.98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 106.86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, certain customers generate negative net revenues that resulted from Supplier Costs that exceeded the Gross Billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"> <span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41.35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 30.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 71.93</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">* Less than 10%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Supplier Concentrations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Nine Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Supplier</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26.79</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier F</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier G</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 59.43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 51.87</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">* Less than 10%.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Nine Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 81.82</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.59</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 29.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32.82</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 12.66</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 53.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15.55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:46.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 86.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 114.64</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.21%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 84.98</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 106.86</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 6pt;"> <span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41.35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 30.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:69.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.78%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 71.93</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">* Less than 10%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> For the Nine Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Supplier</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13.34</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26.79</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13.85</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier F</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Supplier G</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 10.43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:45.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 24.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 59.43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 51.87</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">* Less than 10%.</p> 0.8182 0.2459 0.9420 0.1067 0.2908 0.3282 0.1266 0.5358 0.1576 0.2232 0.1555 0.8658 1.1464 0.8498 1.0686 0.2208 0.4135 0.5218 0.3058 0.7193 0.7426 0.1334 0.2431 0.2679 0.1174 0.1385 0.2418 0.1660 0.1097 0.1043 0.2431 0.5943 0.5187 0.1660 Includes gross proceeds of $9,708,038, less issuance costs of $433,127. Includes gross proceeds of $460,989, less issuance costs of $32,270. Includes gross proceeds of $10,169,027, less issuance costs of $381,878. EXCEL 43 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

;0$7IJ/;E0;ZVIHJ%"G (8L#RG&?Y[GTPMVDI.68-FBQX0J PO*UN.Q7UD57"XPA 'X M*&[1?N*YKA_B&5EGG3Z;[K,I M>Z/I.#D93Q(&IV)*HY1U'%RK3,L8%8P^%7?>SBS++N\>,V6G(<>CL>R?SH- MLH%.%P5.1YT#248W=D[MS5F=W#!E/+ X9@K*AC(#/A/YGN2EQ8_%9(6I9.]D M=I*<3B8]6W9! @U-N.JV2>\--OP^Y^$35N=DLE7Q=-**0!F#?(%2_$KM\Y!EQ#2O%[8JZT"68 M-N50,ON43##\W/%S37RX+BL?YJ5,WVE^1=#LB$/4AM]F$XC!6O1"IJC8<>3I M#@S'Y=^*!9XK#PHH6%8G]O58^5KGK/(?-(Q2F)%:&C+"O0.:1>YDSDWW4;MY M0ND9_J0$?D/CF/=JF<2 G�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end XML 44 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 45 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 46 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 132 193 1 true 41 0 false 4 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.kubient.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity Condensed Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00305 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityParenthetical Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION Sheet http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION Notes 9 false false R10.htm 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 10301 - Disclosure - LONG-LIVED ASSETS AND GOODWILL Sheet http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwill LONG-LIVED ASSETS AND GOODWILL Notes 11 false false R12.htm 10401 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Notes 12 false false R13.htm 10501 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.kubient.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 13 false false R14.htm 10601 - Disclosure - FAIR VALUE MEASUREMENT Sheet http://www.kubient.com/role/DisclosureFairValueMeasurement FAIR VALUE MEASUREMENT Notes 14 false false R15.htm 10701 - Disclosure - CONCENTRATIONS Sheet http://www.kubient.com/role/DisclosureConcentrations CONCENTRATIONS Notes 15 false false R16.htm 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.kubient.com/role/DisclosureSignificantAccountingPolicies 17 false false R18.htm 30403 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Tables http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 18 false false R19.htm 30503 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.kubient.com/role/DisclosureStockholdersEquity 19 false false R20.htm 30603 - Disclosure - FAIR VALUE MEASUREMENT (Tables) Sheet http://www.kubient.com/role/DisclosureFairValueMeasurementTables FAIR VALUE MEASUREMENT (Tables) Tables http://www.kubient.com/role/DisclosureFairValueMeasurement 20 false false R21.htm 30703 - Disclosure - CONCENTRATIONS (Tables) Sheet http://www.kubient.com/role/DisclosureConcentrationsTables CONCENTRATIONS (Tables) Tables http://www.kubient.com/role/DisclosureConcentrations 21 false false R22.htm 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) Details 22 false false R23.htm 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) Details 23 false false R24.htm 40301 - Disclosure - LONG-LIVED ASSETS AND GOODWILL (Details) Sheet http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwillDetails LONG-LIVED ASSETS AND GOODWILL (Details) Details http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwill 24 false false R25.htm 40401 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Details http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables 25 false false R26.htm 40501 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details http://www.kubient.com/role/DisclosureStockholdersEquityTables 26 false false R27.htm 40502 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) Details 27 false false R28.htm 40601 - Disclosure - FAIR VALUE MEASUREMENT (Details) Sheet http://www.kubient.com/role/DisclosureFairValueMeasurementDetails FAIR VALUE MEASUREMENT (Details) Details http://www.kubient.com/role/DisclosureFairValueMeasurementTables 28 false false R29.htm 40602 - Disclosure - FAIR VALUE MEASUREMENT - Additional information (Details) Sheet http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails FAIR VALUE MEASUREMENT - Additional information (Details) Details 29 false false R30.htm 40701 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details) Sheet http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails CONCENTRATIONS - Customer Concentrations (Details) Details 30 false false R31.htm 40702 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details) Sheet http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails CONCENTRATIONS - Supplier Concentrations (Details) Details 31 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 14 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:PreferredStockSharesOutstanding, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - kbnt-20220930x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - kbnt-20220930x10q.htm 9 kbnt-20220930x10q.htm kbnt-20220930.xsd kbnt-20220930_cal.xml kbnt-20220930_def.xml kbnt-20220930_lab.xml kbnt-20220930_pre.xml kbnt-20220930xex31d1.htm kbnt-20220930xex31d2.htm kbnt-20220930xex32d1.htm kbnt-20220930x10q001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 49 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kbnt-20220930x10q.htm": { "axisCustom": 0, "axisStandard": 14, "contextCount": 132, "dts": { "calculationLink": { "local": [ "kbnt-20220930_cal.xml" ] }, "definitionLink": { "local": [ "kbnt-20220930_def.xml" ] }, "inline": { "local": [ "kbnt-20220930x10q.htm" ] }, "labelLink": { "local": [ "kbnt-20220930_lab.xml" ] }, "presentationLink": { "local": [ "kbnt-20220930_pre.xml" ] }, "schema": { "local": [ "kbnt-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 304, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 18, "http://xbrl.sec.gov/dei/2022": 6, "total": 24 }, "keyCustom": 44, "keyStandard": 149, "memberCustom": 17, "memberStandard": 21, "nsprefix": "kbnt", "nsuri": "http://www.kubient.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - LONG-LIVED ASSETS AND GOODWILL", "role": "http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwill", "shortName": "LONG-LIVED ASSETS AND GOODWILL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - STOCKHOLDERS' EQUITY", "role": "http://www.kubient.com/role/DisclosureStockholdersEquity", "shortName": "STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - FAIR VALUE MEASUREMENT", "role": "http://www.kubient.com/role/DisclosureFairValueMeasurement", "shortName": "FAIR VALUE MEASUREMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - CONCENTRATIONS", "role": "http://www.kubient.com/role/DisclosureConcentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityTables", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_k7Rbw9WmdUubarF4lpFp3A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_k7Rbw9WmdUubarF4lpFp3A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - FAIR VALUE MEASUREMENT (Tables)", "role": "http://www.kubient.com/role/DisclosureFairValueMeasurementTables", "shortName": "FAIR VALUE MEASUREMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30703 - Disclosure - CONCENTRATIONS (Tables)", "role": "http://www.kubient.com/role/DisclosureConcentrationsTables", "shortName": "CONCENTRATIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_6G6Gn6vQWEe116X8whu6eg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:LossAccrualReversalOnCustomerContract", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_6G6Gn6vQWEe116X8whu6eg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:LossAccrualReversalOnCustomerContract", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_R2eSD42SWkCfMHy8KbVgNQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_R2eSD42SWkCfMHy8KbVgNQ", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - LONG-LIVED ASSETS AND GOODWILL (Details)", "role": "http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwillDetails", "shortName": "LONG-LIVED ASSETS AND GOODWILL (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "0", "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_k7Rbw9WmdUubarF4lpFp3A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_k7Rbw9WmdUubarF4lpFp3A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_k7Rbw9WmdUubarF4lpFp3A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - STOCKHOLDERS' EQUITY (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "shortName": "STOCKHOLDERS' EQUITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_6G6Gn6vQWEe116X8whu6eg", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_R2eSD42SWkCfMHy8KbVgNQ", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_6G6Gn6vQWEe116X8whu6eg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "shortName": "STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_6G6Gn6vQWEe116X8whu6eg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_1e0XVHTjo0qbvEav9jiAWQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - FAIR VALUE MEASUREMENT (Details)", "role": "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails", "shortName": "FAIR VALUE MEASUREMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_1e0XVHTjo0qbvEav9jiAWQ", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:ChangeInFairValueOfContingentConsideration", "reportCount": 1, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40602 - Disclosure - FAIR VALUE MEASUREMENT - Additional information (Details)", "role": "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails", "shortName": "FAIR VALUE MEASUREMENT - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_11_30_2021_us-gaap_BusinessAcquisitionAxis_kbnt_MediacrossingIncMember_l_m7bb5VYESSXAnGWfXrDw", "decimals": "0", "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_k7Rbw9WmdUubarF4lpFp3A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_NGnZVjBA4U-qKah9-fHHeA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_k7Rbw9WmdUubarF4lpFp3A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_NGnZVjBA4U-qKah9-fHHeA", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_kbnt_CustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_dnZoT0WrbkeUyKUIAbl1JA", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_uPMoUyf5RE2FKkiE88BnBw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details)", "role": "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "shortName": "CONCENTRATIONS - Customer Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_srt_MajorCustomersAxis_kbnt_CustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_dnZoT0WrbkeUyKUIAbl1JA", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_uPMoUyf5RE2FKkiE88BnBw", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_CostOfGoodsProductLineMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_kbnt_SupplierMember_Vpx-dHd9kUqb0MIonCnK7g", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_uPMoUyf5RE2FKkiE88BnBw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40702 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details)", "role": "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails", "shortName": "CONCENTRATIONS - Supplier Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_CostOfGoodsProductLineMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_kbnt_SupplierMember_Vpx-dHd9kUqb0MIonCnK7g", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_uPMoUyf5RE2FKkiE88BnBw", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_6G6Gn6vQWEe116X8whu6eg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_6G6Gn6vQWEe116X8whu6eg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wdgbjBNYJE2wbFLkMq50lg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_dUsQc7_hKUCnKp4kfQmXBg", "decimals": "0", "lang": null, "name": "kbnt:SharesIssuedValueUponExerciseOfWarrantsNetOfIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "link:footnote", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_4_1_2021_To_6_30_2021_L2BksmYcpk65u0vr3MyxcQ", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityParenthetical", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "link:footnote", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_4_1_2021_To_6_30_2021_L2BksmYcpk65u0vr3MyxcQ", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "link:footnote", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "Condensed Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "link:footnote", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_uuwyxcL6sUSX6TouQEWhBA", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION", "role": "http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation", "shortName": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_eNq7NHj4mUCZbnBQ1_nswg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 41, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document and Entity Information" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Adress Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kbnt_AccountsPayableSupplierCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable to supplier for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Supplier, Current", "terseLabel": "Accounts payable - suppliers" } } }, "localname": "AccountsPayableSupplierCurrent", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "kbnt_AccrualOfWarrantExerciseIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrual of warrant exercise issuance costs in a noncash financing activities.", "label": "Accrual of Warrant Exercise Issuance Costs", "verboseLabel": "Accrual of warrant exercise issuance costs" } } }, "localname": "AccrualOfWarrantExerciseIssuanceCosts", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedAndOtherLiabilitiesCurrentOtherThanInterestPayable": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other other than interest payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued And Other Liabilities, Current, Other Than Interest Payable", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedAndOtherLiabilitiesCurrentOtherThanInterestPayable", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedCommissions": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 9.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued commissions.", "label": "Accrued Commissions", "terseLabel": "Accrued commissions" } } }, "localname": "AccruedCommissions", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities", "totalLabel": "Total accrued expenses and other current liabilities" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedExpensesAndOtherCurrentLiabilitiesOthers": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities, Others", "terseLabel": "Other" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilitiesOthers", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedIssuableEquity": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued issuable equity.", "label": "Accrued Issuable Equity", "terseLabel": "Accrued issuable equity" } } }, "localname": "AccruedIssuableEquity", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedLegalSettlement": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued legal settlement.", "label": "Accrued Legal Settlement", "terseLabel": "Accrued legal settlement" } } }, "localname": "AccruedLegalSettlement", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedMediaCommissions": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 10.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued media commissions.", "label": "Accrued Media Commissions", "terseLabel": "Accrued media commissions" } } }, "localname": "AccruedMediaCommissions", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedPayroll": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Payroll", "terseLabel": "Accrued payroll" } } }, "localname": "AccruedPayroll", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedProgrammingExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued programming expenses payable.", "label": "Accrued Programming Expenses", "terseLabel": "Accrued programming expenses" } } }, "localname": "AccruedProgrammingExpenses", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedSupplierExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 12.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued supplier expenses.", "label": "Accrued Supplier Expenses", "terseLabel": "Accrued supplier expenses" } } }, "localname": "AccruedSupplierExpenses", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedWarrantExerciseIssuanceCostsCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for warrant exercise issuance costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Warrant Exercise Issuance Costs, Current", "terseLabel": "Accrued warrant exercise costs" } } }, "localname": "AccruedWarrantExerciseIssuanceCostsCurrent", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AssetImpairmentCharge": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charge", "verboseLabel": "Impairment loss on property and equipment" } } }, "localname": "AssetImpairmentCharge", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_ChangeInFairValueOfContingentConsideration": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of change in fair value of contingent consideration.", "label": "Change In Fair Value Of Contingent Consideration", "negatedLabel": "Change in fair value of contingent consideration", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "ChangeInFairValueOfContingentConsideration", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_ClassOfWarrantOrRightNumberOfWarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercisable in to shares of common stock.", "label": "Class Of Warrant Or Right, Number Of Warrants Exercisable", "terseLabel": "Number of warrants exercisable (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfWarrantsExercisable", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrants Or Rights Number Of Securities Called By Warrants Or Right", "terseLabel": "Warrants to purchase shares of common stock" } } }, "localname": "ClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRight", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "kbnt_CommonStockSurrendered": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares surrendered.", "label": "Common Stock Surrendered", "terseLabel": "Common stock surrendered" } } }, "localname": "CommonStockSurrendered", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_CreditCardPayable": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 8.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of credit card payable.", "label": "Credit Card Payable", "terseLabel": "Credit card payable" } } }, "localname": "CreditCardPayable", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer B.", "label": "Customer B [Member]", "terseLabel": "Customer B" } } }, "localname": "CustomerBMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer C.", "label": "Customer C [Member]", "terseLabel": "Customer C" } } }, "localname": "CustomerCMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer D.", "label": "Customer D [Member]", "terseLabel": "Customer D" } } }, "localname": "CustomerDMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer E.", "label": "Customer E [Member]", "terseLabel": "Customer E" } } }, "localname": "CustomerEMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer A.", "label": "Customer [Member]", "terseLabel": "Customer A" } } }, "localname": "CustomerMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_EarnoutSharesAcquiredByCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of earnout shares acquired by the company.", "label": "Earnout Shares Acquired By The Company", "terseLabel": "Earnout shares acquired by the company" } } }, "localname": "EarnoutSharesAcquiredByCompany", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "kbnt_EarnoutSharesFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value of the earn out shares.", "label": "Earnout Shares Fair Value", "terseLabel": "Earnout shares fair value" } } }, "localname": "EarnoutSharesFairValue", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "kbnt_EarnoutSharesParValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Par value of the earn out shares.", "label": "Earnout Shares Par Value", "terseLabel": "Earnout shares par value" } } }, "localname": "EarnoutSharesParValue", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "kbnt_FinancedDirectorAndOfficerInsurancePremiums": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 14.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of financed director and officer insurance premiums, current.", "label": "Financed Director And Officer Insurance Premiums", "terseLabel": "Financed director and officer insurance premiums" } } }, "localname": "FinancedDirectorAndOfficerInsurancePremiums", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_FinancingOfInsurancePremiums": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of financing of insurance premiums under non cash investing and financing activities.", "label": "Financing Of Insurance Premiums", "terseLabel": "Financing of insurance premiums" } } }, "localname": "FinancingOfInsurancePremiums", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow from issuance of convertible notes payable and investor warrants.", "label": "Gross Proceeds From Convertible Notes Payable And Investor Warrants", "terseLabel": "Gross proceeds from initial public offering" } } }, "localname": "GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_GrossProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow associated with the amount received from entity's first offering of stock to the public, before deduction of offering costs.", "label": "Gross Proceeds From Issuance Initial Public Offering", "terseLabel": "Gross proceeds from initial public offering" } } }, "localname": "GrossProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_IncreaseDecreaseInAccountsPayableSuppliers": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of supplies used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Suppliers", "terseLabel": "Accounts payable - suppliers" } } }, "localname": "IncreaseDecreaseInAccountsPayableSuppliers", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_InvoicePaymentTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the term period of invoice payment terms in 'P1Y5M13D' reported for the year.", "label": "Invoice Payment Terms", "terseLabel": "Invoice payment terms" } } }, "localname": "InvoicePaymentTerms", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "durationItemType" }, "kbnt_LossAccrualOnCustomerContract": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents loss accrual on customer contract.", "label": "Loss Accrual On Customer Contract", "terseLabel": "Loss accrual on customer contract" } } }, "localname": "LossAccrualOnCustomerContract", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_LossAccrualReversalOnCustomerContract": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount represents loss accrual (reversal) on customer contract.", "label": "Loss Accrual (Reversal) On Customer Contract", "terseLabel": "Loss accrual (reversal) on a customer contract" } } }, "localname": "LossAccrualReversalOnCustomerContract", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_MediacrossingIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for MediaCrossing Inc.", "label": "MediaCrossing Inc [Member]", "terseLabel": "MediaCrossing Inc" } } }, "localname": "MediacrossingIncMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "kbnt_PaymentsOfOfferingCostsForIssuanceOfConvertibleNotesPayableAndInvestorWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from payments of offering costs for issuance of convertible notes payable and investor warrants.", "label": "Payments Of Offering Costs For Issuance Of Convertible Notes Payable And Investor Warrants", "terseLabel": "Issuance costs" } } }, "localname": "PaymentsOfOfferingCostsForIssuanceOfConvertibleNotesPayableAndInvestorWarrants", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_PercentageOfEarningOfGrantees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of grantees earnings.", "label": "Percentage Of Earning Of Grantees", "terseLabel": "Percentage of grantees earnings" } } }, "localname": "PercentageOfEarningOfGrantees", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "kbnt_RecomputedFairValueOfEarnoutShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Recomputed fair value of earnout shares.", "label": "Recomputed fair value of earnout shares", "terseLabel": "Recomputed fair value of earnout shares" } } }, "localname": "RecomputedFairValueOfEarnoutShares", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_RepaymentOfFinancedDirectorAndOfficerInsurancePremiums": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt.", "label": "Repayment Of Financed Director And Officer Insurance Premiums", "negatedLabel": "Repayment of financed director and officer insurance premiums" } } }, "localname": "RepaymentOfFinancedDirectorAndOfficerInsurancePremiums", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the accrued expenses and other current liabilities .", "label": "Schedule Accrued Expenses And Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued expenses and other current liabilities" } } }, "localname": "ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "kbnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Number of Common Stock Shares During That Period Canceled", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period", "terseLabel": "Shares of common stock related to the forfeiture" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ShareBasedCompensationGrandFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of shares granted date fair value.", "label": "Share-Based Compensation Grand Fair Value", "terseLabel": "Aggregate grant date fair value" } } }, "localname": "ShareBasedCompensationGrandFairValue", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_ShareIssuedAndForfeitedDuringPeriodValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of shares issued and forfeited during the period.", "label": "Share Issued And Forfeited During Period Value", "terseLabel": "Surrender and cancellation of common stock" } } }, "localname": "ShareIssuedAndForfeitedDuringPeriodValue", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_SharesIssuedAndForfeitedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares issued and forfeited during the period.", "label": "Shares Issued And Forfeited During The Period Shares", "terseLabel": "Surrender and cancellation of common stock (in shares)" } } }, "localname": "SharesIssuedAndForfeitedDuringPeriodShares", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "kbnt_SharesIssuedAndForfeitedDuringPeriodValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of shares issued and forfeited during the period.", "label": "Shares Issued And Forfeited During The Period Value", "terseLabel": "Surrender and cancellation of common stock" } } }, "localname": "SharesIssuedAndForfeitedDuringPeriodValue", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kbnt_SharesIssuedAsPartialConsiderationForIntangibleAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Shares issued as partial consideration for intangible asset in a noncash financing activities.", "label": "Shares Issued as Partial Consideration for Intangible Asset", "terseLabel": "Shares issued as partial consideration for intangible asset" } } }, "localname": "SharesIssuedAsPartialConsiderationForIntangibleAsset", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_SharesIssuedSharesUponExerciseOfWarrantsNetOfIssuanceCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued upon exercise of warrants, net of issuance costs .", "label": "Shares Issued Shares Upon Exercise Of Warrants Net Of Issuance Costs", "terseLabel": "Shares issued upon exercise of warrants, net of issuance costs (in shares)" } } }, "localname": "SharesIssuedSharesUponExerciseOfWarrantsNetOfIssuanceCosts", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "kbnt_SharesIssuedValueUponExerciseOfWarrantsNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of value of shares issued upon exercise of warrants, net of issuance costs.", "label": "Shares Issued Value Upon Exercise Of Warrants Net Of Issuance Costs", "terseLabel": "Shares issued upon exercise of warrants, net of issuance costs" } } }, "localname": "SharesIssuedValueUponExerciseOfWarrantsNetOfIssuanceCosts", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kbnt_StockOptionsPlanExpense": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of stock options plan expense.", "label": "Stock Options Plan Expense", "verboseLabel": "Options" } } }, "localname": "StockOptionsPlanExpense", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_SupplierBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier B.", "label": "Supplier B [Member]", "terseLabel": "Supplier B" } } }, "localname": "SupplierBMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier C.", "label": "Supplier C [Member]", "terseLabel": "Supplier C" } } }, "localname": "SupplierCMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier D.", "label": "Supplier D [Member]", "terseLabel": "Supplier D" } } }, "localname": "SupplierDMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier E.", "label": "Supplier E [Member]", "terseLabel": "Supplier E" } } }, "localname": "SupplierEMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier F.", "label": "Supplier F [Member]", "terseLabel": "Supplier F" } } }, "localname": "SupplierFMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "his member stands for Supplier G.", "label": "Supplier G [Member]", "terseLabel": "Supplier G" } } }, "localname": "SupplierGMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier A.", "label": "Supplier [Member]", "terseLabel": "Supplier A" } } }, "localname": "SupplierMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopFiveCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents for Top Five Customers.", "label": "Top Five Customers [Member]", "terseLabel": "Top Five Customers" } } }, "localname": "TopFiveCustomersMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopFourCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents for Top Four Customers.", "label": "Top Four Customers [Member]", "terseLabel": "Top Four Customers" } } }, "localname": "TopFourCustomersMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopSevenSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Top Seven Suppliers.", "label": "Top Seven Suppliers [Member]", "terseLabel": "Top Seven Suppliers" } } }, "localname": "TopSevenSuppliersMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for 2021 equity incentive plan.", "label": "Two Thousand Twenty One Equity Incentive Plan [Member]", "terseLabel": "2021 Equity Incentive Plan" } } }, "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://www.kubient.com/20220930", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ExecutiveOfficerMember": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "label": "Executive Officer [Member]", "terseLabel": "Executive Officer" } } }, "localname": "ExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r120", "r193", "r197", "r328" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r144", "r145", "r146", "r147", "r159", "r168", "r212", "r214", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r327", "r329", "r339", "r340" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r144", "r145", "r146", "r147", "r159", "r168", "r212", "r214", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r327", "r329", "r339", "r340" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r120", "r193", "r197", "r328" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r142", "r144", "r145", "r146", "r147", "r159", "r168", "r202", "r212", "r214", "r239", "r240", "r241", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r327", "r329", "r339", "r340" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r142", "r144", "r145", "r146", "r147", "r159", "r168", "r202", "r212", "r214", "r239", "r240", "r241", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r327", "r329", "r339", "r340" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r121", "r294" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.", "label": "Accounts and Other Receivables, Net, Current", "terseLabel": "Other receivables" } } }, "localname": "AccountsAndOtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r6", "r21" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts payable - trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r122", "r123" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 13.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Bonuses, Current", "terseLabel": "Accrued bonuses" } } }, "localname": "AccruedBonusesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 11.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued legal and professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r15", "r297" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r70", "r71", "r72", "r248", "r249", "r250", "r270" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition", "terseLabel": "Stock-based compensation: Options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r244" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "verboseLabel": "Total" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares excluded from the calculation of weighted average dilutive common shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Net Loss Per Common Share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r55", "r139" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "verboseLabel": "Impairment loss on property and equipment" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r10", "r68", "r107", "r110", "r116", "r125", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r260", "r264", "r283", "r295", "r297", "r311", "r320" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets.", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r20", "r68", "r125", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r260", "r264", "r283", "r295", "r297" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r211", "r213", "r256" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r211", "r213", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r257", "r258" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r7", "r297", "r336", "r337" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r7", "r57" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r51", "r57", "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and Cash Equivalents - End of the Period", "periodStartLabel": "Cash and Cash Equivalents - Beginning of the Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r51", "r284" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (Decrease) Increase In Cash and Cash Equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "verboseLabel": "Exercise price of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r27", "r313", "r324" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r70", "r71", "r270" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock, par value $0.00001 per share", "verboseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r14", "r182" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r14", "r297" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,402,500 and 14,253,948 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommunicationsAndInformationTechnology": { "auth_ref": [ "r41" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense in the period for communications and data processing expense.", "label": "Communications and Information Technology", "terseLabel": "Technology" } } }, "localname": "CommunicationsAndInformationTechnology", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r99", "r100", "r120", "r280", "r281", "r338" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r99", "r100", "r120", "r280", "r281", "r335", "r338" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r99", "r100", "r120", "r280", "r281", "r335", "r338" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "CONCENTRATIONS.", "terseLabel": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r99", "r100", "r120", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk (as a percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r97", "r99", "r100", "r101", "r280", "r282", "r338" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r99", "r100", "r120", "r280", "r281", "r338" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r194" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Contracts with customers, revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsProductLineMember": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service, Product and Service Benchmark [Member]", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r98", "r120" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentrations" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCosts": { "auth_ref": [ "r9", "r310", "r319" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.", "label": "Deferred Costs, Noncurrent", "terseLabel": "Deferred offering costs" } } }, "localname": "DeferredCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r55", "r106" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r193", "r195", "r196", "r197", "r198", "r199", "r200", "r201" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r37", "r75", "r76", "r77", "r78", "r79", "r83", "r85", "r87", "r88", "r89", "r92", "r93", "r271", "r272", "r315", "r326" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net Loss Per Share - Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r37", "r75", "r76", "r77", "r78", "r79", "r85", "r87", "r88", "r89", "r92", "r93", "r271", "r272", "r315", "r326" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net Loss Per Share - Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r90", "r91" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r245" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense", "verboseLabel": "Unrecognized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized stock-based compensation expense, period of recognition", "verboseLabel": "Unrecognized stock-based compensation expense, period of recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EnergyMarketingContractLiabilitiesCurrent": { "auth_ref": [ "r24" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current liabilities attributable to energy marketing activities (trading activities). Current energy marketing (trading activities) are when entities engage in both financial and physical trading to increase profits, manage their commodity price risk and enhance system reliability. They may trade electricity, coal, natural gas and oil. These entities typically use a variety of financial instruments, including forward contracts, options and swaps.", "label": "Energy Marketing Contract Liabilities, Current", "terseLabel": "Contract liabilities" } } }, "localname": "EnergyMarketingContractLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r31", "r32", "r33", "r70", "r71", "r72", "r74", "r80", "r82", "r94", "r126", "r182", "r189", "r248", "r249", "r250", "r252", "r253", "r270", "r285", "r286", "r287", "r288", "r289", "r290", "r293", "r330", "r331", "r332" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "FAIR VALUE MEASUREMENT" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r273", "r274", "r279" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r160", "r161", "r162", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r274", "r298", "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENT" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENT" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurement" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r160", "r161", "r162", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r274", "r300" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair value of Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary of changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r277" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r276" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending balance as of September 30, 2022", "periodStartLabel": "Beginning balance as of January 1, 2022" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r160", "r161", "r162", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r298", "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).", "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureFairValueMeasurementDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r41" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r8", "r128", "r130", "r132", "r134", "r297", "r309" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONG-LIVED ASSETS AND GOODWILL" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r55", "r129", "r131", "r133", "r134" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Impairment loss on goodwill", "verboseLabel": "Impairment loss on goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwillDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r55", "r137" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill).", "terseLabel": "Impairment loss on intangible assets", "verboseLabel": "Impairment loss on intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwillDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONG-LIVED ASSETS AND GOODWILL." } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r141", "r143" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r54" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "Increase (Decrease) in Accounts and Other Receivables", "negatedLabel": "Other receivable" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r54" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Accounts payable - trade" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r54" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r54" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r54" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r54" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Accrued interest" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r54" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (decrease) in stockholders' equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "verboseLabel": "LONG-LIVED ASSETS AND GOODWILL" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureLongLivedAssetsAndGoodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r135", "r136" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r34", "r105", "r291", "r292", "r316" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "verboseLabel": "Interest income" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r49", "r52", "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "verboseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r68", "r111", "r125", "r148", "r149", "r150", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r261", "r264", "r265", "r283", "r295", "r296" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r19", "r68", "r125", "r283", "r297", "r312", "r322" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Deficiency", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r5", "r25", "r68", "r125", "r148", "r149", "r150", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r261", "r264", "r265", "r283", "r295", "r296", "r297" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r26" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes Payable, Noncurrent", "terseLabel": "Notes payable, non-current portion" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r51" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash (Used In) Provided By Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows From Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r51" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used In Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows From Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r51", "r53", "r56" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used In Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r29", "r30", "r33", "r36", "r56", "r68", "r73", "r75", "r76", "r77", "r78", "r81", "r82", "r86", "r107", "r109", "r112", "r115", "r117", "r125", "r148", "r149", "r150", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r272", "r283", "r314", "r325" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other Income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other (Expense) Income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Costs and Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "verboseLabel": "Costs and Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r107", "r109", "r112", "r115", "r117" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss From Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r268" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertaintiesAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r40" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "terseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r47" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Payment of deferred offering costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "verboseLabel": "Issuance costs on initial public offering" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "terseLabel": "Stock-based compensation tax withholding obligation" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r43" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r43" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "PSUs" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r13", "r166" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r13", "r166" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r13", "r297" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of September 30, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r44", "r247" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r44" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "verboseLabel": "Proceeds from exercise of warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r29", "r30", "r33", "r50", "r68", "r73", "r81", "r82", "r107", "r109", "r112", "r115", "r117", "r125", "r148", "r149", "r150", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r259", "r262", "r263", "r266", "r267", "r272", "r283", "r317" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r140", "r297", "r318", "r323" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r39", "r127" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r46" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayment of PPP loan" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r55" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Common stock" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted stock awards" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r16", "r189", "r297", "r321", "r333", "r334" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r70", "r71", "r72", "r74", "r80", "r82", "r126", "r248", "r249", "r250", "r252", "r253", "r270", "r330", "r332" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r103", "r104", "r108", "r113", "r114", "r118", "r119", "r120", "r192", "r193", "r308" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net Revenues" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r99", "r120" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r191" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue recognized from performance obligations satisfied" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r35", "r68", "r103", "r104", "r108", "r113", "r114", "r118", "r119", "r120", "r125", "r148", "r149", "r150", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r283", "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of calculation of weighted average dilutive common shares" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r243", "r251" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of stock-based compensation expense related to stock options, restricted stock awards and restricted stock units" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r12", "r13", "r14", "r66", "r95", "r96", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r171", "r175", "r180", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r97", "r99", "r100", "r101", "r280", "r282" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Summary of customer and supplier concentrations" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "verboseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares of common stock granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Number of common stock issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "auth_ref": [ "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Employee [Member]", "terseLabel": "Employees" } } }, "localname": "ShareBasedPaymentArrangementEmployeeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r63", "r69" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r28", "r31", "r32", "r33", "r70", "r71", "r72", "r74", "r80", "r82", "r94", "r126", "r182", "r189", "r248", "r249", "r250", "r252", "r253", "r270", "r285", "r286", "r287", "r288", "r289", "r290", "r293", "r330", "r331", "r332" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Changes in Stockholders' Equity" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r70", "r71", "r72", "r94", "r308" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r59", "r60", "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Shares of common stock issued in satisfaction of accrued issuable equity" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Stock Issued During Period, Shares, Purchase of Assets", "terseLabel": "Shares issued as partial consideration for intangible asset (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r13", "r14", "r182", "r189" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation: Common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r13", "r14", "r182", "r189", "r225" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Common stock issued upon exercise of options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Stock Issued During Period, Value, Purchase of Assets", "terseLabel": "Shares issued as partial consideration for intangible asset" } } }, "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r13", "r14", "r189", "r234" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation: Common stock", "verboseLabel": "Common stock aggregate issuance date fair value" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r28", "r182", "r189" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Common stock issued upon exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r14", "r17", "r18", "r68", "r124", "r125", "r283", "r297" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficiency:", "terseLabel": "Stockholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r67", "r167", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r181", "r189", "r190", "r269" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental Disclosures of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Cash paid during the period for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]", "terseLabel": "Supplier Concentrations" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TechnologyServiceMember": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Technology assistance, including but not limited to, training, installation, engineering, and software design.", "label": "Technology Service [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Common Stock Purchase Warrants", "verboseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "verboseLabel": "Warrants term (in years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r84", "r89" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Common Shares Outstanding - Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r83", "r89" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Common Shares Outstanding - Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r268": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r341": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r342": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r343": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r344": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r345": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r346": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r347": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" } }, "version": "2.1" } ZIP 50 0001410578-22-003348-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-22-003348-xbrl.zip M4$L#!!0 ( $J ;E7:&K@*@PT $6! 1 :V)N="TR,#(R,#DS,"YX M;F]JB&$9#)[DYKL%A"2=2T!#LCNW+UL"5N :HS, M2G8^[J^_EFP9&W]#4NOL^67&6*U6=_]:K99D*5]^?-[8Z)%P01UV?=(Y/3M! MA)F.1=GJ^L03+2Q,2D]^_.&O?_GRMU;K:V\Z1)9C>AO"7&1R@EUBH2?JKM'< MV6XQ0_>$IM2((=GI!6JU AX]+*".PY!B=G[:"4OZ 3^'7:%. MI]WYV#X_.S]'EU?G_[RZN$23^Y#R'@136X9L;LL2>[8)- MV.\>ME7K8"J;2$O$""+%8%LFKD"(6&M/%Z<.7T%#9YWVU_OA3,FGB<'D*XRW M884E%@M%'A0H^30Q)\L8Y^<%MS7O3VTHU82"NRWW94M$DF]8%.,L.5EN2!UE M?-GV"R,2<\=.8ZU+XISM3)$OVE^'E'W3E Q34\1%$,0\73F/;5448RO5R! C M+(I5\%R>*6GNB2.NKOE&?)#28RT1&_6W946=]<69<+%S"31#D-SW&2?_MN"N25B M4( ]\S;G:9WQ_ S0=PD3=&&3EB0C'+L0RD7K_#2L;KE\SZHQ^:"X+8L5O]99 MIW7>"6N2+2=F&>!WE#N/<8N]Q=VU1-.!A((8CE9NO[5V_=:,!,>XWY%E,M;1 MU%CWR8]U] 0&$X34<((99[??D@=C_IC]H)[!400H MKFPHXWU0.R#)JVEBV_3L RKN),NN%[S5F!T%)1C.59E!WV$6=$]BP8-P;&K) M'M+#M@P%LS4A&L@J%?)@A""E8 SYP7/($D5YHH I\KDV$%:","P5X^5XJX-N M&2PS:N:#>EX6U!UWY"S1CG\#[\'P]K%8W]K.4V5T=Q7SP?UX&+B2/5+\&W S M1]*N:7*/6(/GK;2G@'%L[*X)[ZL,VQU2O* V"$;$#7$QM1/#:N7Z>5!_!*@[ M^V-LM]^?/@QNT.#K9#":#6:H.[I!X_E/@RGJ/TRG@]$<#8UNSQ@:(6-"/C<4 M8=>@=7C\76.V(L)@,]\A5=,L(S-:^)2T/L5723.M\A?+M_ 7]!W,1F:,2!G"DU7C"[!2A#> M3;721-EJ F8W8;">DD?"/#(EIK/RQ3@)EQ-S)NC7X71GM( M",8/H[DQND.3\=#HRU&_A8+&4*2U)AW1N@/20;1- B\IM$JLW&)THMK^V']BS,,PGS,;U,Z>'S!I=ZH743P?#DOPWD1O&+U(F"3G34-V)8_? =[G=%V M&LQ+8'Z+*?\%VQZY)UC^5I.U='SS2/.Q_)3LI+==8XI^Z0X?!NA^T)T]3 ?W MC/H [[SY-I)? >S61QY_2VOXY;2TKD4 M;88=MG 6;H8U;E ZL/<\01D18LQ7F-'_*ME'V(62Z-;TE(IO74!K5,U(8.6PWI([&Z0L"8"KWPSG&L)VK;^Y#E4.;C M=9'$:S@>W;6&QB^#&]2=S09SO\?=C<6S>'&S *Z2"],-*)76N*!@,[QPJX(9U E#\P+ /.B,I@^XP;*5\@7TV&M6CT? MXH])B*M^#-L@7CV)S.BQ673Y&%ZF=-/4+QT:I [)+-.QRJ',1^M3$JVL+>\& MKVKI9CI2J33Y&'V?Q&AOHZO!YHAEK(R-RN(*^=N3E1>U_J\V)>4_\HS\E"R1 M.GY^)<\;7Y\(NMG:\DBT>K=6UQG(@]$M?0#Z-U#W]'EC:Q+)/^>0M?*"?0L% M#6L6F)L)+HGC\<#$V1(N4YFV%OX$M5]-+3!I5;7B*-11*1LOJBH%58A=5WV@ MPU359Z^/O9Y6@>34E=7[NU:0;$9\0%@NT&O5O[3WCZ0';^)'U]7!=;""PUW$ M$O>B9!S"]V]3&3JFXN-3BRQR^:#L>0I-:?GRFRV^F2!+@J*:ZKJ]62?%J=\U;GT^&"1"^3*".$JB)_A9=62#$NI!@7G?)BI-\!4U( M74&V?%F^S:RK9'*],/7*G#:Q71&RJ>B4&9?P'"&%?'.H$+O+9,H)H.G]QN5M M.*D-!W<9J<1(!L+?#/;H4)-,\(N:8!"^@;1)RG5]DEX$V9+,3*]/7.Z!;_IQ M5EV,>?'O''6^K22F00,!3SQ (J6/-%2/-(E]H M>3V+Y=D5ERKFY-GMV3 #U@H>SR;5&.%-+%>N)GUSBP0JZ(_CM"I:T^SB'#@W M#H/LE;\<(;P?BUQ=M/"_Y;H^,3FQJ%M*)7GPA0KAK_;'M(F7U%>1OJ+I8VY! M5Y(R:CW2"NJK1F#U"7=6'(/EV2K#R](I:J]8UK5#M3V""RLK776VY M;2&"[A=^NNQK$=$UGZK6"DJ8-#P17 +IU>OY&C.#N03FU.Y>B#J&07W-8C!Y MJZ4@-\3_WV 9&$=RH0HUWE;Q74*PI[E%%D6*0P-"0'PV";'$+7XXM;AAA"> M9#->5K?6JW/]@PQ8*L\)CM_+7O>,&.8H*J""= M_HHREL D"NN;G*A-^O%6;29.H%Z08X>H9!;7=VS5,30]LM;?.)>/NE1;U$EAX+ZYX%!.$NL&Y@7*)]3^6>R=EM^1KUC9HZF/328TS= M,XCP:'RZ^.\E@[A-[S6W-1=?]0%LAU$IM1?$.DP)XAK/U&9^+ 6!Y;L]<;&"(?OHVT1SQQ%D#H* MG3O.B.EQ?Q$:VS:Q>B][E"=9R>LAK(Y(0H^Q6:9Q]*!ZE^C=B9(Z=FN]28A? MN*,/',?V%W7!N_'6>RC'IISO010RF)G )8N@CO!,R=9?LAXO#XM(AS)X/Y$Z M<%2%:NP;A'U73E*\&Y^.9GGJ%,+#UF$ZT]V%TQ$!F/<2W]0LLR*/]^,,427] MYR,M597)FPY/.8;*'KS5]=8&"P^PJ!TN>3;0OT]H-U&(#M,5*KU/YX#@!Q.C M)0$QK!M/+OI-5*-*VPQ?**CSYS*$3U/1$KI2[7I!, 0,R0K;,^*Z=N02@>@8 MD2!X-T/$_,F9KQU/8&;-G^#URY@%VRN&.@\%DV:Y/Y&<@U:K5\_C11]I$.YVBCNJH3I2X+/D.AAPKC,?[_;*0_/T$)X@DTN_P"@:= >9,K25( M=5P2BT<%=/O(;GWR/WHT]J^JEYN&,[6,#^.H/-BP&WDS"&H74:7)'<_U(W[7 MA(C!Y7Q=^B!F+Q&-B@CKK=D$)SI<1GF*PRF2.FF3%C^R"&JJC_QC')NM!XE' M)#F-Z1";_183UR8R9N_]^IK+/SZA=SM8Y/)FQ32B= '=N]%7[548$"4H5W>? MKN5?$X^F;.GE[T8_OS=5GXW\R28C$7>5?W"'B_+NG4=?&P.4]F7W@7 -(:EDI@B06:IR*Y*S<]ZFC"U %2,QDIW+ M_/J1C W86+9\ 813=2HG@9:LK[^6U)*ZY>M?/Q>6]@X(A1C=5!IG]8H&D(%- MB&8W%8=6=6I 6/GUEW_^X_I?U>K/V_&]9F+#60!D:P8!N@U,[0/:<^T5+Y56K M?7Q\G'U.B'6&R8R5KK=JOF!E)7GU26% ^J/ERS9J/Q_N7XPY6.A5B*BM(V-3 MBE<35:YQ>7E9<[]EHA1>4;?\/39TVU5^8KLTH03_J^J+5?E'U4:SVFJ>X&VOJTZ\&D#5L)M;=>M>95K7NTN#H;$PD;@018?X# )DL0A48;)'5.F.IVX PN;;V:Z MOG3'\AJP;.I_XO+I/TBU(ECX!ECM?!;ZL';9- S!ELQ]G@ J;%I#Y MH]/JUMOU=NNBT3IOMML7YY=;C=XRB1X)ME\GAE\_^W7'2H(CM2=1H\YBX=96 MA8Q:O_R4X,6NYKR'X30-Q\0$A/D0%2^QDZ\F<$EO)#??H.5>6'L/ #G.7Q\ \%UGPSDS MM 2V8HJH2EY<\R)H38M0=;^%+X788,+_XP/*NV[Q)5+/[NN$?+$)^_^ZY0 ! MW5)ER\%[=JBJ.S7/!"QUZ"\J_36ES-@L4;(5:7WCQ0(C5Q6Q;F1(K$1L2D$[ 0]QM3N;R&2$9(G(E$6GNMLWYJ=#")A#G2"V M=*',OW$6G 5@#L 4&E#D\R47+!';&<&JONG&1R1HN^>@?#V+D!:44(_N+)Y46H"JC]=;.DCVYLM!81(@U8?D>XQFKX L'K$-Z+/^Q1>7(NXB M1)4F,;)Q$13*XE+=Z[UU*)LW*&7#R@0B5U'K,84'4E!H>N$TOI*^'C$R8G=; M -W_.;;KF 9.)9$M>>Q?#?"BW^RW@3T1J87 M9[FTX#KV*L231 FE"8MKXX:WK"A5'\!#D%Z);@*YS?"($B7@.2O*/?O)XH[* M@R3]S?I=M.['KW,=C9 -"*!VM+^5K[(2T+X'!:CNAOMAB&/P#I"3T.FCA4M M? : "AYT;:\CXHF,D"P1B[+HTH4CK=5Q70L%E^\SXER4E+#-@##TO"D;>KYY MBH:GVM9S#FS P!XAIAAPCZEH(R'<:%\>GAR45)"P5'[M\RH)4D$FWL;OX M!6P*I,O':!J@Q6\&"58G?>8IS\ (W>F0N">(3U/!/E;4L< \S&#Z(;].[3G?8?:# EA@%:I:3PTE/TS7_5/8?Q#ZIK4HUJ6R:B(B&+@ MJ^A"^4KQL)^5;F6UZ4>Q1;0&&F M8O4=\H328U2PN_E9IZ/%DCET?*LE9@*-%CY].C/@4W!VW;3Z:1I._)9.@$]3 M1WF(SP^[^'6-Z%"--VK37K8<([/H [,HP=.G+"4V!8]#?@.(0;9ZR.R9"X@@ MM;D"WA-V;!-*G3ZQ>8#*G)@<(;K707!UZ1B3"FY MP@%5M.KM[M%OM\C*>0Z\'O4=A:A_ 9;%%U_(?-#)&]C2AX!N<8'R4)P2HT?K M13*M1SOVW+JZ3.K4LYWMU),_1EL]Y_#W$82R[,> C<;08(WTLO"#'VQ)/@," M,>O&_.Y("@9@]?]Z8X(Y5>X^\I@A'4ZG8&<5>9Q&,%.\:)UWF,_5O*PWSIOM MSA&B)8#-83P3_ Z9&=U^_6 &,D+K?MBMOG+2GP*XBF?91]T#;#7:W"HX5+ M3'<&X![AEZH2OKO_M'M3K3#&-+GH-S"&S&KP-V?JL?-X1.K4$8W#N]'4S_"+ MO-E4VEQD*ON6!I19,;Y)B3?\G_8.%*6#H)NMKM'CQLHUI7( MJ0F??F4W]1+QN7<#I)YOM@N7V$0*4(1O(#?T")O@ CV-T#L;#7,$ M0T54H)Z1G%(PE*Q"50^28#.L&WGYBGL&4R8!X1-?T=%+4KF@-EKM;N?H">/Y MF(PX?\FD@\2(JJIJ)B%\_9^L;0@K^(Y&DDX94CFOQ[06@<+N(-*1D6/&BJA M/6LYI1E+5J&JWY3(4QY3X#L2G1+^'JQ8*[?B_ZX2PZ=.WVY@ M(6&1[\!Z6OBJC_UCL P8LC"L)"@6Q-IN=[OULE$M!7D/UUD)CG/7S7F:KC ! M<\!\7X.5Y_LSTRDT^+4]U"'\NV<"%M!91![M9JNIQ(P7K97$V-^-412<>CJ MU+ P:R/PSHG\%%M_"\^[-'CKB&C 7XUER66@,J#UAE;5-H]A?_3Z_?&/X4 ; M_GP>/KX,7[3>XT![>OW?<*SU?XS'P\=7[7[4NQW=CUY'[-O_> _\;[IY'^=K\JH*=3IM-K;"5]?GPKWGQ+MXTD/.0L!?C'_O MB&3ILE&=%?)17U3!%@5,/>&TJ B)LK$5!^MP%QMY;2%X1O3%0GP#8()TZ":;H',]UZ 3;S!R/. M*V(DRT:4##P%;Q8*Q0'%OTPE6K@,3&9 >)Q4KSX!)F3K7&+&O-EJ1Z@,%*5 MMN<,KO@1T7WC,.5)@W%NQI94:AR%(5%R\:3%+[D!*C# MSUD;-W8*W*;KUAU(>JUJ?*$R<)L#:7).TC[[I)\P([$Z"XN6@;?4^)1/(?+ MW&+$VB?7+X.R0=B==O>R<7*TI@>X[\0?02_,>7R4^73D-&DM!+-4RHWX1.BZ MMF*!_9CH%/SR-U!+ P04 " !*@&Y5HPZ="[@> )PP$ %0 &MB;G0M M,C R,C Y,S!?9&5F+GAM;.U=6W?CN)%^WW/V/W"=A]U]<-ONGIZD^TPG1Y+E MCDYLRY'5DV1?YM D)#%-$1Z M*W\^@5(4>(%-]X ...7;EDJ /55%6Y5!>"G M/[UL0^<)(!S Z,O)Q;OS$P=$'O2#:/WE),&G+O:"X.1/?_S/__CIOTY/_SY> M7#L^])(MB&+'0\"-@>\\!_'&6<+'1S=R;@!"01@Z8Q3X:^ X%^?O2*7O/CBG MI_LZQBXF96#DI)6]?W=Q^&6RKP]&GYV+B[.+'\[>G[]_[WS\_/X/GS]\=.YN M#I0WA,%5("<-@^C[9_K/ VG4(5 C_/D%!U].-G'\^/GL[/GY^=WSAW<0K4GY M\XNSO]]+3IT]GZ:\'4E)1(*BZ M /M [\>' D7BCV?9CR=$T([S$X(A6("5DS;W.=X]@B\G.-@^AK2N]+L- JLO M)]\?HOB4*NO\TX=S"OIWEWM[RO\?1?XTBH-X-XM6$&U3D9\XM/YOBUF)]^_) M0T *O//@]HS^?J9650I-2;YG7;'=Q\2B*2<3&/D@(I9//F 8!CZU],.O>+Z: M;-QH#? LNH^A]WT#0Y]TRNFO"6%>$7Q/;6F4SF6 O1#B!('[8!V1'NVY1&>> M!Q.BM&A]1WCW H 7X E$"6G#@X2*ZO 2Q&X08E6KZ-R,?3*Y!?$UQ/@.H G< M;F%TOW$1&$0LXI;,2*9FMJV1\VNR!%GZ33IG$O$_DF[M=NH 3>LW(H4K-T _ MNV$";H!+_TZ']):(A759@V[D^^F(XX:%F:I/R.(&C,B!S$X>X0REK.!)@F.X MI8-,\=NV(FA4MP7H[Y/'QS 8!KVD[L;H4X"Y"*JX>UZSYFK '@ M;\^F+S$97H*'$$PCLCK+^+@.<(S+4J,UX7RQ6:N/BO,,A#&FW]#*<2KA5+JT MF1.F5HJLN\C+N=]_K(H6X*W[#B0(/M+_4D;. :KLSW]V7- !M#3R$4(/@/$ M;K(*J2K<$*%#?;3!T_T?!,[%'TXO+D[?IWN"WU7;4M&"=!9P(]]%/ED>9UUC M]!+@2[AU S(DK-PDK*I$/&4I5]96)P>9!5%\Y@?;@]S<,&PG_,+^A>[!/J:8 MTMIZX(I\IH8.HU,_%4./+-:K[H/?M*K3+=@^M#5F-K/E>GO@=$.80E[R $X/ M@NB17V;M_=I#UB&&,8B\[B+'Y,L@V\MJ460^J6@:CU)$*_ M.R7LV4R71S#B&Z?*8-Y6Z'[ ,+43R8O\\M%123*I^E4KNS>EA5R5X>Q7/LO'WSM9)4LXD-F,5N,KL)5;7(6= 6RL MP;Q[19D%U\$3\&<161ZMZ7YYA#&(\7AWX_X3HDGH8M$BI$$-W#FZ81V6">K( MX*V[!<*E2\-:V@B,5T_GY4X[1<-.3&M?%C4"65PDM0!GMN>/HCCP@S")"L2L0C!0#MLCM M* .W:8_BI$./K%A#$?8\N.BQ#=@,E?;19U I%$QND2 M8^3]F@0XTYE@_A60[@5$ R],.F.37847\10G)!9![',F$TD9RIG5U@,$NJ:V M+Y&3^=F!3& NVMV[(9BOTJP2R?S I!<.F-P21B ?V:#S]'RU1&Z$74_:*^0% M^4)0*MK+]"'3#FS*E9&9A(.B-)RT CE'BQ61=&*WO0EGZ(!,0; U6UJC M"1P8>62A!?N&-R_/+O(E6_L2#=])5:4RLD1+G3#5W.810C3BDYZ%&.^.-'?N M+LV4I9P?V8]\.NA)O7E#-,5?!@[46/>]%LF>TQ> O "#.Q1X@)<$,F!+#6<2D?HL^9&/? M>R!R40 Y1LVD8UH EU(;I'V[WR+\"+ST^@RN;7-IV=!$U)VL6R9>J," 5@OG M,)P;N9!1LZOE6>3!+3CPG]]U(ECU"DIP%T>2,A8!%ZXGA66:@N]QC:>F$MB M)>VK+B&$XNI)RKK9_D3OS)C ]"8-$-%[-,:[6S=.$)BOCE_O!-U+O0*NP36K MPKR4]MP)NYZ@A*(<:F4Z=[M6JH+*_&GO@TWP%+ND!(?9#EFZ_F 1X._CW9AP MN=FZ2)2I(BO&-3J5@G;((>=*V.]DQ1K(H5ZP,^IQ&K*$'4JPPG%0@#"KF3:"9&=4]K? M7<0ZR,,F8N[1V62ZD&2)=24>N+X'+BT3EY"ZD^]!*%BHT+I6QP.+V]SK(.32 MEAC=5PA]>NC[%D9@^QC"'0#Y^>]"0N9XE]]FI12.:U.I0F"G;;6O0<(YSXKQ MM#:5]B;A>K4]1LDZV@XS(-86EL'85SLQL,-<;>&;':/&;DBO1+[? *#B%N61 M5, 6O,+1@%^@$>8>>[&"#J J,]K['I_Y8J\2,VVVQQ3N'9U%CXGLL"B/ MG&L]H@*VX!7V&'Z!1IA[[#$*.H"JS&CO,7SFBSU&S+3I SXAO:3]SD7QKC 5 MXO&N^(OPU(]J!8+S,4VJ,"TER=&@*J$2ZEX/!+70!Y2Q9>" D#J,\JDA%OMF M^]@E>" =GYYF2M.M^7VI3LBU'C:I>732\PH\IO+CV1$,_1(EAO1!V"2\_W2HM*6 -9[(SGEV@&NT]GO((B MH#([^EWQ?/9+CG@QVZ8]EA#%2X"VM'O+;L%AT0J\7QQJ*V!*_(%,:G6HO7KP MQ$*'2FP8\+@QV2X[TKCLFLYUBM:Q6I=@D0KR=MC$-F"4)"FQB)5Q]IJ:))0W M5&'"0/X1B^ERIA&/6;,](3^S*>@!11*N152)3&(16KKBB>4!SAISY A%C6JW MY#*310NV[73O.,%!!#!6N[J,0\WW]_/I;0%+/R(@MG9IN48"J)7L'O>0J@4V M9$E_](,'H13\4&'=]'F*/;A.EWDWK$5P]*!Q/18*K<'%WBUJ:BN\P2[X;J]\ MV)EY ^<^&H(MGP5I!=+L"/&5>C= >H(E$8T!-3JNH3(IC4,3]E,&I1J\'ON9 M2,!0VKSVGL)@M]@7.&P:]A <3O=*S9U%RM\Y\>[P\<\!0$08F]TU> *L.PV;%>9:D7IQHY(I M)&K@.I_";M6H#KF<5&OI_I9+4\7"#MSJ?\1%$5WI_9:FJ*K=^J>SBC*NR9^- MGL;L])9QIG#.:YC'XDZA?/[L9?86E9%7+RN'JDCS[9T*MP9M'!3@H'5F/R"=.WE%-95Q U+%T;.5J4[_NP?TWZL!5; M'0>'U(*K3PFK'O;/(1RNNV_&^GX$^/'#B?.( HB">/?EY%QA/&C[2B[TTM2. M_/]1Y&?7N.X^XJ*']W(=[):G7*UJL^V'\RL\0"" M@?=N#9_.?!!D8P?Y]2TQZUIY#*Q[V+2!0ZL7* MG8GY'O5QFBN."2K**$6^Q8 J@X!F#75^>W@PC=2?7V>KHY&M2=\C-JT/PLZ6 M;J.@]YWYM*B ;B@]E*<9L1*$YE0^N5SCWZS@]QE00J%7:+0*_'U'@5=X[T_8 MK68N,O>#&>FNU4E 3CZ0T-TP;#C>UR!0:8OGANIZCS#CQY\]LLHBBY5IF(Y> M7TXP6-,/Q]]#B('_Y21&2;<97%U3-,U#H)GL9Y/FWU8G&>?'%6M]$:Y%OG]- M7!0#%.X6X!&BZI9/2*E5ZA_ZD7H-A'$%I.5?)M,K\]WW(O(K L-RIMPN1@>X0E0(3F$0Q(DMEGZ\& M22FM6OE#'UJ1 #*LI*7[,O,)GF 59(?J):,2EUZK8C[UH1@N%,,J&?D^HLE^ MV7\4Q 57'4Q:O5Z(\SYTP<1AG1[>-]##>]UZZ+AE%N"P0P\3\G&.EO"YZAL5 M4NK50<%'1I()Z\YND/P*8@\_A3.(]>KBXX;9S$4.Q1R!W'LAO\7/ I7 M5&QBOTA M34OF+E)XY'HC7+WL97E0C+OC8D"SS8(G<.G&[IY+@1^.3:Y7(;UL:GE0+(@! MH G96*PAV@G# 4JO>+O93];06!8ZO=;-PSS [5H]$J]EYUK!8%AJ4^W M *W)6/@5P>=X0W-EW(AO\QQJO5KH9 R --KTF/&8_;L\#R)<>Q&=+_"7YD*"^E522]A M8C$@TRH"]$F:D)YP?_D+X'>,&IU>1?02&:YA,.?*S);$5P'VW/ ?P$7\E" ^ MJ5X-=-PS\V$83\HZ\G1%OA&EY]8H]68F=MPMK["PBGF4+A0T,"7J<'74X*8F6>\COPSD]Y'>HDWP^-.H46SV2 M8 >NG'W#3A YQ:;_VSDT/OQ1P$X'[5A' GE$;XR&0B5(RKRJ8X(2+&:5LP Q81OX4Q=%0;3& M0JWPB$T>H&JL#AX(LWHXC+&UA29O^BX0ZC_ *6>;.4_;<6BSYMHQG91U?_>NA8;!CHU'3>&-M!NM%WGXVV):IVO3FC#XJ"E=9;[ M:!V:32J2^/<%=#;TH3X4-*1OGW,A5=;F#.,$^.D%1M_([#I](3NY (/#$S?X M%L3S%:6B3WI.8.$:L>+]5!TJLV&!T4&%7>%KU7/VN2]%-ZW-Y$'P(33=%+]6 M58\BGV!8@2 &_F6"R)B2^8M3\Y1I5E+8Y)GR(10I@6N%WC*:MHK+2YL\G*Y3 MFU8Y%&3&= XC:$M(<>!R(:1(I^G?.,%R-Z7 ?< /04>R(2P !Y< M9ZKE>E\UM6[RDH$>K4V;O"RR4.$P6T"5+WMY+K$6]1B]#T'73,6&;K\![(?8 M[A8@K,CH50S:YJG7:@.I!=\ER-NX=+^;O6+4HO_7JS!Z_8.FKE]';;_&,X/M MIG)>'4:OF=#5UZU6^BV(LZONKV'MC!6'QNAU%#TJK0)+\_CA_/WY!;VS_] 8 M3?.;?;V=7S#T5 M(=-.5@$PP""G(EEFRDOM5\.Y>$P[*,EPP#P6B11OB#RVR98KQ\KO)@/F'*7G M@JQP:D"4[HM8E.7?38:V9:(L4083><1Y,$ MQV2UB^@[58RGTYH4M"%IH[$J%+%9M#G+F?I;$&]R1J\#]R$(Z>ZFM#/X%]<' MU[02&](TVHR 37%:I.=I!-!Z=^.B[X#N_7(D.?=D&\B^ JA%>1MR-]IHMP%$ MBQ2[1\9;A!Q_MB$QHXU:C@CLD_H"4/"9,RX][!EY8/X0[M]>%JM$5M:&A(H. M^I+!L],7=@MB.H??T=DZ/0A%W:M-W6'OF[O#2+L.;=@A+3M9TT[:]BMPBMU[ M&^ G(74^$UGZ09C0N]7VUQ 2F4Y?O# ADKHBID6CUTF\MZ;\# W!G&(5'I7M MN1'=&1G=F![OV!4(#NH.VJ(]SL)AC*^4GC&D( WG"3$YHQ>&"L\;RXM9M!/%=;;F\ M?$UM]##8\\ &EJ^R M2$E_U9N+J/0MHE+N3\^+W%=X@KXC\-&6;O2',;^\;GMGY'ZLL"\O#N>D=$4_(% W\\:Y"*>_;;>JT(<*EJ:^W M$8]%?9\Y<.6G(>[(/@?4D5;?5^U8EPUQMR%'B99B,1?_J25Q-XOO?&2D.R_G MD[_\>7Y].5W<_[NWV?(?KRIPD\IDO$M5J1:%891XRV46A2>X(GY+97Y+ M97Y+97Y+9=;GZ$Z\.#M!%KJ1((+,H34PN/*N%E0;7"5X+%.(,/+*I;8DX"HT M+Z$N>HF0XW, $DYWK\IFL"G?S"&0KOUGDD;_)HIBRP!QKVE1@0Z!4 M8E>'W5Y#:/HG@O1QWOEJ%OG!4^ G;LA9_G'H#(Q6'.=<@Z4@!XL%PJ>9SPL0 MIOM$O D>ES![O(@Y:K6JP8+EI=#DN#J2 =.O/;()]](M_WRU(MMPQ%U,\0A- M+U!;FE^N(AXLP[%4>EA\21H0)>^5:0P,8AQW<\,E5P6'!9< U^Y0&E'/U#I[ M<&:\.]+LCU.E"(XP(I_.AM(,N6&:LF21QS3@VEW#O:.W8)W^BC.$>/ZI ?O$ MJ\DJ*IQ0R*Y3$6J52VU#_%^7/KE"L*J76I]7R=LJF.F5=NCP*XT4T6Q=-TY$ M!QP8= ;629SH;,-U$@.+14H0+G68E):L5+BFQ)6]'8N->M\^=OT\FUTXMC6I MP(9EB,#F_"@.W9L!A5MJ,!Y6!1+M)@*/-G MFE'A,CU>$I-N)FQ83INW0XYP+#).Z9:#M^/8WS"R MV[#A2:'ANRP;NYYGX6K\4M/UK]P B5_RDY:SX7T>M1ZLAF?XTT[9G5.4U_OT MJCF"K.8\$%):\;B-FLQY$"P:+O<]%* )N %,HSCI">9A=1W!8$\;5)64LB; KF*V"CBR) MNH.05+<>1?[A#NCI"S5,2:Q=6LR&"+N2"9:VLE)8AC-40 20&Q+^1OZ62!7' MR*6YWBHJ4RQK0PRUL=X4L9E5WA)XFPB&<+W;3P9"=7&I;0@N-E80%\TKB$Y+ M9^?:QJ!-^+E)*^:R9 82&#N_IM>UTRO,S-E# SX;^7YPXQB=:F$;QGL-5J4J M#HL<<6^)6;W.61J,["VEZRVEJP\+YN3:O&8+;IT,-I"?\Q#AN@$N_9O.^LU\ MFC_6K\2Z<6SL^CZV]3YV8ZNO^VF-Y,;Y>OP'5YD$;VDC;91Q4>@-I+R)]' M"WJ+&LHVR,0(4/XGL9! Z*[LL7[-@]V!\_'N\/'/ =EL(F^SNP9/@'4U0]/" M]C@N>S>$XN"B*@ZSTQMK9,!U?H5^S(9U6.+7;&;K3,VJX;5$P;/H,2'S(07V M0>B+$9:PP='9RF:9"F0AM$1='88DF8>FYS;,^6<&$1;34+I/$*_0(\/J9S3) MXUL$'S!9,E-@60^BR]S((W+)KFU95"2\?SZ5E6LV<%LV^'OT66F_LK-H$]X6 M(0?@5Z(\^A3C+,IN1YY%^77(/5MGB_9M_ MV1F.Q1;]B(#X,CV%\WP ]\^7,,^W,F+MYP3"C[Z3?A+(0/>I])Q@>>)#B&6X#* MWS9SW_V^GB VF=].IK?+Q6@YF]_>TR_V[3CEAEZ!WZ[$\"+ WT5..!ZQ[N5^ ME8WQ;@PB;[-UT7>!:TU>S!X?FU@MI56_%)7AVV1K_.7<"1UG\F*6^,U4C5&L MLRHXTU?1/X$H =G;NI1/+XTRY:.3-)+ M3#P0I($YH/_PE1SA?K[1,>D3VO M7,H',1X&_>*FC^/,5R5>N.]8"F@M>+&2;SBYQ 7\#^(S$BUSF12FWYJ4&L/1 MAU/A?'@'W+[!L5R:8QM6G>W$.=8NSXE7;_>I*LJE.-3 KS;/L1%K'0V M-M-F"8\E,=#[Y/$Q#+K&0&M'&&HQT+R=MQCH6PST+0;Z%@-]Y3%0>OO1?/45 M0A_?(>@G7DRG K&G65C$2C>S0BQ-C,JTDM[B:6_Q-..#W2N-IS%7AM)XFK24 ME0.=.)XFQ63+TV?I,)RE;8+R'7]XB=P(NQYE<;S+ 0E&PJZ5OJ:X75^87Y<9 MY+P+A]RNE5HR*O?31;K82E4P@SP!M6^#[ZVL4M@P&/=CM\=GFBH0AW]X:]^@ M((99(['!F360W/4%.P_3LESP5@0[!Q:\OJCH@2&YX*V(B@XL>'WAT[Q%0?BT M1F+#^;^!!*\OSIJW>"47_)41P7/.\ TD^"OM@O\J%_Q7(X+GG+4;2/!?>]EQ M\H/>]_3\0MZ8..K-)M4J>\Z;UCW+GHO5,O=9+1;Y%B!_"Y#_U@+D/YUE@@NR M4/$?_Q]02P,$% @ 2H!N5V<[-B8@H$AA&P0X "B9\^FOGGBQ"B@\*^&=V)V1R:K,_"4SL[)>67_\ MUR_[ #WC./&C\$_?O'OS]AN$0S?R_'#WIV^.R6LG<7W_FW_]E__Y/_[XOUZ_ M_O>+NVOD1>YQC\,4N3%V4NRA%S]]0@_1X>"$Z!..8S\(T$7L>SN,T+NW;PC1 M-S^@UZ\%C0LG(7VB$#%B[]^\R[ZY%/2B\&?T[MWW[_[P_?NW[]^C'W]^_T\_ M__ CNOV4M?Q$!-SZS4T#/_S]9_I?CX0I(E##Y.?GA313O2/^W[[[_]T_7]^X3WCNO_3!)G=#%WR#2_N>$?7@=N4[*]%3H_N4Q M#B2!'[[/>&E;T'^]ELU>TX]>OWO_^H=W;[XDWC="1/JU 1/9G'[KI5F'8N,? MO^=?9DW/2 OX[W[ZZ:?OV;??$,4A],XKQ5BUE$,??T_[?AWA'?U$*\R<*\]W_I3#_M_CXVGG$P3>(MOQ\M]8"_JE$ M2W1B<(QT]#W'PTV!=KXF?Y5@X2\I#CWL26"470UI)DVN*4H[5FA);QF71G=B5S,B?#9H0+;YW(^(IA_1U('X;UGT;1WNUJ)Q=I/CR;\%C MA]]68BD!B7$2'6,7M_I1B_+K=)W)2%K0((G#UY_O6PC]+U6/7(PQ;4M*4.#ZX#SFGEV 7M,4L,4U 93&IVL'U X;Q>UMD@7* MZ#=&^S][V^/621X94Y).[!SGP(T2!VDB/\FM4WSPM_N4Q'HJT>KO1^(?E]'^ M$(7DG\GRBY]4-&/:!ZB]MH),#=>H T +;B=W5U/F1%%.%?U&Z=HQXPK"JVCO M^*%&+;JVP,VV%F+17)4- 9MIO;Q#F2?ZC1.V8Y]$C'T4WJ>1^_LGO'_$L487 MJG; [5(+K6B39XT VZ->UJZVR"DB1A+]QHF>V>$@N%(<)_C:&K@%.C@Q>G:" M(T;_Y^V;M^0_[] !QRAY+8"=/:6%)M SR.*"$5 M8TBI >#XH9:SJZD):I;#QK"82O'PE@C[1%?R!(_$5I@8Y7<[0S/-*L.U'^(U M2?ZK4SB#YD##A"G0FA6'K"W X&$L\K K#Y0^8@PF#BS3X;6^^/= *-:@%U_/ MP.V*0*IN1K\#[E8E$7N;%:4VH1']V]&)B3,%ISM\B&+5/H6^Y0Q,2P.O:F65 M9L -3B=M;]O+""-.>T?"#/* MTUOC+8[]R%N%WI63UHVQU78SL$,EM*H1EAH!MT"UK+W-CY,E&9Z'*.$)C(\G MDQ_\ -\<%G(,+T MQMFK(INF&7@K4P,K6UJY#6AKTXC:T^)RJHB2G")MZ@;=)(]AE$ZWM MIBS23O:< E)@O$V* H1H(5HKPFL^H'Y\O: M(ZF"O_7YL=*&85O?'KPE-T MV["F,6CK;9*YI]T2\JA,?^J!?^EY1&N)^!^Z M'/I.JPQU6_!&6@.Q;*"*AJ"-LT[>GH8I:"[D'X@MW&_"Z:+H.;CW+13Q?IZ& M^=[4,-_/S##?CV"8N5T^O$13V^4E^7,3/T0OU5-_]2WG8I/G\)06F3>;@STJ MI!W*&BEIFG!2XE.;(LMV-_%M'#W[H:N?-VF;S\4H-4"5EEEI.P?SU(D\C(V* M2=$F1I+!U'9Z&R6I$_R'?ZB=W6L:S\5&E2"5%EIJ.0?[5 L\5 3EU!$A/]5L MG<;L98P=C3E6O@9L@"H@V2V\PG= C4PI8N>C?LRH"+6IK(C>'0YNGZ)0OSNC M: +8FG2 I$55OP=J55HQNUH6(X@8Q>D6:>ZQ>XR)2;][__C@I\J+G(HF@*U+ M!TA:5_5[H-:E%;.K=3$J*-JB=^]?/7Z')/T)3.PA=FA1B/O3_C%20:U^#]BX ME%"D996^!&I6:AD[VQ2GACBY":/5ZHO[1$3&FKUD33/ AE4'K!JYBFV FEFM MJ%VM31)%DNJT>\F7QSC&8K3:TS<&;:3W0ZND&55O09MH@LK0D78[Z6G#^-))\2Z*3UHE5%N!-THEK/-CAUD3T":HEG2 PXDF?:-$.)]3'.5UK\/97"[-LA\JFH.VQ7N*>=BF)(TX="?+3&>B7_)X+ MOW*@UX.J*7S3U *LV.59.]A&J1>WKT5^*5Y]XK2G&Y^?_O(7K(^G_F;[P0^=T/6)[T1\$4GS"$G+ MKD#-L8L"E$7X:_H!-.).XG>OJTHF-2%]]8G\E42![[%GGBZ<@+ZP1!>0\ % M2;N8_3))".L& S]K!-R4U:"*1EMN =@\-8)V#K2,G$5+$Q,L(X,[;SL+N]- M/#>_2D/P5JB3M^]DFU/_V<[[#T[RM P]^C_T88IG)\#T'9;TTHGCDQ_N?J$E M\S5:,>T+W&I;J:#T=H1)1\!6W4[^SE9.R+-:Q^R/ J,%2'&S-+3$]/J MP:5_X)R1G='(=6G)H^0.NY@(\AC@&YRJ#YD:=@'NY2: 2T-437O /FTD=N?L M21!'.77BQ%OB8&@9!-$+2^:WM)Q6C#T_1=<1*WF@/I(ZC6]/HX^XH(\0]S]] MV\>C223;I$\XSA$GQJ[=U';R=_;W.DHQO@4 @%Q=,(* MB+>/JP<./?=Y.R/X;8P/CN^MOASHRHI$7)JI:+1DUA.XK[> 7_1T@VZ _;R- M]%VM6_! @DG!V3D?RRX^I0HP9\(#7L1TX(HYNP-D(Z[5P<=%@[ MG,3AHM0):L?402$]4':HO/)EQ8O684H0^&3XYD*0_&#UQ0V.]-C?QRCR7OQ MIQ'#KL!]KHT"BJYHT@^PA[82OZN5YTRR09/P0:\R3DBR^L[.*#JU%ARA!5N3 MXP:/GH_7UGGF#+QO,-N2A.RXS^@P)II!1@<#R9%'?'K"3&8G=?6[$B2\0(\]?L90,V#!G:UXX 6B&%N=H;0UG M5WB+20;M749)6CV2JFL#W#>5D(K.6&H V/O4509ROH #VFXJ _=9,WMA<*QEHD<3BXLBU[SSZ M@9_ZF&ZEL.N13U'@D>! A]7TU'!\K45WX/[45A%%CS/M"]@G6T/H7#,W9\1R MK"*K;Q$9)GS7QZ%[=B=RFD$/B!HX,]L!P>P$:VV'^3B]P5E6?>MY./98IUH+ M+#H=;?W],4R9(;[]Z8>WS!CI)]D6_ZUSHGOO]\?#(?!QK-X.,^L!U!Q;P*7V M:-#[^N_2\UP E,<=;TF1[H1$Y"RVBG3Q@]BGLH";V'@CSV)N06 M18^!OV.R)LCGLRZ/1>4#%P^E$4J$B.S4VRZ*/!ZW$QP_^RZ6!\-(O_3)29$3 M8W2DMV#\D#1#F%W\_S9!CZ*JV1OTF7Y+Z!(/"+";,NGDEC,K1!J%4NB@,%:\ M\@B>%S]](H1IV?D3O2M+)!(?T>9A%.])4DG7,1Q6S]0]N02#OT5!%.YP_-TX M*;,J"$WQ6V=GE03]!9(<+)U?F!2TM-#7F8':/64L\-(ZX]CL)**Z!]!(W0*N MZM2AHCG@U,%$ZN&\EI$'1;\%^([*@&2(LB1PDXR9UE?->=3"[9H=8?R#C_C\-B0 M]&D; QTQS$"J-B_++0%G>0T"]][P$W0M9W9CHXPY72L>>!.E6*:L]>ZG;@G< M]VK@%1U/T0RPU]5)V]48&'[F1Y<_28(8"^K M$7: C3O+US5& %>^LW%M.;.43X!<1OM'/V2SUR^"@"/#,+BZ^IGDC@KL%R@7 )4D6&2>>+)_+-"N MX@HJPE!,HV@'V_5IQ!TJ^;;OIB!@/ M$F,8A:\K"Z2VL_+F5&D&7G<.1Y. 0_8QA90#I-S6,^V!4FS;J35]#L5/]YA7 M4,E&55?O0O4]@+N4 =Q2N3]]<\ N9R)U][PKH\TK_!6I6ZKE-R%_],)LCR4Y_IAI]LR!_D M$X>V[XEEXOTCCM$/;Q>(^AUK>(5=\>D[]ND[:UFT>+BPMGKV>3/@_JX#5DV2 MBVT >[I6U#[Y8?Z:) ?'PMAC7?_5.O>[_ZP^,/;]XL?R;?47\D_W__XP^*G M/_S3H%Z_0(34 ;NI_XP#._?EEI['7E!Q@EO']];AI7/PR0Q?\SOI6P./" TP M2X?=U4T!QX;>P%VWQ;"=[5PR0))'NA5 M@8N89*>62OQ-@+\(UN,T@2R#&:\ZP'==/;CZY2[ KEDC[)"+/FB9IK'_>$SE M;=U;9[2MUP-["G05>NT6O?J?&1%7EQU^,P6'XTPU.+S[U(E3NP ?\QTH>RUDGS9JBN&_ X:PJ\38D?P#'86/2A:MFH;7KRK?IQP)[M MW\,JWU->["7#X"9F[[YZ;%GH%L?W=/G%:*6XIC-P!V^G!/T.AJXG8&=O"6"P M?8Y;?NF5\^(KHO31=,380=CWF$ 58K$T6R-%K_P0>5$0.'&"2%[%ES[/)HD6 MX@)#GBRS]5HC#2HZS2H.Z$#K_;_:8S9^KQ5\,'_G'%#. H*/CPA;^/;93@<8 M9^:[3RW4E'68H1.7P38Y,&\],^>M"#VTX\(YD# 2W++#^DJXUIQUD^]XMM!1 MN=<,W58!N\EW"UUFYL JR8?VX@(/.*X\#O"R/T=ZX%.?_&DYQS;K"=RY6\#7 M'!F:X=2ZC?3#'"P".*F>4 F0I],%-1C.I>M[S,??36;1-NY.:M^MJQI.BRI31+W*-;CT:JU[+IX$@6^Q^:Q&2-VU6-S$"5\[-RK%O5 /Y!?FUXA MI[A_]=.GRR-QLSV.B6KX4]GTB3;R?]Z#\T6CQ6Z4@-M]#_64CY>W)@/87_J@ MZ7X G?%$].=!DBNK,8XD7Y*N2LY(LD:$MZU#Z=,KZ0:GLMRPG6BRD17>5Z)> M=\-X6-<>>&1HA%KT?VUCP%[>+'-7,\TH(TD:_2:)_^HWE_'@\L> M$.8'0P5I.S4:[G$0T( 3>I^<^'=YB2^_A&' M)-\("+REM_=#G^8:M(I#_8C5<3%O29!Y'QP_I@MZF^TZ3 DF_S' =%Z?)JLO8IK_,8J\%S_0+D&VI '< MS3NII+2(W(8 X!#0#4=7Q\BYT97EG!_B#-&KC"62/$=Z>J\Q1EA33! E"8K8 M^X=2.P[C:FOA ;XF^KS(2@GF/"^?G'A736YJ&P(-=,W@\E=25:W OX!:*W3G M*BK9ZZ8OL9_BUU[TPIX4Y69'GY"/=B$]'H7$PZ$^VYE#B=PQ>R.6^.EF-WT. MU4_8BZB!O_=3]GCI@EDUFC?]@KRI],,[$3QI1+>4V$U&7*NL9 PYX9R-+L M3=D2<,;6('#G.8L@NRBZ)J5L:8HV#DJ%:\K@:BN]LH^T1_I$165/(#O!)I1; MQW([615QFSH C2OF8+.TJK8U]/3*3/B>:5:,#T1X=LZ(F:C#&5)3=05+]K # MY3EQZC,N?DH="?)H$V8'1+)S(Q:>4)\ <=WO"^,TB.G6.]Q U0BM]M0'X+1' M+^MPISSL5,0:'IEX)?;L6(==)^.G6&LF&^J6JR&OL]\YG= H?,=063[\8^%]FX3C ^_DWZ1/+4'#'G8N>$Y#HD"L%)6G\(X[P5 M<*_5P"I?VBDU >R1.DD[+^0(>N,2(=5ZTZM>@-UMXYJR):*S;M"7S?N@*3[A;ML]9CN MQ#O9UKW+9* []%LBA2A-1#_/!*%_YI),O+0\H8HX*Q+3$&4FZE-MMOGCT"DJ M,9PZM;"D#V/+L+ ,/R-M3+-Z2 >_\TF>;EE'VQKHR&$(L[22J&X*.&%KDKC? MS%RQ/F%G*6)91U@GMK/*/!Y;OL''/ M5,><:3P3IXV[:M4VT#U0!:GD=<4&D#U-*6>?RAFE?;,I7]1K7H4?'&LPVLG# MQJ Q.!;5*#P42]O5W/,7L?- MJE0O$*-L)VZ, U+Z7 X2O5:CM.*%5WYP3+55;?6M9^:)%9AUOBB:SL@;JQ(/ MZ8^"-@R/' JHTB0:3)K48A!,=B?D%E$8D$X44JQF'==W4A16;&4I6AIE$V+-GLAN. M\IKV!1Y$6JF@5"_1I"/@@-%._E'K?_-MXH3N$X-Y1#V3\(&N?C;I4#::B[&7 M0"FMFK68@_F6!>U<_U*20[\Q@F=GS23N?-\YHXXH^=Z/ 4OPKO#6=WT[=^ZSL?R:@%R3/W7G%I0-@7N?'IPRC'9>N\KQD2.*\S_=QV>3R#OHB#X$,4O3JS;A6Q/!;AG=E1+Y=VP M-B0 ^W17)-WO'G$^Z)7D^)UN.0']1ADCP=E24+"G'Z^HGZ2D'VQQN<5P$V.& MVQ1&&Q%SVFH8?L%\JL<[#SCV(V\5UMY"'A[>A4,ZNA@Y*;M'AD./O6//G^\< MY^ R1TKRA#BUBO41[_R03C+J$/>X&5I\%IE=9OI\B,+5%QR[?H(WVU^=.';" M-+G!M+(T:45E8U6+*@KI30QH$!I&2=DUTLZ4H-\J[0^L\SG_TLW2[(I*&.&.#=$1RS.DJ?+EL/HR/HXQC$./3(Z4XMP:4 , O[&)RM#PHYE MLD70B:,B;]-5.5GONYFN(C!4D X5&758ZO] XD'[:Q4;>&FAP M'$HCQM&Q;_XXP)D.(@57RMDH(>_U8N\RVM/B&RIO[$4(:)CMKYSRF9&V5"#O M474',TA\6?#D:L'CR&O:PD.WSHF=25G2N=J.'>!8(&=+XH$,1-H@Z# JD6E!($39R=KN8E37,9_+TZD2AD!ZD.,QM?XA MW$!IGI'81#T&H;B.S/QBL1&:@8*Q/& P[V@\KL:,PK'U1'#I_=./[Y;$[2FXPX\T$W\,Y0O $W" M&G! G5H#G2\$W*XO#6(NEV>!LC.*VRAF6SRH((RMVTOST+0^> L1("6+/(A SQ^=E:-\8Q=101P3.N.I9?/R.5 L0#(F>:3=]9$<,ZVIBU5 ML9A>0Z7$3[?S',$+,")/[A]AZ@G-,\08*,=\*OIU!!D3,+TFHF)D+N8'Q10( M/9[461*]^B'S(S)[E5*Q2AE<=%"A:$P]MHE%UB>I=:'ZEOP:3PX]+;1,$GQV MG+$CB7G&HEJ%F&8ZU?[SBS_U,$;,;R1/ZCN<*ZAX,I)>RMOA"3HX<>H[0?DI M&C8)]<.4\/!I^7.',H<43#B,?M%$2V.>X:1>)<99S?P#2@..,2**7&$''E+& MTDSWF#+2T=R/<90DMW'D8NPE],EP>1QY39>L._5!:1S1][DCL*$OD.LD3<8!M$+U0XX]?'3I^)QWAB[ MV'\F7] ?$!$D?GKZ-D%;/T[H65\N%CO9Q@)2&O'S:TSJ!7K$Q,TP\K!W=.59 MIJR3C=MQ$ZN;L4.2'Z(,\YL3@B7B/)%D:N&A#(X M(S4:UBQ<\ MMQ RS8\87UMO_5$)R*#\3.8LWL7I,Y%W'6[D X=+DD\]$S_$3>;>B1!P)^BN MG,K3@BVI ':8'F#Z//+#O$0RI7LGKRA?,D1\AS+6*.>-?I/<+=7ZLJ"F/)#P M_%^EEY_MY+EQM/73FL=$2PV QX1S,*7L-?L6L \KA.SCFZ4'1-F1KN#('KJX MC6*^[5EY4_2&:#D*4R)GX+-7?8D[X<32(Z,#*T/UPNCTAV3I.3.2FP>X].SH M0S3,4#\2*^"./Z:"M6==!^(#.!B-"K=[C?E,*!JP,K'0^8/)Y.NY)2=S4'F< MJ3P4495^2O]F"\I'KF"4OPWOV$]RGOV$#'\#QR4CL'N7S&2$:8;#_3!.D!;J,L>>+=TU77^CI,1)L[O S M<6LG&*=TJ$F6-)X6+AP/>?@Q19BCM>*_5[24 MV<(B#)WP&F?RQ#;[FG6>P_ MZJXU&G8%[L]M%%#T:Y-^@/V[E?A=+;S(9($R-JP&0Y&1'>>>7 4,MU.#>Z*7 M>TCJXKOT.4BZIRQ"K49'VL; O;H>9/GE'E5+P)[;('#WFCJ2K+@+$L7H%FL0>IO U M/\HC#_ ?"$V9 4Y=D6HDN.6[9)3RJ$&D9OM^5)@V[YN>/ZJ2+5*(N[H-BYFM M" -2=V54?\2D:XWX*2@ XC^[^N4WA_*E_RRUS@MK_=-J)/"L\Z%I3EVX)HE M_8'O//J!Q66Z@741X?S?K.*"S7B#QP1%*M\PP:" MGSC^D!4/JWWH:!(U9'AC+5[+OKX,O4WZA.,&>;AWET&>-V9I_ ,HF6I#K$VA*/MA'3 MA\NJ8:=BAC+@ J@^AMXZ)QKF[H^'0^"3F9MJH:95;Z!1HZ,:LI53\Z[0%U,[ M(.DW_:8Q@ RHQ+;9GF M1 "_P>:[V\JNLPM*>@74!Y[S?K,*+C7B#QQ )*<\@[DYKX5G*T2,H 89!GS- M941+CBY7QNCQ__#L3=TV_6;GXAKH]?Y=Z30KY];)/K!G2S9(\('BU$/#SW#& M:IS RFMH]-2* ' ?;Z^,;F4T 'M]!Q 3ELT8)Q1$J1/4A0(;.F%J6(=&6K 9 M*-;A,TE&!JC#4T]HGH'#0#D& :2&ROP"B0F8D0)*QAK257<+:JK6X5'IQ=(5 M=5&[[R%:TEV^F"1=LBYQ[8$6DW[ (X@Q=%4I2FTGP/'!7/;>Q2G3" D>*&=B M^:C)!/ +1<^K];WMI!!GF$G4(^E->J)W?=)EZ*W(IP?:Q%1I=03FYO"-RJCU M?&WO.86 9A!#Q@+);<$NOM%W=D,/92S!!(81E5*($ ?!A2D!ZY0 ;*;1.Z>" M'R;:*Z/;C )PF.@ 8L(9!*@EB5%U(I_)#&FFJI+$BJ]6*N:EST&\JM#G\=,LQ/+ M)OUFY,G&3RLW=IJ)3X_SX&_9R$&]Q#XU>"C/K=_A0_;BSQ5^U*7XBF; W5<' MK%P2K]P&L'-J1>U>!N]0>'V*DK2U9#<>-(KL]O86!9'3J02EYO)G1E\^DH6] M*S_&+NE/CS)OM[Z+XW68'&/ZW6V,]_YQK[P(VID24.<;0#W9!=%N9*!?%NV) MJD]A/E98/3JF[*E.CS_URZY[LE=T\RNB<=%]G-TN9BZ,DJ^^( MBN0I?XYWA.<[VV]_C@B9(O;DV>OR(\S MS%Z+]C"]^OVRNBV70'8ZSN F'![ M M1^YZ@Z>24V/+_+M7-Q,M+))&&#RDC_GYX'>78"S$HDRAKL] N2'Y4_*+2\ M92GS^1T7\3+>ZHO+"K7='Z48 J>5 ' 8M:2(/EN@ M"QYX"G(L4.&U!_8EG7I4/RMUX*(CQ>6ZXM.7$@&B$!#'8">TS^QWHL-#X;YB MIN9UF/\^U1]E?N/#&+_55QZ]!P_&7VMLA1(J1PEW?"UR%=9.9FOV 165'J-:\0^: MSCT:=@4>M=LHH!B<3?H!CL&MQ._\0%"!"F5<.4G;A E1P*' M.G^NDW6XC>(]VS>S-"@17( MT#"&*AAZ5K];L24=Q;9>$9(%J'ROKOA:M15PW]; *I=<*C4![*LZ2;N74\HJ MHOG>@J[PB+4>\8:6_P^VG,T;+::KKV)P,GDL55A;>*'!YH;8,_DSOY,5>HK] MBCR?:!B@!R +W+N'4EQU!:8/3<#Q8S!HO6_M+)"0H7 WD,Z;K< >A1K%6^RGV+MB^0M?ROC%"8V?AC8[I-,&*67N8GZYTZ;&O('#D.R]NSW?@ M^Z^N4,Y<#^]T,\YR$Z#AKPY0:3&D\#W@+$@I9F<;9#>Z.#5+JQ:#PN$1MN(^ M,N+ZY-_$OY*MXTHO56'8%Z M77OP6<9AU MZNM$.1.A2\>5'(CA(:K&3HV5G:O0)+28!\8V""'3^=E9J$EQX MM:)*H*;!:HM36G,^2BKK8V(#!.5OWVVR-+D WM(<<;$V@9D&U MKC'TX&DD>Y^+R?F:5A[?6-7=ZLU0=&0+'"0:(L-EWXF#XZBJRK<#-MO1[Q<; M!;J)X"IM8<"@]3&.DJ18 (;$:I)@IS1"WD0IEN]H+D./[W%$L4BKE3&M'SG( M(6\ 1641L0I*(ZDO MI,IJCTT<1FTJD/%&6;$F5D^QP!XQ_O+5/+;E($60"P$V(K%]C1U*Y:W\T&?) MY^'X&/AN=DU\P*"=WW3?".)L38-FUL+.-]M^<7QP#I!#^SCJS*+]L.2A#P C MH1VL^ ]ST6+YKW(9!SY)G,UH 4S;6640DJ5+@?A*,-V'R=?PQQ5@NEWW M7E3NO9&]B7=.Z/^#^3Y=TXD"W^,GHD/OEI_48/^4!9?(*'A//C&Z4#04;: # MS2@J+.ZY#T(8\&;]L/BZ.N'%Y_OUS>K^'FWN/BYOUO^Q?%AO;A;H9OGP^6Z% M-A_0YG9UQSZ\7Z"[]?U?[M'RY@I]OKEK MFP?69WY.G1]L?,!?T@LBX>]C_'YJ-E^SJ]879FH[ M ^!S6"+P4S?&G!8,A"Z\[;F^N/-^L/Z.9A?Q1U<"0'\7@W]AY7_);\)<^\ZC'["36)?L?EIJ-M%K M20EX/.BA'L74L T9P/&B#YK.)[(O+^\^$[]9_?OMZN9>+(ML'OZ\ND.7G^_N M5B2_O%XO+];7ZP=;>655+6?'#\F!6'*13-;1C5&KH ]WH3P$5'KVL/V+>-Q.Y\;6JYOD._+*\_K]"G MU?+^\]WJ$\G1P-AOTQC6U&>&%EP[5M5VF)D-#Q>"*75>LJM4,-S^*#0R;#B^ M>^4#1FL^A#+L"-^4V"BB5^S7H!]BP6XG?V;Z+3!#E FNB-(T2 M[#OY'7[&X1'?83?:T=NF4&JV:.@%V;'/9NY?991S0 M;YPPLN[&TT$NL+#BR"LGIF^!T</38.J!/JUZSXA5$!Y>\8BUC9&TZ@7O,R^>_ M8'_W1!\5<)YQ[.PPRGX*61F<55\ PR<]^B&,>A2,@['?5 MQ]!(U0\'K7)/&>23^%1-'RI9.Q%O LH@^%B*QPUL1 M.[SEBD-:0>$0U]3E;RWK+0M2\IR;E("5C.%GW.19MN)9-]MQ'Y;R"F\UF)F9 MY11ZM3\$T0F3\3%^]EW,!KX+ LFC0R,1GU]0#Y@8;)04<_I_8(^_,<.J]IAG MTL/S SIT3*9J=5X],+-9I-=C8>Y5./LU_=M#HMP56M)Z53M6TV$A(ZPG7K// M'@-=(%'AW79LG8&."X&7/:(C].T6Q)&1&,68)-[DRS02#^Y$!_I]LD#T3=+8 M=^F7_!OGQ8D]'KK/OCN&OJ428=DA@<)(]@D[-,GQ-N$=G>/02FKD!_'-S\.T MI 4\WO92D?+\3!M"@.-D/SS]S]LL2EFCY(SH3J?DC1AS,%'/CL;NC_N]$Y_8 M6L$3'2O80TAT_K*ENGQF9Y?(E]?XF2CAA]*4)7UR4D078_92O>3?Q6[TR8\X M4_\/CDL8FZ:6[2@!#V(]U*-*!UN0 1S M^J#IFUZP6K;E\QGD \IQ@1Y/_*P&YPTF>EE15R%V'4FRM!>/AB;'PR'PZ02X M*(F=T'/E)\YN%^-=EJ"RS6KVJVE4V= %># Q 5R,&G7M 8<'([&[&G:9./-] M>:R#,3CS\>ZFG,1IP8S)OW(3)O_XVQU-"99?_&IA^>IW0(U2"8%:7^D+@&:F MEJ_[U2CZP&OJNTX@4V&V// ;I3ZQ,7W"^T<QJ8H(:^HW3FSBY M'0W/=)[A?*GWC,KWD#U#!27SC.*74#U#*6-G2^+4;'K&&'@@3=*N_1"O4WSV MXF>+;D#]J2UP@PE;U@>@][46?82)&V6"&!=+*S2C@Q^AO*WF4-DZ?(Y\%XM= MS@<W1@>[[\G57& M43X.QKYF.QO?WK[[ZX^?WOUP]2V*\2&*Z3XK?2:,TCAA)Y[X&-88FA$TLT, MC*J%4U)C8BO]K@-&%GKO@)WJ<@(:'^/$"3;AI5AH1J!Z)S#3I^SB;.0U= [[DXG#%Z%0O6W]&MTVQ+PQ7L)PY-TZB$7?19 M2@7<90K8A$CR0I*9A1@VH1+45N"P-BA%\(OBQ3YH9_3 E6N!1.NUNH8V-!, MPE4CHP<[=<@5$FL5,LTUZ1#'N],G)_X=I^P=5B[O>;ELC3[;] <>/UJKHG2) MVK0SX*C1'D/GB]6,$\I894E%N<"R8&?I8O5DVLC V[X:(N*?;H6U\#5P5ZX" M450LL;U,4^>(9R+V+,8Q\7K#X#!H#0(Q7MHM"D0WTNEC9#C>1O&>/53^&/@[ MU42V;=]Y>)29"I0%@NHZPO=%0_E[.BK-DP4?5&"$I#E\D%3**.0&O,Z M!(>"1J*,78+H39]DZUO*H(>K.5!S"G5P)L##S3A*':<,"?"SL2,!A5=^9, 3 M;BW9';UMIN=1MELYX#KS9H_(^LW,+A>@#V_8"41XC'.1N-066%^'9DRF?Z37X MN_O/RJ.LIGV 6[<1Y/)4MZ8#8+LVD[O[;"XKH<#((T8?O2(.Y8&\M(N=G599/:?1 =4M@;M?#;S2/NEY M,\"N5R=MY[U/01.$VXT!\+Y87@G0A,QX_GK=<--D0/+ G7IH10ZXM'(]@QLN M@T,<>M&D]4+KM>U[,V!4"JLN?D^U\#W%<52>T?ZZ8UU9A0,&.D[XZXUR%7R6 M0YS=_748JF2T$H1+FJ-7LJS7K[\,G"39;']U:"75=!/?40%NCC1MS3XEZL*Q MZR>*W?2N-(!&KEXJR6X,M24 _?)09SR=,P%&FSF$H$Y<)R//"CA&PA58<33A M&W26-/$EHLE5PQBBS18)XF@3(\9T@836\N]HJ,XX6[AAQU21;(YIDCJA1T8<>GU4,X09= ,:3ML"+^9X37T IV_&HG>U\\R_:35( MS@(5>"S8E>A1')ZD)8]1?<8U'7IV)YXZ-;W8WLVGC;*B1(2N1,:N/)&\=(( M>Q>G2LOF:-B))E W'U1EFBRJ/<%Y954]\/4?+9-\')+5Z>?+=)SX_8>E& M/J"B*$8QY8[VS@D]TGE)2&("F;*\01_(=_B+LS\$9,[W>$Q1&-$+.'N?/Q*P M0#^^?;MX^_9M/CA7:7#N[V@CUI /UE93.@N_2S7%2[(<+RGD>(4).1<$79S. M>UC/^BSH+Q\?(G0@V)[(IYK9@IVKYJJT6*3!^#;V77RNO7>:P;8K+: CR2 J M*MT_[T((<&K9#T^_B!3ED\XHFW1*WH@Q+[1)LD;CW)4SR$3M*"O3R$%J)!OO M:*[J14% LE5Z]88')3MST?7^X/@Q35 VVS7)4L*=3Z;(RR3!J5@=)>GZQRCR M7OP@6#XFJL) ?6D!#T*]5%0,0IT( 0Y"_?!T+B*SN?GX^GK]R^H*+>_O5P_W M:'ESA3YN-E>_KJ^OSY+$:38)*>9<'9?$GW?:R][:QL#]H!YD:5].V1*P)3<( MW'GGC))%.5TD"-L:"$>"60#(ZGR1K/H01V1@2T]L90K__>@?]HIR$]/X)G\X M]"(*CTE3S15=6^B>60>QY)BJAI#]LE;>SFXIGI(59"U70QD7XR,G.^":J*!\ MZYP(/N7,_ZP%4/>I@9.M/I:_AKZ6J)&V\WR/3%A.M&("?^?.2>2;WX].P&H% M)$^8#'">D[+Y3;%R@!^R5YGY(ZP'Y\0VWF@!VH1(?R2V=J*?4BGSINE3'!UW M3_R]/4:4=J;EO9YP( Y+8'&LEDV<4E'0@>X"\Y=3$UK: /O/A;,5^P7EP)-1 M1)3GIZ=OZ9)CZC[13]C<2^+*J=/ZSHP]JT;H/QXY+,*)MJ,@N'1;[.'8"= Q MY'W9*.B'R3%F"B+CX"YV]LD;]#GA3Z02UPJPF_)55?%P-:W/*TY^T(^+;P^^ M\HCBJ0K(E#$*>>U>.J,6']'F(:W<$" ZX#JLY)-[^T=U M'?%VW2$']0Z*R")^B[[0AX,N4+I:]0,[Q2;&"X<7 &X:,+9"/N0) 5E(C;B( MI2C*A5S(B#EQ1)M2CY(7DLP0X88$.Y3Q0Y*AA7AH11V&)C)\HGLO7MD4S\HK M(Z>^*>0HV0"PF@-7VT&/?DUB]ZQN3N*7(T;R["%6+'C8R;B&1RKP2<)(4K:7 MA(V&\>PW'#Z27..=$]SC- W8^X$U*,];SB".:.!5PTBEV4RBB$[JX8)(0#F0 M>:QD82>&#(Y3H&-T44[87@09"V'U][.YV'T;1UN<),2DG> #-ESUUG<"&GS: M@5:L@VMZP%\0;Q*\]UI+@3ZB#&"LD8\-F[LP6[$L*F"+Q\@&Z,U6G[&HFU*4 M6P%UQ 98U0R@T&0FH[]*XN%&?C>G;F?0'Q2> %6@:6^L'P.8JP?6/RA\PI[O MF$4&1=,9A <=P&J,J+:;2:#0BCU%'C$,)!\N MS3CD7+(E<4NQ9$S<^8)'AM;^)L>82%6_Z_#Q9ITD1VHIJ[\?_?14 _6LX0RB MC!I<-<"46\TDMFB$'BZL^((!.Q2>GNQ$DJ%1"FR2+.)T[<6/D?!5?CL[]]5" MH@&9Z&26I9A.Q?6^@SM=1#=5AWZ#K3'*!-D@@W3"0)4JPO(#M M"\F12T7_;W@4?XI?4L8F61H@N_XNN2'&SE)@MJ6-,UMD)CA\W);31'H4EQAB M+' 4GM1F']VF4TD-D7T7"J7S<_:PYXV?#V0MU1S<]QF0B?DNP MU3S\K6L+W'1K(9X]S%AM"-AM]:WG9J/Z!ZPU M3>=DIP,]5ZVRU!YO5&MF20\OT<-3=$Q("O+P0C*/TR846X9K\K.&]+T9REKY MHF8G D!-M;LRLAE3J][09TW=P'0O'.$G:,]H(?8^0,)6\8FYOA,;S72IG[-% M!\)DXLG2Q-IXB9!DAS@_1!B*(P4H8RF"@I4G3BVHA5F#4@?#C=U)G!;&;?*O M?,PF__C;@Y_2_'D=>OZS[QV=0)%/UK4#&OP:H=$8IVT$<&QNEK6S;U*J=):3 MTQT\@6QKA+_ZZ=,=YB_')4_^X2%:L1)GRF2R&X4Y&:Z9.K0F7=]]+L9NB&)0 M-^B1G79RA-47[+(7$47E(6626ML0L%G7@Y/6JVX%U$@;A.UJBQG9K$*6G91H M2HAV"DN\.+'W0!C4K*)5VP#UL%I(I2H1Q08 _:I>SLY;-I0:HN1LKHZQEW(O MB$#T#C?=*F&CV9*>IMFQ\BK)Q2EO<^NPPJM,]%P;H4_0 M- 5LX$T2=[71 ETDGDFWD\J-#O3^LYU]_8_T)"K&][0 >U*3QJG: ?EF[FIV@B#A)FZE="5MM9J9N.2=;U.=%BF9SL<>!LI*J1=K,3,Y3 MLCQC6XE'(6J3E58$@%MP>V6H$_ZFWH#MO0.(SL>G**O7C!<2S%"!VP))?I;S MH0E5(LG9R9/$RVAJ"]S#:R$JWLTM-P3LM_7R=KZE*-^] MY<<;?Z.4$2-MR1?'@7G_L+G\RY\WUU>KN_MOT>K?/J\?_FK% Z7_W_-'G=1K M*C?TM?@DQ7SA)&''JXO?T_M\-U'Z5YS>83?:A?X_L*=1YYC\@$>"T55=C":C M,0,-0G'IE4B(FU8#=XR:JOGF/4[V MP;QYQ5'V7[^048S>>V0ZTDU/!F;QM4;.&H4.$C(5]+_&6%D'TV*0Y ?PA%PB M/MK*44'I5JKDH%1)C[O-1$!Z2]#9XS%.'CO@:'D!#X:@J'20)4S'X&K.P6IQ#G)-J3L,N5&F8F(%QP?*9 MZLRFJ*-H]^;("G!4)Z<^XS)@7J9&34.\]\'QXU]H&7#5R#VAH:@T]2]9, M.D'/V5IAZ%^ ,^%>+M95>.WX+>'#:\Q/G,--@ET;&AD?1!DAQLE"2C?-C[_; MQ7A'?VCVJU=_\R%?UV31D1V\NV?U.CT>*3Z!%.[814KT]I)+4'C[:/3IF/D^Z26]'AUH5Z#& MX@$T)HVJTH8I87<&T-.VT?#V2?CR]9)R8L2SORM>N/?AR4GE44 I!83IIT7= M,6ZH817O0JSB(<4JGCQPDBD4K>VLXP'6[_DADY@/:_35._I.W3:*M]A/C[&= M<_/Y:P1&!R:7 1.#_+795H]$LE?;S-ZF&)87T"%H$A6KW\,8D!'@A'IN+WM1VF)\Q#U0(I\:W]T$_2V*&5W4V&5=.^P/VSE0I* M]1)-.@+VW7;R=ZZIR+FP\:;,!\AX.[T:G!(?N'5"&E>*KAMJT0W/!7@L&4FM MK4MYF+, ')_&0FIQ1?/:=ID^<#IE9PW.-]_LO"C#<6-/K1;Q\VHT:]P9> AK MIX32XS1&/0$'G)8 QHXCMJ[C3J0&5F7&BI]GI[R728+3A&1^U[[SZ =^ZM,W M%9SD&&-O$Y+0=XQCOA1S$]'"-/R?1"-^[0;OD/2!1XO!55D,*(,1!QQSAL?8 MU1_S.QD+E+%CJ4R1H=5=V4Q9%Z?LSS_[9%X5NT^G:_R,52_@MNX\%Y>.L/S%YGYNAEG$!78\^%P1M?N[;6G,Q1G:J$3I$R8$ MYN :K7",XR$VMX@SR.OP<"0S51H4?JA=QJ[O,1?[U\-56OMY\SG8=HW40V0] MG/P",0;H!\OKTJ.C9A=1Z;E<@7>V<[&F9>BA>?UYA3ZMEO>?[U:?5CO7O*F"49O M1G,(FJ/@'2)X%@1CUUE14321!**R<,45,2;>(HN[IQ'KF/ :E"L2%V>G<"(T M5=:C$[#WDQW^6!EQ2I; HA_>+A ->R.J[3YUXG1^BKO .S\,SW7W_YSPZ,0G M]$ZM.-#CDD9A'QT_O(Z29!VZP=&C5PY%A<7&1'X"_E_I^-7YIQAB3&O-_"L< MY[KK .#8MT!4;O2*2OX=DK+3.H8K30G3B6<6X'^Z[T\UMBVMR1"IZ,%\ M^CN1/Q/?P[&]@S&9.LOZ.=-F69EGZLNN$VVV_(+1ZDN*"3;2_=I/TJ;?>_Y9C0*CSN1=BRLQET<4S\$"?)TOW[T4_\AAO<^M; (T,#S*(K M:YH"]KTFB3O/LP1=5"!L!EE=#4S:#7,VN0NGM5 M,C]!>[[@EZ1.Z"7L^5'&[5)PHWG#Q.5H1T)[!LO2^8%),5H9*B^=Y$D36<57 M0".)"D!Q3*.? QZV2N)U7O @1.PL"HTF?H]1DZXC1<>4U\@3P[-W<:)3*R<\ MJ3R[L0=0VV\!-QM-ZYM#'U4-I>__/@KFC&2A=T>PHD_/T-**+F*T+=.OKW<'0-9Q./JN#484BVFE7T.1.Z M>PWUPAX%-3@:>U!ND#:#S& @*[&%8K;U5LVX $40.3C#OTI3$KSV'2UMR]D$ M#OU;6>IFLPH=PSV)5#YT#BQX# >S$CVL/G4U,D01/T9YUHKN2.T/QQ3GCW+Q M%U@S/"K 1KT@!Q9SV%F0:>X"/>"T0-#59',6E8,6Y>[B'+B4JO;8A4&W MV1FX&GB]@9?[S,K -:*/8^ V:R+B,UBMJS"I1NS4L71= M6FZ4WFW /COE6^OB-W43T%)U2DU;P+[;*')7XY2$44[9LE-."15(FGEZ M(.S:3:$*/8![I@'T(W9#';)H.N[0#9J0\D[&[:;;0F0,M=I:@O8\!HA2OO3-@1JALWR]K?&X6_0U:['JEL M-:X:.-FI%5 KJ(TG5 9>'=3OBCN6ZZ\LN?Y0^'(@$%Q_ M>%0#NOY#=/C@/^-L<5P? ;0M(0>">GA9/% W@QX6&J0>(CK$^$!$IX^VL0A! M."+*,@L54]],&POR&2Z;@6,RD /'$:(&PSBB; D]CNCAE>+(>;,YQ)$:J<>* M(X2EU3@R!N0S7+;CR"0@89S[NVYX;Z^V ]#@8PZV]M#?]0R>M3,0NG/FO+FY M7-T\W"T?UIN;^W%"3?,AJ*GPP?#&6QS3#YP=?F>JD'*7N7FD G"M3Q;:S\DK M56(/=Q1W@7+Z0-QT/, Q/9GYRDF0@PZ6?#=)-]N/4>0EMW'D'=V4AJ;Z MD\?U7<#[;C/@LN_JVX/V70.QNYMRPA[>8.398Z[W.'[V74QP+W:$';1L1NZ /9M4\F[FK*D#^\R@1WD M=N:XK-[4!1'+8Q&+OS2-]X<@.F$L0FOR$#MAXKA4RHN3E+[F!F=OHM#CP"!* M*X6)7A0A1Y%A@/5V-8O71]NJ0,I<>\.T-]&OS,742NOC8F6*7Y&+:8#U=['A M;X9(VOJ]GK,60.VZ!DZVMU/^&OJ>CD;:@4^,9-8U]'E7F)OMV8L2$/> M#)%$:VZ&G#>9@\_K;H94OI^+UX]\,R2SK:EOA@R-+P<"P?.'1S6"Z]?<##EO M,@?7U]T,J7P_%]#ZPZ,:P?5K;H:<-YF#Z^MNAE2^ MGXOKCWPS)+.MJ6^&#(TO!P+!]8='-8+KU]P,.6\R!]?7W0RI?#\7UQ_Y9DAF M6U/?#!D:7PX$@NL/CVH$U__0[/H?9N7Z'QI<_\.\7+\J[EBN_\&2ZP^%+P<" MP?6'1S6"ZW]L=OV/LW+]CPVN_W%>KE\5MZL1-7C^1TN>/Q2\' @$SQ\>U;#7 MN.[I$P&2>/T]+DU3R)&@ 6#Q)I>J'?3(T"3VP,D!O0K$^&7!PL)%KG$ GR.S M?)5K*IA%='_\/I?DFOQ%/I0?"1+_\O\!4$L#!!0 ( $J ;E5)U<=MS2L M "80 P 5 :V)N="TR,#(R,#DS,%]P&UL[7U9<^,XEN[[C;C_0>/[ M,#T1XTPO\J**JIF093E;T;:DD>2J[GG)H$E89B=%JKDXK?KU%^ BB2)6KB#D MF)Y*60) GO-]. .#@Y^_>^/E=5Y!ZYG.O9O)^=?SDXZP-8=P[27OYT$WJGF MZ:9Y\M__]7__SZ__=GKZ][O98\=P]& %;+^CNT#S@='Y:?IOG86S7FMVYPFX MKFE9G3O7-):@TSD_^P(;_7+9.3V-V[C3/%C'L3MA8Q=?SK>_#.+V'/N7SOGY MU_/NUXNSBXO.U2\7M[]<7G6F3]N23_ %7TUV4+Q^> M^=O)F^^O?_GZ]>?/GU]^7GYQW"6L?W;^]>]/CW/]#:RT4]/V?,W6P4D'EO_% M"[]\='3-#_6T5_WCQ;62!BZ_;I]%+('^.DV*G:*O3L\O3B_/OWQXQDG\BNAG MCH[W>U_#7$ZB]3N=7U[' #+QVPN]^\3=K\-N) M9Z[6%FHK_.[-!:^_G?QXL?U3A,!9[_(,2?+_[F.2)/_V;6-H^Z:_&=FOCKL* M]7C20>T_ST:I=_D1O)BPPA?=67U%OW_E:RH4C4MI7XO*-O:192]OP- -_C%%&H13DEG6HN+/<&?%/7K/+%/FA>&AUL?_4F MKY,U<$,VE@,[J6DI91^\:?82>"-[[COZCS?',N"8,OQ7 +MIZ(9C@^MK)IP* /0WG%>:4**I"SPHB= $H\HW M:$23SF%!-#AFPIKA=%:(Q(^.O;RT7P'1M_SX/0 M:O^;XQ@_X=)#6#Q:4XW(!I7L!L 8?JQ1WT4O-($]TQT$+NJCCZ;V8EJFGP=) M@9:;X6W>R0.]B49D>=!,]W?-"L 3T-#?R.(*2X-OI!%YX!"BPZ>+S7#)U>6S MB]78QX;M)/7=%MJ+5;:\29MR6\Z+ZS0L/*_K=Y52#4M@32 MSX/UVC*KD9[1MK#TZST7Y2/\,189O4,I>[%[2@4?/K -8&R_-7WTD+.SL]Y9 MY[23-+3_4;.-3M1J)]\6;R@D%--R]-2[6&@#WW'3"*/F/-A>V)8']"]+Y_VK M O(<^#%#FS0L<8FO MZW"+X51_,ZTM&UY=9Y716_PD)\?;.RX<%G\[.3_I!!Y\)V<=&3BT+ O&K>2RA:X)TN-6T=H0,LWTN^V<$4?_%]N^$2#==HD'9LM/_2_S"] M [RXZD@#G# ^.VCS"RHEQ@=O?^^L--,F8(LMFQ;ULGO;.VL&T_S 9,'EEY0( M:LTXQDMB-*-^ JL7X!(PS)23#C]^W6=QXY..TA'!*X#K3>,Q4AI1FE 4'RYD M0%BR=K3_T%Q7LWTJTJDR2J',EBQ&^$(.A'--BN#T%HR@(3L<:%G%I4&ZP!B; M2\8*,"]K8.8GP *V2 $<_2P[P'24\" 3Y>*8,YW7!,W_!)H+R6%M9F#MN(=+ M*$I)%0'C$9'2(1/L+NOJ5G"\\$(G%!.\PZ(JHLX(BIAQ25;#--5XS#-P-)$_BO; M'VLK7-_"%4N+U(73M_.6P\4A7PS9=>.0C6S=<:'9#D4-O1T#M%/NPM6404:0 M6DL]0,7%C?&]:1S?A?8Q,J#\82!$&,E--Z.$\NIA*B)HC.9MXVCV#0.JVHO_ M04*?$Y'$E%4/15XA8P1[$B)X(8#@Q3$@B!3>C0^%4! ^**PLCCYP)EC173-4>SM1+3QW/ MUZS_-=?4*2NNL+(XLJ5,4&S2(X.,1M\%&@&W_9_3,EQU>^?=UB+%E"O!IDF_ M"TKS84W?')OL=SDLHA)&7+(E.#7I>)D#/4!/.K]X6:"@,@Q.AT54PHE+M@2G M)KTM"U=#Z83FF]6+8V% 2OVN$D)LP1)XFG26)#P:?NAAL@B"_Q)73"6PN.5+ M,&O>)1*?Z8CVGA#1H*X#7)P#K;A*& K+F6#9O'-D9/L 1;^:[^!>\[58!HH7 M&E= ECSGI'Y2K.L)/<+ M$;!4J;1$UW!EV7; V.(E@-'<'_4 -EP!=PE-^S?7^>F_H>A'S2;W-&QI]0#D M%S,!LDD/2/S.'[L8FB@H@XQBIJB"$/+)F.#7?'3*_ U8%JO_[1=2#S.F= E: MS0>I[(7UAX?^O4G@H]2P:)5*7C90*JF'IK"T";K-Q[,, #H9:HUL WS\#9"[ MXT$Y!3'D$#"!K4G/2[R:>3 ]7;/^ 327')E)*IJ6[0;JI+W;.$(R)O@UZ85) MY-V]\0/\AG;0Y*"D2NB)B)B UZ3;)?V^T62+#[Z]LNH"R!(RB6IOTMO2AZ]K MA*]L:;CY2^IWE:!B"Y; P^5;^?7K83Z(@EDBQ-+9[ZF:F"SB_ PEB]BV"S]O MF^[LM]V)&^\()\MO*"7 Y/7!M.$;F[#+.='"CY!<0JQJS0=IXRQ;]#=/%TKS M]K;;N[R6Y, [!R;[QV@YQ)(R94'TWO&LBPNZ@[+2(/YI(RHJ3)II?2Z/11"WSK8V2*5-060!.=(2]2IGAK(4F2AY#]IXZQN[T8) M:+BREQ,P',N\U:6C1=[=@D("*S;)V],%WS8$N8)T_"B$,Y4V/))7L561O0H! M?;/U?TVU#7)Z;:\JP"[K.6K(C"2/ZG?8Y16VTJV&8JDBB[B38PV@4Y& SXF, MJ:$.._(**]<80#8*Z!:JQ+6955+X]>)-L\,37L#S8_$)]B)?8^J0I0(]5.I7 MJ-_*)&NI^-(_NH'!%TZIJ7?6[=VVE2XYY*S4HU"_FVGL^" QJ70N8$JJ1P1> M(17S-V3UQKVP4(\#G#(JYI](3K0.G-4+7*!]J%)_JF5#<.,0UTL]F M[-@ZE2V%VI296&6L5,M73J4SWOJ')G0U[0*XJWV;3#)+F**J\X=;YDHGL(V. M5>Q!2GD2,$0M:[8JR2"%3IV:_@I$861;5DS7RQ1KIJ(QXS>.E0#[1P IJ1TU!#$$A=CP2=DI=[W^EFPE]" >A3D MH)AZ^'-)*)=SO?C6R_;*^*EF&B-[H*U-7R,%U1%*JT<%$4$56V7,T)WQ-C"& MFFO#:9/7U_5@%5CH[.P]>#5UDS2+8%=4CR7G.X"[IZ%&=%X-??LK]6252I\F<#],0AS?@F_IN+L), '&5 M)P%$YR^IA_W'R6="B"86GQ"$B1N^IQ'.O:? #;.K<:U'294/>D\7_MGTX)(O M)+2 N(J=2D]K(DK UP_\-_A"?^Z, I4MAY4490F7F(JM9G$:&'E>(,2,J(+2 MK*"(J-AJ%B<].:6UX2)5A" M4JX4+Y$7-3NXMK]ZD]?).@YPY,UN>L&;W73WE([SVDD]1TZWULB&^@/;UV9X MLHBE:]\D"X]+/,#^@<*+T#O\8?IO@\#SX?NY\#6CA"SHE#?\G['0/HB[9L(M M26<8&!BF-\S*$5UEG/&+E2B76+[-W! 3JB37U3MP7QPI.# 'EH68 M;QM/FOL#["F"Y-8G5I".!6+08C95Q415S#J@"51@FWHTE$,E[&6%7P#]S78L M9TG:8N6KK!QC"HBMF%/\&["A*BVH@KZQ,FT3J1%=ETDW+HQ:RO$EC[R*)5X; MK=::Z48+O,,L@]QY&$7:4(Y$Q:67ZY U*7<#$F@GZP NZI?XO RX@LJ@+BAB M2;YPTH2U?GN1$'DG_:.3N1V77CBMJ&ZW=]ZPV[/P,,(O9J5N\+*Z.GK[,*N( M9DWL9)6>K-QQ79Y:01FXPE&]@-W-* O[9R?"A#?L6\C6%GR.J5-(/$EU:. M*'GD56PR052AZ/0RK:RKYBYT+IL<8A(K=M)T#'SF>C-51CH:B*PNF((HAFYR MD#Z)*K_3/%,GH(PMVV:T^062RW=<.NKWIA7XQ!!J0FF5D*>)I)@3^0]@+M^@ MK'VX>-&68!RL7H [>9)<4$KC:V6ACUQ_^$-PQ=L14$&"8D: MR"8G,F$$[%_F"]B/']PQ[<[^H_^]LWVXG%'\>T=#7AS>75] 9]\V[NZN>AVSQI(1%F8P,!4YN$:5$=^^TV1- @QLE+CI5 M3EX4N0')@LHG94GQ\NGM!SDR65(Y0*VC)!_$):X@&K[AC)942N +*\D% 5$K MV'NJV\64UM.]LX*RDQQ,N+)*4H!?4N(F4U.3-[CT R/XD3ECVQ:4%\%8JI_5C>R=1? =>T]B/[%+NJ#@..Z%")Z'XW@Q 5#PX<,R!^V[J(-+M#.C.TC8I=*WI MZ4="\2:U66E(G306.1JG]I25+,M(#GOA=HZ$JN7H)?'V<71\0[4<4DQ%,E02>M.TX#5W_3D.+WFO>Q8Z8-?&VZ"K.7!7 MTF;C-Q<.E%/7T0$P/'3K2[+C/D+.,,V:!B^6J4]>(L @! MM=U7+$'H"L(UZ[Z[5=O$MB.^;LQ>XF)B6,7;3XE<$E:24J[Y443SWAXLYR?O MQ6G=G.>PX6,ZR7.D'P&V2N$W_)@J]2\QT4M (_=N0N3N-L\0DY&]S:W;UWWS M'1H[YEU8X@W);!&(6!XL0\L06;%KDJ Z7DW:'02[ M(QH"1$,6,&76;%*)#: MPD5[KG"0M$#*:[-PRC$[53SJ>&A9F_8J/0=7?XA=J X/BO#@N/=.\.*_!E9? MUYW )L^+*56D(UQMO,!:2C$]*68[&[W^ZQI.U7NIG#['1;[BBJLXA;A\=X<= M*V4$M5/2 2EEKQT[5AKET%!)9Z'DH=(]@&^NFR'2\+,%0LAMH[]R7-_\DQ8I MSE/UDV8EZ*L59ZJ:N!CC6!E5ALJ*'KQB7+]3OR6; :@[4P^]Y8[^@WYC K[P M)[=R:4BNLU2D,Y][H;E32[/Q_* 5_61'#OV4=-B)-&&ZE" -TU:;\0$9AM>4 MOP'I"%>9+[2@3BK-@-'$78*'VDB<<+"3 _.=DGN9IZITM"J(/@^=.+50\9V$ M,E$)+CS"&[9V&B$Y$(3:2*OU'';X[M&0BU<=1?V4TDV]LRJ9NF"MF<9]+$]R MR5>L(.KQC'R-'2/OOK2YW MRE!$I>F?9)B_'VACX6J&^/1JO[*Z?"I!#Y4Z,R698+D!E,+47DPK6@S%%GFK M]+W?1(@FT.R14K"HABK-1B4#.9/;N.-N"A?TW 3,5CU&DG%J02Z7: 5$2B:= M,_ .[$Q61>YZQT@A'A4H=D=\S:H":AE;:WZ!=4Q^N3M"!QS4JPDLI8@-'S"TQG53L?)=Y "P\ M\!T/R0KJI*P-:;GG6-LCV$7G6)2&I*-<27,L49$K#7&X:N(0US:Q0WP=19(O MD7*(BUA%.I:4A#IF]!/50B47VS9\QGFK 9&,ILQZQTDB?E4H=HYT!M;;9"+W MX(4T9!T62ZOFLGM[>ZLH2[@DKSB4H*S3"5M9DL0QP+B'2P<=UD>;1*^OI@[< MD>T%+OIMZH*5&63N52W0DOJL*5LY1<,.I N2FJ8Z$^V*,XX:ZO,IKQ**QA

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�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end